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Abstract 
 
Intraosseous transcutaneous amputation prostheses (ITAP) provide an alternative method 
of attaching artificial limbs for amputees. Conventional stump-socket devices are 
associated with soft tissue complications including pressure sores, neuroma formation and 
tissue necrosis. ITAP overcomes these problems by attaching the articial limb 
transcutaneously to the skeleton. In order for ITAP to be successful, it requires an 
infection-resistant transcutaneous barrier at the skin-implant interface. 
 
Fibronectin (Fn) and Laminin 332 (Ln), are glycoproteins found abundantly in the 
extracellular matrix. Dual coating proteins 125 I-Fn + Ln and 125 I-Ln +Fn were covalently 
bonded to Ti6Al4V through silanization. The hypothesis tested was: silanized dual 
coating protein coatings with fibronectin and laminin, enhances both keratinocyte 
and fibroblast spreading and increases vinculin focal adhesion plaques on Ti6Al4V 
in vitro. Both remained stable when immersed in foetal calf serum compared with 
adsorbed dual coating proteins at all time points up to 72 hours (p<0.05). There was non-
competitive binding of laminin on Ti6Al4V in the presence of fibronectin. 
 
Keratinocytes and fibroblasts were grown on Ti6Al4V surfaces with single coating Fn, Ln, 
and dual coating FnLn on adsorbed, silanized with passivation and silanized without 
passivation discs. Vinculin focal adhesion markers and cell size were quantified. Silanized 
dual coating proteins without passivation (SiFnLn-) produced the largest number of 
vinculin markers and biggest cell size at all time points upt to 24 hours (p<0.05).  
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Hydroxyapatite (HA) is a naturally occurring osteoinductive mineral in the body.  
125 I-Fn coated on HA discs was assessed for optimal time for loading, concentration and 
durability. Fibroblasts were grown on polished, HA and Fn coated HA discs. Vinculin 
markers and cell size were quantified. Fn coated HA discs increased fibroblast attachment 
compared to uncoated controls of Ti6Al4V discs and HA discs (p<0.05). 
 
My thesis demonstrated silanized without passivation dual coating proteins FnLn produced 
more viculin markers per cell unit and per cell area when compared to uncoated controls 
and single coating proteins on adsorbed and silanized, passivated discs. Further research 
is required to establish whether dual coating proteins will produce the same effect in vivo. 
This can be achieved by silanizing ITAP with dual coating FnLn and implanting them in 
animals. Histopathological analysis at the skin-implant interface would provide valuable 
information whether this biochemical and physical modification improve soft tissue 
integration to percutaneous implants. 
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1.1 Background, Objectives and Aims of this Thesis 
The aim of this thesis is to explore the behaviour of skin keratinocytes and dermal 
fibroblasts in the presence of dual coating proteins; fibronectin (Fn) and laminin (Ln) on 
titanium alloy (Ti6Al4V).  The hypothesis tested was silanized non-passivated dual coating 
protein coatings provides a superior surface for cell spreading and provides more focal 
adhesion vinculin markers This provides a  bio- and physicochemical modified Ti6Al4V 
surface that promotes cell spreading, which can be applied to the design of percutaneous 
medical devices. 
 
Intraosseous Transcutaneous Amputation Prosthesis (ITAP) is an implant that breaches 
the skin barrier. For it to be successful, it requires a tight skin-implant seal, which prevents 
wound down-growth and marsipulization that leads to infection and ultimate failure of the 
implant.  
 
The objectives are to: 
1. Assess the release kinetics of dual coating radio-labeled Fn and Ln coated on the 
surface of Ti6Al4V soaked in fetal calf serum (FCS). 
2.  Perform cell bioassay to assess the influence of a Ti6Al4V- dual coating protein 
fibronectin and laminin (FnLn) on keratinocyte attachment though vinculin 
attachment markers. 
3. Compare fibroblast attachment on silanized dual coating protein FnLn to adsorbed 
dual coating FnLn, adsorbed and silanized single coating Fn and Ln on Ti6Al4V 
alloy. 
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The hypothesis was: silanized dual coating protein coatings with fibronectin and 
laminin, enhances both keratinocyte and fibroblast spreading and vinculin markers 
on Ti6Al4V in vitro by modifying the surface both physically and biochemically. 
1.2 Amputation 
Amputation comes from the Latin word amputare, "to cut away". It has been present with 
human civilization for thousands of years and remains of prosthetic limbs have been found 
in preserved human Egyptian mummies.  
 
Removal of a body extremity could be done as a result of congenital deformity, trauma, 
infection or prolonged vasoconstriction. Nowadays, the main indications for amputation are 
to relieve intractable pain symptoms and/or to preserve life eg. Gangrene and cancer. In 
few countries, amputation is implemented as a punishment for criminal actions.  
 
1.2.1 Limb amputation 
Amputation of the lower limb is ablation of a leg from below the pelvis at any level. Starting 
from bottom to top, these include digit amputations, partial foot amputations (Ray, Lisfranc 
or Chopart’s amputations)  and ankle disarticulation.  
 
In a similar way, amputations of the upper limb include amputation of digits, metacarpal 
amputation, wrist disarticulation, forearm amputation (trans-radial), elbow disarticulation, 
above-elbow amputation (trans-humeral), shoulder disarticulation and forequarter 
amputation.  
 
(a) (b) 
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The amputation rate in the UK is 5·1 per 100 000 population in major limbs and this figure 
has not changed from 2003 to 2008 (Moxey et al., 2010). The number of lower limb 
amputations referrals for prosthesis across the UK was 4957 between April 2006 and 
March 2007. In the United States, there was 1.6 million people with one limb in 2005 with 1 
in 190 individuals affected (Ziegler-Graham et al., 2008).  
 
1.2.2 Amputation Prostheses 
Once amputation is established, prosthesis is required for both cosmetic and functional 
purposes. Prosthesis comes from the Greek word prostithenai meaning “to add” or “to put”. 
It is an artificial extension that replaces a missing part.  
During the 1980s, advances in lower limb prostheses technology led to the invention of  
the Sabolich socket for below knee amputees (Sabolich and Guth, 1986). The design held 
the patient’s limb like a glove, locking it and distributing the weight evenly over the  stump. 
The main advantage was to snugly fit the patient’s remaining limb allowing rotational 
stability and comfort. This enabled patients with above knee amputations to walk with a 
more normal gait, run, step over, step and walk down stairs. On the other hand, despite 
advances in using thermoplastic and gel liners to accommodate for the prostheses, there 
remained a large element of skin irritation and need to re-adjust the socket due to changes 
in stump size. 
 
In 1999, microprocessor-controlled prosthetic knees became available. This made walking 
feel and look more natural. These prostheses used hydraulic and pneumatic controls and 
a microprocessor that provided a gait more responsive to change in walking speeds. The 
hydraulic cylinders controlled knee flexion while moment sensors in the prosthetic limb 
sent signals to the microprocessor, which in turn sent signals to the hydraulic controls 
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about the resistance that needed to be supplied. The leg had a knee-angle sensor to 
measure the angular position and velocity of the flexing joint. The main disadvantage was 
that it was prone to water damage. It had a learning curve, taking months to accustom to 
the amputee’s gait, during which the patient was susceptible to increased falls and injury. 
In addition to this, the patient must possess a satisfactory cardiovascular and pulmonary 
health.  
 
Robotic prostheses have biosensors that detect signals from the amputee’s 
neuromuscular system. These implants utilise surface electromyography (EMG) signals 
detected by electrodes from normal muscle contraction. A controller in the prosthesis 
analyzes this information and initiates movement through a motor that mimics the actions 
of a muscle. In 2003, Jesse Sullivan became the first person to be implanted with this 
bionic prosthesis. He was an electrician who lost both his arms getting electrocuted. 
Surgeons reconnected nerves in his arm stump to his chest muscles in a procedure called 
targeted muscle re-innervation. Surface electrodes were then attached to his chest 
muscles. He was taught to move his prosthetic limb by contracting his chest muscles 
(Miller et al., 2008). 
 
1.3 Intraosseous Transcutaneous Amputation Prosthesis 
(ITAP) 
Intraosseous Transcutaneous Amputation Prosthesis (ITAP) is an amputation device that 
fixes residual long bone of an amputee to an external prosthetic limb. It overcomes 
problems of conventional stump-socket prostheses; pressure sores, infection, uneven 
distribution of forces at stump and neuroma formation, through transferring forces normally 
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encountered by stump-soft tissues directly to the skeleton. It is currently under 
development at the Centre of Biomedical Engineering, Stanmore, UK.  
 
                                
Figure 1.1: Picture of ITAP patient (http://www.dailymail.co.uk/health/article-
1092793/Survivor-7-7-bombings-fitted-clip-arm-fuse-skin.html) 
  
ITAP is formed of a Ti6Al4V rod with a flange, where the proximal end is implanted in the 
medullary canal of a long bone and the distal end penetrates the skin providing an anchor 
to which prosthesis may attach. It depends on the concept of osseointegration at the 
proximal end and a tight seal at the skin-implant interface for its success (Figure 1.1).  
 
In 1974, G. Winter at the Centre of Biomedical Engineering, UK published results from 
experiments looking at percutaneous implants penetrating porcine skin with a view at 
providing an artificial limb that attaches directly to the skeleton (Winter, 1974). He provided 
good results to overcome wound down growth and marsupialisation by penetrating skin 
with porous polytetraflurethylene implants of 10µm diameter and hydrogen sponge of 40 
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µm pores. He found the implants became invaded with fibrous tissue and this prevented 
epidermal down-growth and subsequent infection.  
 
It was not until 2006 where work in the same Centre, identified deer antlers as natural 
analogues of ITAP (Pendegrass et al., 2006). They studied deer antlers’ morphology to 
determine whether there was a difference in pore size and frequency between antlers and 
the pedicle bone structures. During the growth phase of deer antlers, a velvet hairy skin 
covers the antler which is abundant in blood supply. As the deer matures and androgen 
levels increase, the velvet layer is shed and the antler is left exposed during the mating 
season. The presence of a subcutaneous pedicle, which is a living bone that undergoes 
continuous bone remodeling, and attaches to the skin with sufficient strength that prevents 
wound down-growth and infection.This aided in the development of ITAP by implementing 
design modifications to mimic deer antlers through providing a flange with pores, coated 
with hydroxyapatite at the skin penetrating section of the implant. There was a significant 
decrease in down-growth using these implants, compared with the straight implants 
(Pendegrass et al., 2006). However, consistent epithelial attachment was not observed 
and further studies were needed to provide a tight seal around the implant. 
 
In 2008, Pendegrass et al., demonstrated that changing the surface topography of Ti6Al4V 
affects in vitro cell attachment. Attachment is measured by calculating the required force to 
displace cells from the surface using atom force microscopy. They compared smooth 
polished, machine finished, sand blasted and acid etched surfaces. They assessed 
proliferation of keratinocytes on these surfaces using immunofluorescent microscopy. Cell 
morphology was studied on each surface using scanning electron microscope and cell 
attachment via vinculin; BP 180 and 6 integrin antibodies were assessed. They found a 
positive linear correlation between cell attachment and number of vinculin markers 
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produced. They concluded smooth polished discs provided significantly greater numbers 
of focal adhesion markers than other surfaces at all time points. They suggested up-
regulation of intracellular signalling pathways required for focal adhesion and assembly of 
hemidesmosomes, may be lacking in surfaces with greater roughness. This is achieved 
via ﬂattened, spread and well attached cells with high proliferative capacity compared with 
rounder and more loosely adhered phenotype.(Pendegrass et al., 2008).  
 
Further research was conducted to determine the effect of extracellular matrix 
components, such as fibronectin, that have a role in regulating assembly of focal 
adhesions. RGD sequences present on module III of the fibronectin provide attachment 
sites for transmembrane integrin linkers. These in turn provide attachment arms for actin 
myoskeleton with the aid of vinculin, talin and pixillin. Adsorbed fibronectin enhanced 
fibroblast activity and adhesion via focal contacts in vitro (Dean et al., 1995, Gallant et al., 
2005). However, in vivo studies (Pendegrass et al., 2006) histologically assessed the 
percentage of soft-tissue contact area and cell alignment to the plate. They concluded 
adsorbed fibronectin does not affect dermal attachment around ITAP implants. This was 
because of lost adsorbed fibronectin during implantation and competitive binding from 
other serum proteins. In 2007, Middleton et al., investigated the effect of covalently 
bonding fibronectin to Ti6Al4V surfaces via silanization in vitro. Silanized fibronectin to 
Ti6Al4V was durable when soaked in protein-rich fluid compared with adsorbed fibronectin 
and increased early fibroblast adhesion and spreading. They also showed that silanized 
fibronectin did not affect cell metabolism. 
 
Keratinoctyes have shown to adhere more rapidly in the presence of laminin, a 
glycoprotein present abundantly in the basement membrane (Fleischmajer et al., 1998). 
They measured integrins present on the keratinocytes using immunofluorescent 
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microscopy, and measured total RNA of keratinocytes using Northern Blot. In 2010, 
Gordon et al. investigated the effect of silanized laminin to titanium alloy, on keratinocyte 
attachment in vitro. They quantified focal adhesions through immunostaining vinculin 
markers by fluorescent antibody. Their results showed a significant increase in the 
numbers of vinculin plaques compared with non-treated Ti6Al4V control discs or with 
adsorbed laminin surfaces.  
 
In epithelial cells, there are two main types of cell-cell attachments, adherens junctions 
and desmosomes (Lozano & Cano, 1998). In adherens junctions, transmembrane protein 
E-cadherin, binds to , , and -catenins, which link the complex to actin cytoskeleton. 
This complex maintains a tight seal epithelium and prevents epithelial down growth 
(Hodivala and Watt, 1994). Further research by adsorbing E-cadherins to Ti6Al4V to form 
cell-cell attachments at the implant interface showed promising results in vitro 
(Pendegrass et al., 2012). They demonstrated that adsorbed E-cadherin on Ti6Al4V discs 
significantly increased metabolic activity, cell area and vinculin markers in keratinocytes in 
vitro at 24, 48 and 72 hours. In an attempt to enhance fibroblast attachment at the cell-
implant interface, fibronectin coated hydroxyapatite discs showed significantly better 
attachment than hydroxyappatite discs alone or Ti6Al4V controls at 1, 4 and 24 hours 
(Pendegrass et al., 2012). 
 
In 2011, ITAP was used clinically in the limbs of 4 dogs with malignant neoplasia of distal 
limbs for limb salvage. Owners and veterinarians assessed functional outcomes, in 
addition radiographic and histological examinations were conducted. Dermal integration of 
ITAP was achieved at 3 weeks (based on clinical inspection and palpation of the skin-
iplant interface) and dogs were walking pain-free at 8 weeks.  ITAP fracture occurred in 1 
dog at 10 weeks and an ITAP replacement was done. ITAP-limb interface showed both 
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osseous and dermal integration at 1 year. Results and information from this study paved 
the way for using ITAP in humans, namely on an amputated humerus in a survivor of the 
7/7 London terrorist attack  
 
1.4 Osseointegration 
Osseointegration is the direct integration of artificial implants to living bone. It is defined as 
a “direct structural and functional connection between ordered living bone and the surface 
of a load-carrying implant” (Branemark, 1977). An implant is considered osseointegrated 
when there is no progressive relative movement between the implant and the bone with 
which it has direct contact. This can be measured indirectly via histologically examination 
to determine the bone integration with implant. The theory relies on an anchorage 
mechanism whereby the living bone is incorporated in the implant, so the anchorage can 
persist under all conditions of loading. In terms of amputation prostheses the concept of 
osseointegration refers to the bone integration of an implant that is used to attach an 
external prosthetic device such as an artificial arm or leg.  This method provides better 
muscle control of the prosthesis, allowing ability to use for extended periods of time and for 
trans-femoral amputees to drive. 
 
In the 1960’s, Professor Per-Ingvar Branemark found titanium screws used for 
implantation in rabbits’ bones were difficult to remove (Branemark et al., 1969). He 
investigated usage of titanium implants in dental tentures. Although his work was initially 
directed to mandibular reconstruction for malignancy and trauma (Branemark et al. 1975), 
he later extended it to long bones. In 2010, they reported their results for osseointegrated 
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titanium implants for limb prostheses’ attachments. Out of 39 implants, there was an 
infection rate of 18% at 3 years follow-up (Tillander et al., 2010). 
 
Branemark’s work showed that the living bone could become so fused with the titanium 
oxide layer of the implant that the two could not be separated without fracture (Branemark, 
1983). The main advantage of osseointegrated amputation prosthesis is its ability to avoid 
pressure loading at the prosthesis-stump interface. This improves stump comfort, 
eliminates poor prosthetic socket fit and skin problems (Sullivan et al., 2003). Since the 
prosthesis is skeletally load bearing, the mechanical forces during the gait cycle are 
transmitted through bone. This allows patients to walk further, be more active and feel as 
though they use less energy than using a conventional prosthesis. Users feel less disabled 
and because the alignment of the external components is preserved, they are able to 
participate in full daily living and activities such as cycling (Sullivan et al., 2003). Amputees 
also reported improved sensory feedback from the skeletally attached limb through 
osseoperception (Branemark et al., 2001). This is permitted through for perception of 
pressure and ground texture (Lundborg et al., 2006). 
 
1.4.1 Applications of osseointegration 
1.4.1.1 Dental reconstruction 
Osseointegration has been using to replace missing single teeth, for partially edentulous 
segment of the mouth, and for reconstruction of  a completely edentulous patient. Long-
term success rates reveal superiority of osseointegration over conventional prosthodontics 
(Esposito et al., 1998).  
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1.4.1.2 Facial prostheses 
Major maxillofacial defects may utilize an implant that supports prostheses together with 
bone graft to reconstruct facial defects. Osseointegration implants allowed stabilization of 
lower partial dentures. 
 
When external ears are removed due to trauma or tumour, successful anchorage of an 
artificial pinna to the temporal bone is possible by osseointegrated implants. Similarly, 
orbital prostheses have been anchored to the orbital rim. Bone anchored hearing aids are 
osseointegrated titanium flanges that aid patients with sensorineural loss. Many patients 
have benefited from this device designed by Branemark and Kuikka (Branemark et al., 
2001), that provided an alternative to hearing aids attached percuataneously. 
 
1.4.1.3 Finger Amputation 
Branemark and Lundborg (Lundborg et al., 1996) implanted osseointegrated thumb 
prostheses in a cohort of 3 patients with traumatic thumb amputation at the 
metacarpophalangeal joint level . These patients underwent a two-stage reconstruction 
aimed at fixing a titanium rod within the thumb metacarpal medullary cavity to allow 
osseointegration. After 3 months of unloading this rod, a second stage involved attaching a 
skin-penetrating component on top of the titanium rod and modifying the skin graft to 
decrease relative mobility. Skin healing occurred without any complications. The follow up 
ranged from 18 months to 3 years. At the final follow up, patients were satisfied with the 
shape of the prosthesis, felt it was a better tool for fine manipulative tasks and reached 
excellent results in the Moberg pick-up test, pulp pinch strength, lateral pinch strength, grip 
strength and grip function.                 
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1.4.1.4 Lower Limb Amputation 
In 2001, Branemark implanted lower limb amputation prostheses in rat models. Their 
results showed excellent intramedullary osseointegration in addition to the presence of 
nerve endings around titanium implants (Ysander et al., 2001). Pure titanium rods were 
implanted in femora of 18 rodents for 8 weeks. Microscopic and immunohistochemical 
observation of the implant-bone interface indicated successful osseointegration with 
normal remodeled bone. Calcitonin gene-related peptide activity was up-regulated.  There 
was new, normal bone adjacent to and fully occupying the space between fixture threads. 
Innervation appeared in remodeled bone through the observation of small nerve fibres.  
 
1.5 Infection in Transcutaneous Osseointegrated Implants 
Infection has a detrimental effect to osseointegrated transcutaneous amputation implants. 
For ITAP to be successful, it must have a tight barrier around the skin-implant interface, 
together with a stable long-term fixation between metal and bone. This has to take into 
account mobility of adjacent skin, presence of a subcutaneous fatty layer which not only 
may not integrate with the implant, but also allow the movement of overlying skin against 
the implant, and attachment properties of keratinocytes, that are different from gingival 
cells, and hence may nt attach as firmly to dental implants. 
 
Tillander et al., 2010 prospectively followed 39 patients with arm and leg amputations fitted 
with transcutaneous osseointegrated titanium implants for a mean of 56 months. They 
reported an infection rate of 5% at inclusion and 18% at 3 years follow-up. In 5 out of the 7 
patients with infections, prosthetic use was not affected. Staphylococcus aureus and 
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coagulase negative staphylococci were the common organisms in the superficial and deep 
cultures. 
 
Long-term follow-up for dental osseointegrated implants have been reported by Adell et al. 
1990. They implanted 4636 standard fixtures in 700 patients with a follow-up for 15 years. 
More than 95% of maxillae had continuous prosthesis stability at 10 years and 92% at 15 
years. For mandibles, stability remained at 99% at 15 years. Estimated survival rates for 
fixtures in the maxilla and mandible were 78% and 86% respectively at 15 years. 
In an attempt to overcome risk of infection, Chou et al., 2010 examined the efficacy of 
antimicrobial pexiganan acetate in preventing pin tract infection of trancutaneous 
osseointegrated implants in a rabbit model. They applied topical antibiotic pexiganan 
acetate 1% daily at the skin-implant interface for 24 weeks (n=8). They found a significant 
reduction of pin site infection compared to the Ti controls (n=11) at p=0.019 (Chou et al., 
2010). 
 
My work tests whether silanized dual coating protein coatings with fibronectin and laminin, 
enhances both keratinocyte and fibroblast spreading and vinculin markers production on 
Ti6Al4V in vitro. 
 
1.6 Titanium alloy 
Titanium is an element with an atomic number of 22. It is strong, light, corrosion resistant 
metal. It was first discovered in Cornwall in 1791 and named after the Greek Titans. Due to 
its high strength-to-weight ratio, it is widely used in aerospace, military, automotive, 
medical prostheses, dental and orthopaedic implants, mobile phones and jewellery. 
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Titanium is commonly used as an alloy. Ti6Al4V contains 6% aluminium, 4% vanadium, 
0.25% iron, 0.2% oxygen and the remainder is titanium. It has the advantage of being 
stronger than pure titanium with the same stiffness and thermal properties. It has a 
density of roughly 4420 kg/m3, Young’s modulus of 110 GPa and tensile strength of 1000 
MPa.  In comparison to stainless steel, which is also used widely in medical implants, 
Ti6Al4V has greater superior strength under repeated load stresses, withstanding more 
strain during internal fixation. In addidtion, it is lighter and has a lower modulus of 
elasticity, making it is less rigid.Titanium is also less prone in generating an immune 
reaction as it is corrosion resistant compared to stainless steel.(Davies, 2003; Raisanen et 
al., 2000). Due to its properties, popular use in orthopaedic implants and previous studies 
on ITAP in our Institute, Ti6Al4V was chosen in my studies. 
 
1.7 Epidermis 
The epidermis acts as a physical barrier against pathogens found in the external 
environment and is arranged in multi-layers. The main cell unit is keratinocyte that 
produces keratin. They become activated by growth factors and cytokines. This in turn 
increases keratin gene expression and production of keratin which enables re-
epithelialization. The most superficial layer consists of stratum corneum (horny layer), 
which is acellular and abundant in keratin. Deeper to this is stratum lucidum (clear layer), 
followed by stratum granulosum (granular layer), then stratum spinosum (prickle cell layer) 
and finally stratum basal (basal layer). The basal layer produces cuboidal keratinocytes. 
These attach to the basal layer through hemidesmosomes and to adjacent cells via 
desmosomes. As keratinocytes mature, they migrate up to more superficial layers. When 
they reach the stratum spinosum, they attach together via desmosomes and adherens 
junctions. As they become more superficial, they become flat and die, where keratohyaline 
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granules combine with intermediate filaments and cell membrane depositing 
intracytoplasmic keratin within the horny layer. Besides keratinocytes, epidermis also 
includes basal melanocytes, antigen presenting Langerhan’s cells and Merkel cells.   
 
The basement membrane is crucial in maintaining skin integrity and adheres the epidermis 
to the dermis resisting their separation by shearing forces. The foundation cement that 
makes this adherence possible are anchoring fibrils, filaments and collagen IV. 
 
The dermis is found deeper to the basement membrane. It is formed of tough elastic 
connective tissue that contains epidermal appendages as hair follicles, nerve endings, 
blood and lymphatic vessels. Fibroblasts are found abundantly in this layer, producing 
collagen and fibronectin. Macrophages, lymphocytes and mast cells are also present in the 
dermis. The dermis acts as a supportive layer to the overlying epidermis. 
 
1.8 Fibronectin 
Fibronectin is a rod-like glycoprotein found abundantly in the body with molecular weight of 
440 kilo-Daltons (kDa). It is involved in many cellular processes, including tissue repair, 
embryogenesis, blood clotting, cell adhesion, growth, migration and differentiation. 
Fibronectin binds to cell membrane via integrin receptors and to extra-cellular matrix 
protein such as heparin, fibrin and collagen. This allows fibronectin to act as a cell 
adhesion molecule by anchoring cells to proteoglycans or collagen. Fibronectin is found in 
two forms:  an insoluble cellular form present in the extracellular matrix produced by 
fibroblasts, chondrocytes, endothelial cells, macrophages and epithelial cells. The other 
form is a soluble plasma glycoprotein, formed in the liver and circulates the body in 
plasma.  
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Fibronectin is a dimer, formed of two monomers linked by a pair of C-terminal disulfide 
bonds (Mao et al., 2005).  Each monomer is composed of three different types of repeating 
modules: types I, II and III. Each module is formed of anti-parallel beta strands ().  
 
Type I module is made up of approximately 45 amino acids, found in the amino and 
carboxy terminal regions of the protein. Two anti-parallel beta strands make up the top 
sheet, which folds over a bottom sheet that in turn is composed of three anti-parallel beta 
strands. These sheets interact through hydrophobic and disulfide bonds that stabilize the 
module. Interactions between adjacent modules are important to fibronectin structure. 
Twelve type I modules are involved in collagen binding. Two type II modules are found in 
fibronectin, which are 60 amino acids in length. These are involved in collagen binding.  
The most abundant module in fibronectin is Type III, where 15-17 modules make up the 
fibronectin molecule. Each module is composed of 90 amino acids in length. Type III 
module contains the tripeptide Arg-Gly-Asp (RGD) receptor recognition sequence along 
with binding sites for other integrins and heparin. The RGD sequence located in Type III 
module 10 is the site of cell attachment via 53 integrins on cell surface. Like other 
fibronectin modules, type III module cores are made up of overlapping beta sheets. The 
top sheet contains 4 antiparallel beta strands and the bottom sheet is composed of 3 anti-
parallel strands. Unlike types I and II modules, type III are not stabilized by disulphide 
bonds allowing type III modules to partially unfold under pressure (Erikson 2002). A 
“variable” V-region exists within fibronectin structure. Its presence and length may vary. 
This region contains the binding site for 41 integrins. The V-region sequence is present 
in cellular fibronectin but in one of the two subunits in plasma fibronectin.  
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1.9 Laminin 
Laminin is a large 990 kDa glycoprotein that plays a fundamental role in the architectural 
structure of almost every tissue in the body. This is achieved through its presence in the 
extracellular matrix, hence interacting with transmembrane integrin linkers to promote cell 
regulation, adehesion, differentiation and migration. This interaction allows cell 
cytoskeleton, intermediate filaments and actin to bond to extracellar matrix and organize 
tissue structuring and adhesion.  (Beck et al., 1990). Each laminin protein is formed of α-
chain, β-chain and γ-chains, which are found in five, four and three genetic variants 
respectively (Figure 1.2). The molecules are named according to their chain composition. 
Thus, laminin-311 contains α3, β1, and γ1 chains. Fifteen chain combinations are present 
in vivo. The chains intersect to form a cross-like structure that can bind to other cell 
membrane and extracellular matrix molecules. The long arm binds to cell membrane via 
integrin receptors anchoring cells to the basement membrane, while the shorter arms are 
best adapted to binding to other molecules, which allows them to form sheets. RGD 
complex is located on α chain and is responsible for promoting endothelial cells 
attachment through their linkage to integrin molecules which triggers the interactin with 
vinculin, paxillin and actinin. This forms an intracellular adhesion complex which attaches 
to actin and anchoring filament myoskeleton. 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
35 
 
YIGSR 
Cell attachment 
RGD  
Cell attachment 
Cell attachment 
Heparin binding 
A chain 
    B1 chain      B2 chain 
     G chain 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Schematic diagram of laminin structure showing locations of biologically active 
sites (Kleinman and Weeks, 1989) 
1.10 Vinculin 
Vinculin is a cytoskeletal protein part of focal adhesion complex involved in linking integrin 
adhesion molecules to actin cytoskeleton. It is 117 kDa with 1066 amino acids. It consists 
of a globular head domain that contains binding sites for talin, α-actinin as well as a 
tyrosine phosphorylation site, while the tail region contains binding sites for F-actin, paxillin 
and lipids (Goldman et al., 2001).  
Vinculin is associated with focal adhesion complexes that nucleate actin filaments and 
cross linkers between the external medium, plasma membrane and actin cytoskeleton. 
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The complex at the focal adhesions consists of several proteins such as vinculin, α-actin, 
paxillin, and talin, at the intracellular face of the plasma membrane.  Amino-terminal of 
vinculin binds to talin, which binds to β-integrins and the carboxy-terminal binds to actin, 
phospholipids, and paxillin-forming homodimers. The binding of vinculin to talin and actin 
is regulated by polyphosphoinositides and inhibited by acidic phospholipids. The complex 
then serves to anchor actin filaments to the membrane (Ezzell et al. 1997).  
Focal adhesions are macromolecular complexes that mediate mechanical forces and 
regulatory signals across the cell membrane. They are in a state of constant flux, proteins 
associate and disassociate with the focal adhesion continuously as signals are transmitted 
to other parts of the cell, regulating cell activity. Focal adhesions connect to extra-cellular 
matrix protein via integrins. Integrins bind to extra-cellular proteins through short amino 
acid sequences such as Arginine- Glycine- Aspartate (RGD), or DGEA and GFOGER 
sequences in collagen.  
 The intra-cellular domain of integrin binds to cytoskeleton through adapter proteins such 
as talin, -actinin, filamin and vinculin. Many other intracellular signalling proteins, such as 
focal adhesion kinase, bind to and associate with this integrin-adapter protein–
cytoskeleton complex and this forms the basis of a focal adhesion (Ziegler et al., 2006). 
 
1.11 Adhesion markers- Integrins 
Integrins are trans-membrane receptors that regulate attachment between the cell and 
tissues. They play an important role in cell signalling, affecting cell shape, size, motility and 
cell cycle. Integrins transduce information to and from the cell to the surrounding 
environment, which affect both cell and the environment. Integrins are responsible for 
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binding the cell surface to adhesion proteins as fibronectin, laminin, vitronectin and 
collagen.  
 
Integrins are heterodimers containing two chains, alpha and beta. There are 18 different 
alpha chains and 8 beta chains. Each chain contains two tails. These tails penetrate the 
cell membrane into the surrounding matrix. The molecular mass of integrin varies from 90 
kDa to 160 kDa. Integrins aid cell attachment, migration, differentiation or death. 
Integrins are the corner-stone of focal adhesion complexes, which are formed of 
complexes  of integrins, talin, vinculin, paxillin and alpha actinin. The complexes regulate 
focal adhesion kinase and cause clustering of these complexes. The clusters provide intra-
cellular binding sites on the cytoplasmic side of the membrane. The complexes connect 
the extra-cellular matrix to actin bundles. 
 
Integrins play an important role in cell migration. Cells attach to surrounding substrate 
through integrins. During cell movement, integrins are moved back from the membrane-
substrate contact into the cytoplasm by endocytosis. They are transported through the cell 
and moved to the new substrate-membrane contact by endocytic cycle.  
 
1.12 Hemidesmosomes 
Hemidesmosomes are junctional protein complexes that advocate epithelial cell adhesion 
of stratified and complex epithelia, as found in skin, cornea, amnion, grastrointestinal and 
respiratory tracts, to underlying basement membrane or substrate (Borradori and 
Sonnenberg, 1999). Hemidesmosomes consist of intracellular transmembrane proteins 
(Koster et al., 2003) and their assembly is vital for the migration of keratinocytes, and 
adhesion of keratinocytes to basement membrane and titanium implant.  
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Hemidesmosomes are formed of triangular plaques with a length <0.5m (Borradori and 
Sonnenberg, 1999). Their sub-basal dense plate lies external to the membrane and thin 
extra-cellular anchoring filaments extend into basement membrane (Jones et al., 1998). 
Their structure is divided into cytoplasmic plaque proteins; plectin and BP 230, 
transmembrane proteins; 64 integrins and BP 180 and basement membrane associated 
proteins; laminin. 
Hemidesmosomes have an important role in cell adhesion through intra-cellular 
intermediate filaments attaching to hemidesmosomes. Hemidesmosomes in turn attach to 
the basement membrane by anchoring filaments (Rousselle et al., 1995).  
They also help in wound repair and cell migration through modulating 64 integrin 
expression, stimulating cell migration. In turn, these integrins regulate differentiation, 
metabolic activity and apoptosis (Mainiero et al, 1995). 
 
In summary, testing amount of focal adhesion vinculin markers and cell spreading give an 
indication of the behavior of keratinocytes and fibroblasts in the presence of bio-chemically 
and physically modified surfaces. I understand that the methods used in my thesis do not 
directly test attachment of tissues to titanium and should not be treated as such until direct 
in vitro methods are used such as atom focus microscopy and in vivo studies examining 
histological slices for percentage of soft tissue attachment to ITAP. 
 
1.13 Modes of Protein Attachment to Ti6Al4V 
Several methods have been used that improve metal surface fixation and subsequent  
implant survival. Physicochemical modifications that alter surface charge, composition or 
morphology have been used. In addition, biochemical methods have been used to achieve 
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better cell attachment to metal. Biochemical modification of both organic and inorganic 
surfaces influences cell adhesion, differentiation and growth (Weetall, 1993). Enzyme 
immobilization to inorganic materials have been developed (Halling and Dunnill, 1979) and 
applied to osseointegration successfully (Puleo, 1995). 
 
1.13.1 Adsorption 
This represents the simplest form of biochemical modification of inorganic surfaces. It is 
done by simple immersion of a substrate into a solution of protein without changing the 
structure of either. They attach by weak H-H bonds, intermolecular van der Waal forces 
and salt channel bonds. The main advantage of this method is its simplicity; however 
several studies showed that a large percentage of protein coating is easily washed away 
from the titanium alloy.  There is little control over release, retention and orientation of 
molecules. Weak bonds retain proteins, which detach from the surface in an uncontrolled 
fashion. If targeted response is required, an alternative biochemical method is needed to 
couple proteins on titanium. 
 
1.13.2 Silanization 
Silanization is a biochemical process that modifies an inorganic substrate so that bioactive 
proteins could be immobilized to it. A silicon base group of atoms attach to the substrate 
surface called the silane complex. This in turn bonds to a spacer arm of glutaraldehyde, 
which acts an intermediary for protein coupling. This method is biocompatible and 
improves protein attachment to metal (Rezania, 1997). Puleo, 1995 (48) and Nanci et al., 
1998 showed that silanization does not affect enzyme activity of silanized protein. 
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There are 2 methods of silanization depending on the solvent used: aqueous and organic. 
Aqueous silanization provides thinner silane layer with greater coverage compared to 
organic, which provides a thicker layer, loosely bound, but with higher capacity coating 
(Weetall, 1993). Methoxy-salines and ethoxy-salines are chemical forms that can be used 
with both solvents whereas chloro-silanes can only be used with organic solvents. 
 
Silanization linkers are required to immobilize protein to the silane complex. Several 
spacer arms are available and choice depends on silanization complex and reactive 
groups on the protein. Bifunctional spacer arms are composed of two functional groups on 
each end, which can be the same (homo-bifunctional) or different (hetero-bifunctional). 
Gluteraldehyde is a homo-bifunctional spacer arm, used commonly with metal-protein 
immobilization, with two CHO groups attaching protein to titanium surface with spacer arm 
of 10 atoms (Weetall, 1976; Halling and Dunnill, 1979; Puleo, 1995; Nanci et al., 1998).  
 
In my thesis, -aminopropyltriethoxysilane (APS) is used as a silane complex and 
gluteraldehyde as a spacer arm. This silane complex was used based on previous work 
done by the same group, testing single coating fibronectin covalently bonded to titanium 
alloy in presence of fibroblasts, and testing single coating laminin covalently bonded to 
titanium alloy in presence of keratinocytes. Weetall first used APS with inorganic 
substrates in 1976. It has 2 functional groups; the silane group; composed of a silicon 
atom attached to 3 hydrocarbon (alkyl) chains and an amino group. The silane group 
attaches to oxidized Ti6Al4V surface, through its silicone based molecule which bonds to 
Ti2O, while the amino group bonds to gluteraldehyde spacer arm. APS forms self-
assembly polymers, resulting in increased stability and this increases the stimulatory effect 
of biological molecules (Ito, 1992). 
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Chemically modifying Ti6Al4V surface will also change the surface roughness (Ra). 
Average surface rougness is the measure of texture of a surface. It is based on a 
statistical representation of surface deviations (peaks and valleys) from local mean surface 
height. It can be measured either by contact, using a probe across the surface; or non-
contact optical method. Surface roughness (Ra) is mathematically defined as:  
 
n represents equally spaced points along the trace, and  is the vertical distance from the 
mean line to the  data point. Height is assumed to be positive in the up direction, away from 
the bulk material (Degarmo et, 2003). 
 
1.13.3 Plasma Treatment 
Plasma techniques can deposit ultra thin, adherent coatings. Glow discharge plasma is 
created by filling a vacuum with a low-pressure gas (ex. argon, ammonia, or oxygen). The 
gas is excited using microwaves or current. This ionizes the gas within the contained 
chamber. The ionized gas is then thrown onto the substrate surface at a high speed where 
the energy produced physically and chemically changes the surface. After the changes 
occur, the ionized plasma gas is able to react with the surface to make it ready for protein 
adhesion. However, the main disadvantage of this method is the surface may lose 
mechanical strength or acquire new properties because of the high amounts of energy. 
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1.14 Thesis aims and Hypothesis 
The hypothesis of my study is that silanized dual coating protein coatings with 
fibronectin and laminin, enhances both keratinocyte and fibroblast cell spreading 
and vinculin markers on Ti6Al4V in vitro.   
 
I will explore this hypothesis by investigating the spreading of skin keratinocytes and 
dermal fibroblasts and production of vinculin markers in the presence of dual coating 
proteins; fibronectin (Fn) and laminin (Ln) on titanium alloy (Ti6Al4V). Laminin and 
fibronectin were selected as they are the most abundant glycoproteins present in the 
epidermal and dermal layers respectively. My work in this thesis examines the influence of 
single and dual protein coatings on cell attachment when coated on Ti6Al4V, in order to 
design a bio- and physicochemical modified Ti6Al4V surface that cells allows cell 
spreading as measured by cell size and production of focal adhesion vinculin markers by 
direct counting of these markers on fixed cells, which can be applied to the design of 
percutaneous medical devices. 
 
Specifically these objectives are to:  
1. Assess the release kinetics of dual coating radio-labeled Fn and Ln coated on the 
surface of Ti6Al4V soaked in fetal calf serum (FCS). 
2.  Perform cell bioassay to assess the effectof a Ti6Al4V- dual coating protein 
fibronectin and laminin (FnLn) on keratinocyte cell spreading and production of 
vinculin markers. 
3. Compare fibroblast cell spreading and vinculin markerson silanized dual coating 
protein FnLn to adsorbed dual coating FnLn, adsorbed and silanized single coating 
Fn and Ln on Ti6Al4V alloy by measuring cell size and number of vinculin markers 
Chapter 1: Introduction 
 
43 
 
per cell unit and per cell area, use Mann Whitney U test to identify differences 
between each 2 independent sample 
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2.1 Introduction 
2.1.1 Background to Chapter 
For ITAP to be successful, a soft tissue-implant barrier must be created which prevents 
wound down-growth, marsupilization, skin breakdown and infection. To promote the 
formation of this seal, biological adhesion molecules may be used on implant surface 
(Gordon et al., 2010).   
The hypothesis tested was: There is no significant difference between the quantity of 
protein attached to titanium surfaces irrespective of whether they were silanized or 
adsorbed. 
 
The objectives of this chapter are: 
1)  To quantify dual coating proteins ; fibronectin (Fn)  and laminin 332 (Ln) attaching 
to different substrates (adsorbed and silanized). 
2)  To determine the release kinetics of dual protein over time (from 0 up to 72 hours).  
3)  To establish whether there is competitive binding between dual protein attaching to 
these surfaces.  
 
Several studies have shown that using more than one protein enhances cell adhesion and 
proliferation. Laflamme et al. (2008), showed that pre-coating bone morphogenetic 
proteins (BMP) 2 and 7 simultaneously on a collagen scaffold, enhanced osteoblast 
growth, adhesion and proliferation more than single coatings of either BMP2 or BMP 7. 
Garcia-Nieto et al. (2010), demonstrated that treating dendritic cells with laminin and 
fibronectin for 48 hours produced higher levels of key endocytic receptors and induced 
better T cell differentiation compared with controls of no treatment. Middleton et al., 2007, 
showed that single coating fibronectin enhanced fibroblast adhesion and growth on 
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Ti6Al4V surfaces. Similarly, Gordon et al. (2010) demonstrated single coating laminin 
improved keratinocyte adhesion and growth on Ti6Al4V surfaces. Each extracellular 
protein may influence growth rates of the same cell line in a different manner. Berens et 
al.(1994), showed fibronectin and vitronectin proteins minimally supported migration of 
astrocytoma cells in vitro compared with laminin and collagen IV. In addition to this, 
Johansson et al.(1981), showed that the attachment of cells to fibronectin and laminin 
involves different cellular receptors. This suggests that presence of dual protein coatings 
may cause a synergistic or inhibitory effect on cell adhesion and growth.   It has been 
postulated that dual coating fibronectin and laminin mimics the physiological conditions 
found in extracellular matrix, providing useful information regarding cell signaling and up-
regulation and interaction in presence of more than one protein (Johansson et al., 1981). 
This may be important for both epidermal and dermal layers and could enhance formation 
of a tight seal around the prosthesis, leading to the long-term success of ITAP.  
 
2.1.2 Adsorption and attachment of proteins to titanium 
Modification of the surface’s biochemical and physical characteristics affects cell adhesion, 
differentiation and growth. This has been studied in the past and applications have been 
successfully applied to orthopaedic implants for osseointegration. Biochemical modification 
of titanium surfaces utilizes critical organic components to affect tissue response with the 
goal of immobilizing proteins, enzymes or peptides for the purpose of inducing specific cell 
and tissue responses (Puleo and Nanci, 1999). Surface modification of titanium implants 
can by classified into: surface modification by peptides; surface modification by extra-
cellular proteins; surface modification by bone morphogenetic proteins and growth factors 
(Morra, 2006).   
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Successful tissue genesis relies on the ability of cells to adhere to extra-cellular material, 
up-regulate, proliferate and organize extra-cellular matrix into a functional tissue 
(Miyamato et al., 1998). The first step in the sequence of cell attachment depends on 
integrins found on cell membranes, which are involved in the process of cell adhesion to 
extracellular matrix (LeBaron et al., 2000). Integrins interact with short amino acid 
sequences in particular, Arginine-Glycine-Aspartate (RGD) that mediate cell attachment to 
several plasma and extracellular proteins, including fibronectin, collagen I, vitronectin, 
osteopontin and sialoprotein (Grzesik and Robey, 1994). Massia and Hubbell (1990), 
covalently bonded synthetic peptides containing RGD peptide sequences to non-adhesive 
glass surface using 3-glycidoxypropyltrimethoxysilane. This produced a chemically stable 
surface that improved fibroblast adhesion.  
 
Xiao et al. (1997), investigated Arg-Gly-Asp-Cys (RGDC) peptide binding to 3-
aminopropyltriethoxylsaline (APS) to titanium surfaces. The coupling involved a hetero-
bifunctional cross linker, N-succinimidyl-3-maleimidopropionate (SMP), reacting with 
terminal amino groups on titanium through covalent addition of cysteine thiol groups of the 
peptide. The surfaces were evaluated by chemico-physical techniques including X-ray 
photoelectron spectroscopy, radiolabelling and ellipsometry. Peptide surface density was 
calculated at approximately 0.03 nmol/cm2 and the growth of N-C+O component indicated 
introduction of maleimide and peptide bonds on the surface. They produced a cell-
adhesive peptide model that covalently bonded to titanium surfaces by silanization, cross-
linking and peptide attachment through cysteine thiol group. There study did not assess 
cell adhesion or protein adsorption to titanium surfaces. 
 
De Giglio et al. (2000), demonstrated an approach of coupling synthetic peptide containing 
RGD sequence to polypyrrole (PPy) coated titanium substrates. Polypyrole is grown 
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electrochemically on titanium. Cysteine residue is used to graft the peptide to polymer 
coating. They found higher adhesion of osteoblasts to RGD-modified PPy-coated Ti as 
compared to unmodified PPy-coated Ti and glass coverslip.  
 
Bearinger et al. (1998), presented a different method of biochemical modification using 
interpenetrating polymer network coating.  This coating is a thin adherent film of 20 nm of 
acrylamide, ethylene glycol and acrylic acid. It is grafted by photoinitiated free radical 
polymerization. Osteoblasts attached to RGD modified interpenetrating polymer network 
coating at levels significantly greater than on clean quartz, RGD coating. Barber et al. 
(2003), used the same biochemical modification on RGD containing 15 amino acid 
sequences from rat bone sialoproteins linking interpenetrating polymer network. Significant 
enhancement in bone mineralization by primary rat osteoblast was identified. Kantlehner et 
al.(2000), linked cyclic c-(RGDK-) (Arg-Gly-Asp-Phe-Lys) peptide to 
polymethylmethacrylate (PMMA) using an acrylamide end group. In vitro results showed 
that PMMA pellets with RGD sequence bind effectively to murine and human osteoblasts. 
In vivo studies showed that peptide-coated PMMA pellets implanted into  the patella 
groove of rabbits were integrated into regenerating bone tissue faster and stronger than 
uncoated PMMA pellets.  
 
Cavalcanti-Adam et al. (2002), improved osteoblast activity on RGD peptides covalently 
linked to surface amino groups introduced by silane chemistry. Huang et al. (2003), 
immobilized two types of peptides, RGDC and RDGC. Cell culture of primary osteoblasts 
showed that cell attachment was enhanced on RGDC surfaces at 4 and 8 hours. 
Increased cell spreading and greater cell proliferation was also noted. This coated surface 
showed osteocalcin mRNA expression significantly earlier compared to controls.  
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Porte-Durrieu et al. (2004), covalently linked linear and cyclic RGD containing peptides to 
Ti surfaces. They used silanization with APS, cross-linking with SMP and immobilization 
via thiol bonding. They found significant improvement of cell adhesion between 1 and 24 
hours compared to untreated surface. Pallu et al. (2005), compared cyclic RGD sequence 
peptides that were covalently bonded to Ti surface using the same methodology to 
adsorbed peptides. They found a significant improvement in the former group.  
 
Tosatti et al. (2004), cultured osteoblasts on RGD peptide bonded on a co-polymer 
containing poly-l-lysine as substrate binding component and polyethylene glycol as protein 
adsorption polymer. This polymer adsorbs spontaneously from dilute aqueous solution 
onto negatively charged surfaces, yielding water-stable coatings. They found high 
phenotype expression on RGD binding polymer compared to polymer with no RGD 
peptide.  
 
Auernheimer et al. (2005), discussed coating Ti implants with cyclic RGD peptide with 
phosphonic acid groups. Groll et al. (2005), immobilized linear RGD peptides with reactive 
star-shaped polyethylene glycol prepolymers. Human mesenchymal stem cells adhered 
only to RGD coated Ti surfaces and not to controls with prepolymers only. Cells showed 
expression of osteogenic marker genes after 14 days.  
 
Ferris et al. (1999), showed an increased bone formation by RGD coated implants in vivo. 
Rat femora were implanted with titanium rods coated with RGDC peptides. The peptide 
was immobilized using gold-thiol chemistry in water-alcohol solutions. Histology analysis 
revealed a thicker shell of new bone formed around RGD coated implants versus plain 
implants at 2 weeks (26.2 +/- 1.9 vs. 20.5 +/- 2.9 microm; p < 0.01), and at 4 weeks (32.7 
+/- 4.6 vs. 22.6 +/- 4.0 microm; p < 0.02). Mechanical pull-out at 4 weeks demonstrated 
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that the average interfacial shear strength of peptide coated rods was 38% greater than 
control rods. 
 
Kroese-Deutamn et al. (2005), investigated new bone formation using a porous titanium 
fibre mesh implant, coated with cyclic RGD peptide, immobilized using phosphonate. 
Titanium mesh was soaked in coating solution and peptide was allowed to immobilize 
overnight. Implants were inserted in rabbit cranii and compared to Ti implants without RGD 
peptides. Histological examination at 2, 4 and 8 weeks showed a significant increase in 
bone formation in the RGD peptide group at 4 and 8 weeks. Elmengaard et al. (2005), 
examined plasma sprayed titanium implants coated with cyclic RGD peptide inserted in 
proximal tibia of dogs for 4 weeks. Significant increase in bone growth and at the same 
time decrease in fibrous tissue on-growth was found in RGD-coated implants. Schliephake 
et al. (2002), evaluated titanium implants coated with collagen I, implants coated with 
collagen I and cyclic RGD peptides, with low and high concentrations. Implants were 
placed in mandibles of dogs. Collagen was bonded to titanium by low voltage anodization, 
followed by dip coating in collagen and cross linking by carbodiimide chemistry. RGD 
peptides were UV grafted to collagen coated implants. Bone-implant contact and volume 
density of newly formed peri-implant bone. After 1 month, there was significantly enhanced 
bone implant contact in RGD peptide coated implants and no significant difference was 
detected between groups with collagen and RGD low and high concentrations. Volume 
density of newly formed bone was significantly higher in all implants with coating. No 
significant difference was seen between collagen coated implants compared to collagen 
and RGD low and high implants in volume density at 1 month. 
 
Introduction of chemical stimulants on the surface increase surface wetability or cell affinity 
to the surface. Moreover, modifying surface topography plays an important role in 
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increasing adhesion strength. Buser et al. (1991), demonstrated a positive correlation 
existed between bone-implant contact and roughness values. Ulerich et al. (2007), 
modified a titanium surface by patterning  the implant by direct laser etching  with a 10 m 
beam diameter and a pulse energy of 50 J, to form linear grooves ranging from 10 to 
50nm in depth. They found micro-grooves improved osteoblast adhesion on titanium.  
 
A simple method for biochemical modification is through addition of the molecule to the 
substrate i.e. adsorption. Initially, proteins are retained on the surface by weak forces, then 
over time they adsorb from the surface in an uncontrolled manner (Nakabayashi et al., 
1972).   
 
2.1.3 Silanization of Titanium 
Silanization is one method of biochemical modification that allows biological molecules to 
covalently bond to the surface.  This is possible by attaching a silicon-based group of 
atoms to the substrate surface. A spacer arm is available for protein coupling. Two 
methods of silanization exist, namely aqueous and organic depending on the solvent used. 
Organic silanization produces a thicker, uneven, more loosely bound but with higher 
capacity coating than aqueous silanization, which produces a thinner silane layer with 
greater coverage (Weetall, 1993). Chloro-silane is used with organic solvents whereas 
methoxy and ethoxy forms can be coupled to both solvents. Gluteraldehyde is a common 
spacer arm that is used in silanization for protein coupling. It possesses 2 reactive 
functional CHO groups, one group reacts with protein and the other with NH2 group on the 
silanized surface. Robinson et al. developed organic silanization using -
aminopropyltriethyoxysilane (APS) and gluteraldehyde in 1971. Since then their protocol 
has been extensively used by Halling and Dunnill, (1979); Puleo, (1995); Nanci et al., 
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(1998); Middleton et al. (2007) and Gordon et al., (2010). APS is a silane that couples 
substrates silanol, forms self assembly polymers and increases the stimulatory effect of 
biological molecules (Ito, 1991). Silanization is the process that I have used throughout 
this theseis to attach proteins to titanium alloy surfaces. 
 
2.1.4 Quantification of Protein 
An accurate method of detecting small quantitates of protein is necessary to determine the 
stability of protein on the surface. It would also aid in determining whether competitive 
binding is present with the presence of more than one protein type on the surface. Indirect 
methods for protein quantification by Western Blots exist. Direct methods include 
radiolabelling proteins. In my study radiolabelled  proteins were used because it allowed 
us to quantify directly protein attachment and desorbtion onto the surface of titanium alloy.  
 
2.1.5 Hypothesis  
The null hypothesis tested is: 
There is no significant difference between the quantity of protein attached to titanium 
surfaces irrespective of whether they were silanized or adsorbed. 
There is no significant difference between quantities of single coating protein attached to 
the substrate compared with dual coating protein. 
The alternative hypothesis tested is: 
Silanized surfaces bonded significantly more protein compared to non silanized surfaces. 
Larger quanties of single proteins bonded to silanized titanium surfaces compared to 
mixed protein solutions. Non-competitive bonding was present when dual coating proteins 
were silanized on Ti. 
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The aim of this chapter was to examine whether covalently bonded protein FnLn attached 
to Ti surfaces in larger quantites than adsorbed protein coating when placed in Foetal Calf 
Serum (FCS) over time (0 up to 72 hours).  
 
2.2 Materials and Methods 
2.2.1 Disc Preparation 
10mm diameter, 3mm thick discs were machined from Ti6Al4V rods. These were ground by 
hand with fine grit paper (300, 600, 1200, 2400, 4000) prior to polishing with a Motopol 
2000 grinder (Buehler, Germany), MD polishing cloth (Streuers, Denmark) and OP-S 
colloidal silica suspension (Streuers, Denmark) 10:1 with 30% H2O2 (BDH Ltd, UK). 
Polished discs (Pol) were considered satisfactory when the surface obtained was a mirror 
surface finish and a Ra value of less than 0.03m was achieved using a profilometer. Only 
discs that fit these criteria were used in the experiments. 
 
2.2.1.1 Cleaning 
Discs were ultrasonically cleaned for 10 minutes immersed in 10% Decon 90 (Decon 
Laboratory Ltd, UK). The discs were left to rinse under running distilled water for 10 
minutes. They were placed in Acetone (BDH Ltd, UK) for 10 minutes and air dried under a 
hood. 
 
 2.2.1.2 Autoclaving 
Discs were placed into autoclave bags and sterilized in a 2100 Classic Clinical Autoclave 
(Prestige Medical, UK) for 11 minutes at 1260C at 1.4 bar pressure. 
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2.2.1.3 Passivation 
Discs were passivated by soaking in a 50:50 of 99% sulphuric acid and 30% hydrogen 
peroxide (BDH, UK) for 2 hours at room temperature. The passivated discs were rinsed 3 
times with distilled water and vacuum dried for 2 hours using aseptic technique. 
 
2.2.1.4 Silanization 
Polished and passivated discs were submerged in 10% amino-propyltriethoxysilane (APS) 
for 2 hrs at 210C, for the silanized, non-passivated discs group and the silanized, 
passivated discs group respectively. Discs were dried at 370C in the dry incubator. They 
were then immersed in 1% glutaraldehyde solution for 2 hours at 210C. These were rinsed 
thoroughly with PBS. 
 
2.2.2 Radiolabelling Fn and Ln: 125I-Fn and 125I-Ln Production 
Method 
Fibronectin (F2006, Sigma-Aldrich, UK) and laminin (CC145, Chemicon International Inc., 
USA) were custom labeled by Perkin-Elmer Inc., (Wellesley, USA). Modified chloramineT 
procedure was used to incorporate 125iodine to the protein producing 125iodine-fibronectin 
(125I-Fn) and 125iodine-laminin (125I-Ln). Radiochemical purity for both radiolabelled proteins 
yielded 95% incorporation by instant thin-layer chromatography, a specific activity of 
7.5μCi/µg and a concentration of 500uCi/ml for 125I-Fn; a specific activity of 21.8μCi/µg and 
a concentration of 400uCi/ml for 125I-Ln. 
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2.2.3 Radiolabelling Quantification Method 
Gamma radiation from radiolabelled protein was detected using Tricarb 2900TR liquid 
scintillation counter (PerkinElmer Inc., USA) as counts per minute (CPM). Discs were 
placed in 5ml scintillant tubes. 4.5ml Ultima Gold XR scintillation cocktail (PerkinElmer 
Inc., USA) was then added. Tubes were placed in the scintillation counter and CPM was 
obtained from QuantaSmart software (v. 1.31, Packard Instrument, USA). Each sample 
was counted 3times.  
 
2.2.4 Calibration Curves 
Standard Calibration curves were produced for single coating proteins 125I-Fn and 125I-Ln 
against CPM to allow for quantification of protein in nanograms. 50 l droplets of 10 g, 
100 g, 250 g, 500 g and 750 g of each radiolabelled protein were placed on polished 
discs and CPM was immediately measured thrice.  
 
2.2.5 Release Kinetics for Radiolabelled Proteins in Fetal Calf 
Serum 
In order to coat discs with single coating protein, 50l droplet of 636.62ng/cm2 125I-Fn, was 
added to non silansized and silanized, non-passivated discs (n=3) at 210C under sterile 
conditions using aseptic techniques. For dual coating proteins, 25l droplet of 636.62 
ng/cm2 125I-Fn mixed with 25l droplet of 636.62 ng/cm2 non-radiolabelled Ln were added 
to discs in the same method. This was repeated with 125I-Ln in the same manner. This 
concentration was chosen because previous work showed that this was the maximal 
amount that covalently bond to titanium alloys (Middleton et al. 2007, Gordon et al. 2010). 
Discs were placed in 24 well plates and were left for 4 hours to allow proteins to bind. 
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Distilled water was used to wash discs 3 times to remove unbound protein. Discs were 
submersed in 1ml of FCS. CPM measurement was done at 0 hour, 1 hour, 24 hours, 48 
hours and 72 hours.  
 
2.2.6 Quantification of Amount of Radiolabelled Proteins in 
nanograms 
Using the calibration curves described in section 2.2.4 and CPM data from section 2.2.5, 
quantification of radiolabelled proteins (125I-Fn and 125I-Ln) both as single and dual coating 
proteins on adsorbed and silanized, non-passivated discs was calculated in nanograms. 
 
2.2.7 Quantification of Amount per Disc Area Radiolabelled 
Proteins  
Protein remaining on discs against time, measured in nanograms, was divided by the 
surface area of discs to obtain the quantity of protein expressed as nanograms per 
centimetre square. Tricarb 2900TR liquid scintillation counter was calibrated and tested by 
Perkin-Elmer engineers immediately before I carried out my experiments. The accuracy 
obtained was within 95%.  
 
2.2.8 Statistical Analysis 
Data were anaylsed using SPSS software. The data did not fit the assumptions required 
for parametric testing and therefore, non-parametric tests were used. Pair-wise Mann-
Whitney U test was used to compared medians and determine significance between 
individual groups. All numerical data are stated as median values (with 95%CI). Power 
calculations were made using previous similar studies at the institute. Identical numbers of 
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samples were used in all experiments.Results with p-value< 0.05 level were considered 
significant. 
2.3 Results 
2.3.1 Calibration Curve 
Standard calibration curves were designed to determine the results for loading and release 
kinetics experiments with correction for the half-life of 125I-Fn and 125I-Ln. Increasing the 
amount of 125I-labelled protein results in a proportionate increase in the Counts Per Minute 
(Figures 2.1-2.2).   
 
 
Figure 2.1: Calibration curve for 125I labelled fibronectin in counts per minute (CPM) 
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Figure 2.2: Calibration curve for 125I labelled laminin in counts per minute (CPM) 
 
 
2.3.2 Release Kinetics of 125I-Radiolabelled Proteins 
2.3.2.1 Quantification of Proteins 
Using the calibration curves and results of release kinetics of different proteins in CPM, 
quantification of proteins in nanograms and in nanograms/squared centimetres was 
performed (Figures 2.3-2.28).  
 
2.3.2.2 Durability Kinetics of 125I-Fn and 125I-Ln on Ti discs 
There was a significant decrease from a median of 149.54 ng (95% CI 149.76 to 151.32) 
to 149.63 ng (95% CI 149.21 to 150.62) of silanized Fn was seen within the first hour of 
incubation in FCS (p=0.024). A significant decrease was seen between 1 and 24 hours to 
a median amount of 131.65 ng (95% CI 130.52 to 131.90) (p<0.001); and the amount 
Amount of 
125
I-Laminin 
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decreased further significantly by a quarter of its initial loading concentration (median 
113.57 ng (95% CI 113.65 to 113.94)) by 48 hours (p<0.001). A further decrease in the 
amount of SiFn was observed between 48 and 72 hours to a median amount of 111.46 ng 
(95% CI 111.13 to 113.59) (p=0.047).  
 
On silanized Ln substrate, there was no significant decrease from a median of 232.58 ng 
(95% CI 232.32 to 232.87) to 231.67 ng (95% CI 231.27 to 231.95) within the first hour in 
FCS (p=0.09). There was a significant decrease between 1 and 24 hours (p<0.001) to a 
median of 204.45 ng (95% CI 203.91 to 204.87) and a further decrease between 24 to 48 
hours, to 183.17 ng (182.91 to 183.67); a fifth of its initial optimal loading concentration 
(p<0.001). No significant decrease in amount of SiLn between 48 and 72 hours to a 
median on 179.15 ng (95% CI 177.93 to 179.88)(p=0.05). 
 
On adsorbed Fn, a significant decrease from a median of 27.39 ng (95% CI 26.92 to 
27.97) to 25.81 ng (95% CI 22.38 to 26.61) was seen within the first hour of incubation in 
FCS (p<0.001). There was significant decrease between 1 and 24 hours to a median of 
3.49 ng (95% CI 2.76 to 4.01) (p<0.001). There was no further decrease between 24 and 
48 hours to a median of 2.85 ng (95% CI 2.49 to 3.02)(p=0.31); and no further decrease in 
the amount between 48 and 72 hours to a median of 2.36 ng (95% CI 2.22 to 2.57) 
(p=0.122).  
 
The median amount of AdLn did not significantly decrease within the first hour of 
incubation in FCS from 93.41 ng (95% CI 90.55 to 93.62) to 92.71 ng (95% CI 90.81 to 
93.21) (p=0.627). A significant decrease is seen between 1 and 24 hours, with a median 
amount of 57.64 ng (95% CI 55.98 to 58.24) and a further decrease between 24 and 48 
hours to a median of 50.72 ng (49.16 to 51.35) (p<0.001). In addition, a significant further 
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decrease was observed between 48 and 72 hours, with a median amount of 48.37 ng 
(95% CI 46.54 to 48.72) (p=0.047). 
 
No significant difference was seen on silanized dual coating substrate, in the amount of 
SiFn within the first hour of incubation from a median of 155.42 ng  
(95% CI 155.05 to 155.47) to a median of 155.16 ng (95% CI 154.97 to 155.24) (p=0.102). 
From 1 to 24 hours, a significant decrease in the amount of SiFn to a median of 131.75 ng 
(95% CI 130.96 to 132.07)(p<0.001). A further decrease was seen between 24 and 48 
hours, to a median of 114.94 ng (95% 113.87 to 116.23) (p<0.001). However, no further 
decrease was seen between 48 and 72 hours of incubation in FCS, with a median of 
114.71 ng (95% CI 113.35 to 115.23(p=0.233).  
 
In addition, silanized Ln on dual coating substrate showed no significant decrease in 
median amount from 234.99 ng (95% CI 234.87 to 235.41) to a median amount of 234.63 
ng (95% CI 234.43 to 235.59) within one hour of incubation in FCS (p=0.23). A significant 
decrease is seen between 1 and 24 hours, with a median amount of 197.72 ng (95% CI 
197.56 to 197.79) and a further decrease between 24 and 48 hours to a median of 177.54 
ng (177.24 to 178.79) (p<0.001). A further decrease was observed between 48 and 72 
hours, with a median amount of 176.38 ng (95% CI 176.20 to 177.85)(p=0.047). 
 
On adsorbed dual coating substrate, the median amount of AdFn did not significantly 
decrease within one hour of incubation  from 32.80 ng (32.71 to 32.82) to 32.63 ng (95% 
CI 32.47 to 32.69) (p=0.06). A significant difference decrease in amount of AdFn to a 
median of 16.07 ng (95% CI 15.92 to 16.16) (p<0.001) was seen between 1 and 24 hours. 
No further decrease was seen between 24 and 48 hours, with a median amount of 15.51 
ng (95% CI 15.48 to 15.83) (p =0.05); however there was a further decrease between 48 
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and 72 hours to a median amount of 15.30 ng (95% CI 15.29 to 15.30) (p<0.001). In 
addition, the median amount of AdLn on dual coating substrate, did not significantly 
decrease within the first hour of incubation in FCS from 71.80 ng (95% CI 71.58 to 73.58) 
to a median of 71.79 (95% CI 71.46 to 73.52) (p=0.508). A significant decrease is seen 
between 1 and 24 hours, with a median amount of 47.38 ng (95% CI 47.14 to 47.70) and a 
further decrease between 24 and 48 hours to a median of 44.54 ng (43.40 to 44.81) 
(p<0.001). An additional decrease was observed between 48 and 72 hours (p=0.047), to a 
median amount of 43.40 ng (95% CI 41.61 to 43.56). 
 
On silanized dual coating proteins substrate, similar amounts of Fn and Ln were attached 
as when used as a single coating (i.e. non competitive binding). Silanized dual coatings 
bonded to Ti alloy in significantly larger quantities compared with adsorbed coatings 
(p<0.001). Retention of silanized proteins after incubation in serum was significantly 
greater than absorbed proteins at all time points. At t=0, silanized single and dual coating 
fibronectin remained on Ti6Al4V surfaces in larger quantities compared to adsorbed single 
and dual coating fibronectin, respectively (p<0.001). The same pattern was observed when 
comparing silanized single and dual coating laminin to adsorbed single and dual coating 
laminin, respectively (p<0.001). 
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Figure 2.3: Amount of 
125
I-Fn (nanograms) from single coating protein on Si discs soaked in 
foetal calf serum over time 
 
 
Figure 2.4: Amount of 
125
I-Ln (nanograms) from single coating protein on Si discs soaked in 
foetal calf serum over time 
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Figure 2.5: Amount of 
125
I-Fn (nanograms) from dual coating proteins on Si discs soaked in 
foetal calf serum over time 
 
 
Figure 2.6: Amount of 
125
I-Ln (nanograms) from dual coating proteins on Si discs soaked in 
foetal calf serum over time 
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Figure 2.7: Amount of 
125
I-Fn (nanograms) from single coating protein on Ad discs soaked in 
foetal calf serum over time 
 
 
Figure 2.8: Amount of 
125
I-Ln (nanograms) from single coating protein on Ad discs soaked in 
foetal calf serum over time  
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Figure 2.9: Amount of 
125
I-Fn (nanograms) from dual coating proteins on Ad discs soaked in 
foetal calf serum over time 
 
 
Figure 2.10: Amount of 
125
I-Ln (nanograms) from dual coating proteins on Ad discs soaked in 
foetal calf serum over time 
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Figure 2.11: Amount of protein (nanograms) remaining on Ti6Al4V surface at 0 hour 
 
 
 
Figure 2.12: Amount of protein (nanograms) remaining on Ti6Al4V surface at 1 hour 
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Figure 2.13: Amount of protein (nanograms) remaining on Ti6Al4V surface at 24 hours 
 
 
 
Figure 2.14: Amount of protein (nanograms) remaining on Ti6Al4V surface at 48 hours 
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Figure 2.15: Amount of protein (nanograms) remaining on Ti6Al4V surface at 72 hours  
 
 
Figure 2.16: Amount of 
125
I-Fn per disc area (nanograms/cm
2
) from single coating protein on 
Si discs soaked in foetal calf serum over time 
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Figure 2.17: Amount of 
125
I-Ln per disc area (nanograms/cm
2
) from single coating protein on 
Si discs soaked in foetal calf serum over time 
 
 
Figure 2.18: Amount of 
125
I-Fn per disc area (nanograms/cm
2
) from dual coating proteins on 
Si discs soaked in foetal calf serum over time 
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Figure 2.19: Amount of 
125
I-Ln per disc area (nanograms/cm
2
) from dual coating proteins on 
Si discs soaked in foetal calf serum over time 
 
 
Figure 2.20: Amount of 
125
I-Fn per disc area (nanograms/cm
2
) from single coating protein on 
Ad discs soaked in foetal calf serum over time 
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Figure 2.21: Amount of 
125
I-Ln per disc area (nanograms/cm
2
) from single coating protein on 
Ad discs soaked in foetal calf serum over time 
 
 
Figure 2.22: Amount of 
125
I-Fn per disc area (nanograms/cm
2
) from dual coating proteins on 
Ad discs soaked in foetal calf serum over time 
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Figure 2.23: Amount of 
125
I-Ln per disc area (nanograms/cm
2
) from dual coating proteins on 
Ad discs soaked in foetal calf serum over time 
 
 
Figure 2.24: Amount of protein/surface area (nanograms/cm
2
) remaining on Ti6Al4V surface 
at 0 hour 
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Figure 2.25: Amount of protein/surface area (nanograms/cm
2
) remaining on Ti6Al4V surface 
at 1 hour 
 
 
Figure 2.26: Amount of protein/surface area (nanograms/cm
2
) remaining on Ti6Al4V surface 
at 24 hours  
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Figure 2.27: Amount of protein/surface area (nanograms/cm
2
) remaining on Ti6Al4V surface 
at 48 hours 
 
 
Figure 2.28: Amount of protein/surface area (nanograms/cm
2
) remaining on Ti6Al4V surface 
at 72 hours  
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2.4 Discussion 
2.4.1 Effect of Silanization on Quantity of Protein Attached 
Silanized Ti6Al4V significantly binds more protein for both dual and single coatings 
compared with adsorbed substrates at all time periods. Previous work at our Institute on 
single coating protein Fn and Ln produced similar results (Middleton et al., 2007; Gordon 
et al., 2010). In my study, both single coating protein with Fn or Ln separately as well as 
dual coating proteins with Fn and Ln together attached significantly greater amounts of 
protein to Ti6Al4V.  
 
Adsorption relies on  interaction between protein and  Ti6Al4V  when the former is placed 
on its surface. The main advantages of this method are the cost and ease of application 
which may possibly be carried out in the operating theatre. The process relies mainly on 
hydrogen bonds, salt channel linkages and Van der Waal’s forces for attachment. 
However, this means it provides weak coupling modalities due to the weak bonding forces. 
As a result, greater loss of protein occurs from changes in temperature, pH, washing or 
presence of extra-cellular matrix proteins (Ulbrich et al., 1991). Fluid flow may affect the 
adsorption process. Middleton et al., 2007 examined the attachment of cells to Ti6Al4V 
following direct fluid flow directly. They used a novel apparatuts they designed to subject 
cells attached to Ti6Al4V to a fluid current. They counted the cells that stayed on the 
surface and from that equation, concluded that fluid flow affects cell attachment. They also 
found a positive linear correlation between cell attachment and number of focal adhesion 
vinculin markers. 
 
Immobilization of protein using enzymes can be achieved by inter-molecular cross-linking. 
This method is both expensive, normally requiring additional means of bonding. However, 
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since the enzyme is covalently bonded to the support matrix, there is little protein loading 
loss. Marshall et al. (1973), reported that carbamyl phosphokinase cross linked to 
alkylamine glass in addition to covalent bonding using glutaraldehyde resulted in a loss of 
16% of protein load over 14 days. Occlusion methods where protein is packed within 
polymerized gels provide an alternative method. This method permits diffusion of protein 
into the substrate. 
 
Immobilization of proteins on substrates is an effective method of increasing protein 
loading, thereby decreasing protein loss from the surface due to the strength of protein 
adhesion. Gluteraldehyde yields an aldehyde that forms a linkage with primary amines on 
the protein. Ulbrich et al. (1991), compared different types of coupling agents and 
concluded that gluteraldehyde provided the highest binding yield. The time required to 
silanize the protein on the surface may be too long for an intra-operative application. 
However, this time is essential to ensure covalent bonding of protein. Covalent bonding of 
protein delivers more protein attached to the metal surface compared with adsorbed 
surfaces and controls. I hope that this would be a suitable micro-environment for early 
cellspreading and provide more focal adhesion vinculin markers. In my next 2 chapters I 
will examine whether dual coating protein fibronectin and laminin will affect fibroblast and 
keratinocyte cell spreading in vitro. 
 
Middleton et al.(2007) examined the maximum amount silanized fibronectin to bond to 10 
mm diameter Ti6Al4V discs  and found that this is 500ng expressed at ng mm-2 . They 
placed loading doses of fibronectin and found saturation of fibronectin was reached at 
500ng fibronectin. Gordon et al. (20100 found saturation of silanized laminin was achieved 
at 500ng on the same diameter discs. Therefore, I used these concentrations of fibronectin 
and laminin in the release kinetics experiments. My study investigated whether dual 
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coating protein with these concentrations would result in competitive binding on the 
Ti6Al4V discs. Interestingly, competitive binding did occur on adsorbed surfaces but non-
competitive binding occurred on silanized surfaces. Vroman et al. (1980), described an 
effect whereby highest mobility proteins arrive first and are later replaced by less motile 
proteins that have higher affinity for a surface. This competitive binding process showed 
that highly molecular weight kininogen displaces fibrinogen on bio-polymer surface. I found 
that fibrinogen and laminin show non-competitive binding when silanized on Ti6Al4V 
surface. CHO bonds available for protein binding from the silanization process, provide 
binding arms for more amount of protein to bond. Laurie et al. (1986), showed that there 
were binding sites on fibronectin and laminin were different on basement membrane. This 
may explain why there was no increase in the amount of fibronectin bound to the surface 
in the presence of laminin on either adsorbed or silanized surfaces.  
 
Quantification of immobilized protein has successfully been performed in previous studies. 
Rodrriguez-Segui et al.(2011), fluorescently labelled fibronectin and stretavidin and used  
a GenPix fluorescence microarray scanner device to quantify protein on different surfaces.  
They concluded that certain chemically treated surfaces that allow immobilization of 
protein are able to retain the protein.  Nanci et al. (1998), found similar findings using 
colloidal gold immunolabelled and silanized albumin. 
 
The quality of silanization can be tested using spectroscopic ellipsometry, atomic force 
microscopy and water contact angle measurements. A spectropic ellipsometer apparatus 
measures the spectral variation of ellipsometric angles Ψ and ∆ defined through the 
relation: tgΨe i∆ = Rp Rs (1) where Rp and Rs are the complex reflection coefficients of 
the light polarized parallel and perpendicular to plane of incidence. Thickness of films 
present on silicon surface can be determined from the ellipsometric data analysis. Atomic 
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force microscopy can be used for imaging biofilms. Non-contact mode using silicon-
aluminium coated cantilevers with a resonance frequency of 200-400kHz and nominal 
force contact 40 N/m. Roughness can be calculated on images produced. Sessile drop 
technique to measure water contact angle with drop shape analysis software. 
 
2.4.2 Effect of Dual Coating Protein on Ti6Al4V 
I showed that fibronectin and laminin have non-competitive binding on silanized Ti6Al4V. 
On the other hand, there is competitive binding between these proteins on adsorbed 
surfaces. No data in the literature were found to support or challenge this. 
 
2.5 Conclusion 
This chapter investigated covalently bonding to dual coating proteins 125I-Fn and 125I-Ln to 
Ti6Al4V by silanization.  I have successfully demonstrated that non-competitive binding of 
these proteins occurs on silanized surfaces of titanium alloy. This paves the way to in vivo 
studies in which dual coating proteins may be applied to ITAP to improve early tissue 
spreading onto the alloy. 
 
Silanization process allows for significantly higher quantities of protein to remain on the 
surface compared with adsorption at all time periods. I have shown that this happens to 
dual coating proteins as well as single coating protein. 
 
In order to determine whether dual proteins silanized to Ti6Al4 enhance cell adhesion and 
growth, further experiments are required where cells are grown on dual proteins coatings 
and their adhesion to the titanium alloy surface is investigated. 
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Effects of Dual Coating Proteins on 
Fibroblast Spreading and Number of Focal 
Adhesion Vinculin Markers 
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3.1 Introduction 
3.1.1 Background 
ITAP’s success is dependent on early dermal attachment that in turn prevents epithelial 
down-growth and infection (Pendegrass et al., 2006; Gordon et al., 2010). This can only be 
achieved through forming an early tight tissue-metal seal.. Couchman et al., 1983 showed 
dermal fibroblasts have distinct receptors for laminin and fibronectin. In addition, studies 
have shown fibroblast attachment, spreading and prolifereation is enhanced on RGD- 
modified surfaces (Shu et al., 2003). On the other hand, pretreating keratinocytes with 
laminin improved epithelial coverage and rate of neobasement membrane formation 
(Tekada et al., 1999). When ITAP is implanted, cells respond by producing extracellular 
matrix, which contains proteins that regulate cell proliferation, cell division, cell adhesion 
and cell migration. Pre-coating the implants with these proteins that contain tripeptide RGD 
(arginine-glycine-asparnine) sequences may allow the surface to be recognized by 
integrins enhancing cell adhesion and the formation of a tight seal.  
 
Laminin-332, forms a major component of the basement of the skin and other epithelial 
tissues. Laminin-332 is a cell adhesion glycoprotein, which interacts with integrin receptors 
inducing intra-cellular signaling that regulates actin cytoskeleton and gene expression. 
Laminin-332 interacts with integrin receptors: α3β1, α6β1 and α6β4 integrins, expressed 
by epithelial cells (Koshikawa et al. 1999, Nguyen et al.200, Nikolopoulos et al.2005). 
Kariya et al.(2003), found that the major integrin binding site on laminin-332 is located in 
the LG3 domain of the α3 chains, while the other chains are responsible for the matrix 
assembly (Hirosaki et al., 2000, Nakashima et al., 2005, Ogawa et al., 2004). The 
 
Chapter 3: Effects of Dual Coating Proteins on Fibroblast Spreading and Number of 
Adhesion Markers 
 
81 
 
interaction between laminin-332 and integrin receptors induces intracellular signal 
transduction to support cell survival and proliferation through gene expression, at the same 
time supporting cell migration by activating many signal mediators such as focal adhesion 
kinase, protein kinase C, phosphatidylinositol 3-kinase, Rac and nuclear factor kB.  This 
laminin-332 activity contrasts with fibronectin activity, which induces marked stress fibres 
and supports stable cell adhesion by activating RhoA via integrin α5β1. Maschler et al. 
(2005), showed that cell transformation is accompanied by loss of laminin-332 production 
and up-regulation of fibronectin and α5β1 integrin receptor. 
 
Silanizing titanium without passivation not only allows more protein bonding, but also  
changes the physical surface roughness with that may promote better cell spreading and 
number of focal adhesion vinculin markers..    
 
In this chapter, I hypothesize that silanized, non-passivated dual coatings of 
fibronectin and laminin (SiFnLn-) will enhance early fibroblast spreading and 
number of focal adhesion vinculin markers compared with single coatings (AdFn, 
AdLn, SiFn-, SiLn-, SiFn+, SiLn+), adsorbed and silanized, passivated dual coatings 
(AdFnLn, SiFnLn+) and controls (Po, Si-,Si+). 
 
3.2 Materials and Methods 
3.2.1 Disc Preparation 
10 mm diameter, 3mm thick discs were machined from Ti6Al4V rods. These were ground 
by hand with fine grit paper (300, 600, 1200, 2400, 4000) prior to polishing with a Motopol 
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2000 grinder (Buehler, Germany), MD polishing cloth (Streuers, Denmark) and OP-S 
colloidal silica suspension (Streuers, Denmark) 10:1 with 30% H2O2 (BDH Ltd, UK). 
Polished discs (Pol) were considered satisfactory when the surface obtained was a mirror 
surface finish with an Ra value of less than 0.03 m measured using a profilometer.  
 
3.2.1.1 Cleaning 
Discs were ultrasonically cleaned for 10 minutes immersed in 10% Decon 90 (Decon 
Laboratory Ltd, UK). The discs were left to rinse under distilled water for 10 minutes. They 
were placed in Acetone (BDH Ltd, UK) for 10 minutes and air dried under a hood. 
 
 3.2.1.2 Autoclaving 
Discs were placed into autoclave bags and sterilized in a 2100 Classic Clinical Autoclave 
(Prestige Medical, UK) for 11 minutes at 1260C at 1.4 bar pressure. 
 
3.2.1.3 Passivation 
Discs were passivated by soaking in a 50:50 of 99% sulphuric acid and 30% hydrogen 
peroxide (BDH, UK) for 2 hours at room temperature. The passivated discs were rinsed 3 
times with distilled water, placed at -700C for 30 minutes and vacuum dried for 2 hours. 
 
3.2.1.4 Silanization 
Polished and passivated discs were submerged in 10% amino-propyltriethoxysilane (APS) 
for 2 hrs at 210C, for the silanized, non-passivated discs group and the silanized, 
passivated discs group respectively. Discs were dried at 370C in the dry incubator. They 
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were then immersed in 1% glutaraldehyde solution for 2 hours at 210C. These were rinsed 
thoroughly with PBS. 
 
3.2.2 Protein addition 
Surfaces of polished, silanized passivated and silanized non-passivated discs were coated 
with protein. The protein solution used was either fibronectin (F2006, Sigma-Aldrich, UK) 
or laminin (CC145, Chemicon International Inc., USA). The dual protein coatings were 
produced by using equal amounts of fibronectin (F2006, Sigma-Aldrich, UK) and laminin 
(CC145, Chemicon International Inc., USA).  
 
3.2.2.1 Fibronectin addition method 
50l droplet containing 500ng of fibronectin diluted using sterile PBS, was used to cover 
the whole disc surfaces. This was left for 4 hours according to the protocol outlined by 
Middleton et al., 2006. The discs were washed off with distilled water. 
 
3.2.2.2 Laminin addition method 
Similar to the steps described above, 500ng laminin in a 50l droplet was used to cover 
the disc surfaces. Again, this was left for 4 hours before washing off with distilled water. 
 
3.2.2.3 Dual protein coating addition method 
500ng of fibronectin and laminin were diluted with sterile PBS in 25l droplets separately in 
Eppindorph tubes. Once prepared, they were immediately mixed to form a 50l droplet 
containing 500ng of fibronectin and laminin. The droplet was added to the surface of the 
discs in a similar method as the single coating protein. 
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3.2.3 Human Dermal Fibroblasts 
1BR.3.G cells derived from a  dermal fibroblast, was bought from the European Collection 
of Cell Cultures supplier (ECACC Catalogue no. 90011801, Lot no. 05G027). Once 
received, the vial was transferred immediately to gaseous phase liquid nitrogen at -1960C.  
 
3.2.3.1 Resuscitation 
Under a tissue culture hood, a tissue soaked in 70% alcohol was used to wipe the cap of 
the vial. The cap was turned slightly to release any residual liquid nitrogen that may be 
trapped for 10 seconds and re-tightened. The vial was quickly transferred to a water-bath 
at 370C for 1 minute. The rapid thawing was important in minimizing any damage to the 
cell membrane. The vial was removed from the water-bath and wiped by another 70% 
alcohol soaked tissue. The contents of the vial were slowly pipetted into a universal tube 
containing 5ml warm Dulbeccos’ Modified Eagle’s Media (DMEM) (D6429, Sigma-Aldrich, 
Ayshire, UK). To remove the cryoprotectant, the tube was centrifuged at 2000 revolutions 
per minute for 5 minutes. The pellet was resuspended in 35ml DMEM for culture in a 
225cm2 vented flask (Corning Incorporated, New York, USA). 
 
3.3.3.2 Monitoring 
Fibroblasts were incubated in DMEM (Sigma-Aldrich, UK) with 4500mg/L, 1% non-
essential amino acids, 1% penicillin and streptomycin (Invitrogen, Paisley, UK) and 10% 
foetal calf serum (First Link Ltd, UK). The flasks were placed in an incubator (Function 
Line Haraeus Instruments) at 370C and 5%CO2. Media was changed every 48 hours until 
confluence was reached (4 million fibroblasts at 7 days). 
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3.2.3.3 Trypsinisation 
Under tissue culture hood, media was removed, 10mls sterile Phosphate Buffered Saline 
(PBS) (Oxoid Ltd, Basingstoke,UK) was used to wash the floor of the vented flask to 
remove any detached dead cells, 10mls of 10% trypsin (T8003, Sigma-Aldrich, UK) was 
added and the flask was left in the incubator for 5 minutes. Cell detachment was checked 
under the light microscope (Olympus CkX31) using 10x objective. A gentle tap was 
required if cells remain attached or incubating for 5 more minutes. 
 
20mls of DMEM was added and the suspension was centrifuged at 2000 revolutions per 
minute for 5 minutes. The supernatant containing trypsin and DMEM was discarded 
leaving a pellet containing fibroblasts at the bottom of the tube. 
 
3.2.3.4 Cell Counting 
1ml of DMEM was added to re-suspend fibroblasts. 20l of the suspension and an equal 
volume of Trypan Blue (T8154, Sigma-Aldrich, UK) were pipetted and mixed into a sterile 
Eppindorf tube.  The mixture was left to stand for 2 minutes. A 10l droplet of the resultant 
cell suspension was placed under a glass coverslip attached to a Neubauer 
haemocytometer counting chamber slide (Sigma-Aldrich, UK). The coverslip was made to 
attach by placing it on top on the slide and rubbing the 2 surfaces until Newton’s rings 
were seen. The slide was placed under a light microscope (Olympus, Japan), and using 
10x objective, the number of cells found in 4 chambers under the slide, were counted. The 
total number of cells in the original suspension was calculated by multiplying the mean of 
total number of cells counted, by dilution factor with Trypan Blue (i.e2x since there were 
equal volumes of cell suspension and Trypan Blue, by volume of cell suspension). Two 
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independent observers counted each sample and sample was accepted for experiment 
when identical count was obtained. This follows the same protocol outlined by Middleton et 
al., 2007, Gordon et al., 2008 while examining single coating protein on Ti6Al4V surface. 
 
3.2.3.5 Cell seeding on discs 
5000 fibroblasts in a 50l droplet were placed on the centre of each disc surface, spread 
evenly to the margins using the micropipette tip. A 24 well-plate holding the discs was 
placed in an incubator (Function Line Haraeus Instruments) at 370C and 5%CO2, for 1 
hour. It was transferred to a sterile fume hood where the discs were submerged with 1ml 
of Fetal Calf Serum. The well plate was incubated for 1, 4 and 24 hours. 
 
3.2.4 Antibody Detection Method 
Discs were washed for 5 minutes in PBS twice. They were fixed in 10% formal saline for 5 
minutes. To rehydrate the cells, the discs were washed for 20 minutes in PBS, changing 
the solution every 5 minutes. 50l droplet formed using 250nl primary anti-vinculin mouse 
monoclonal antibody (v9131, Sigma-Aldrich,UK) diluted in 49.625l PBS + 125nl Triton X-
100 (Sigma-Aldrich, UK), was placed on top of each disc, with special care not to drop any 
solution from the top, for 2 hours at room temperature. The discs were washed 3 times for 
10 minutes each in PBS in the dark room, followed by addition of 50l droplet of Alexa 
Fluor 488 rabbit anti-mouse IgG secondary antibody (A21441, Invitrogen, UK) diluted in 
PBS (1:100), for 1 hour. The plates were wrapped in tin foil to prevent exposure of labeled 
cells to light. 
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3.2.5 Cell Area and Antibody Analysis 
Oil drops were placed on glass cover slips that covered top surfaces of the discs. Each 
disc was placed on a glass slide and examined under a photomicroscope (Carl-Zeiss x100 
lens objective). 15 randomly selected cells were identified for each surface type and anti-
vinculin markers were counted by two independent observers who were blinded both to 
test substrate and to one another. This was following the same protocol used by Middleton 
et al., 2007, and Gordon et al., 2008 when examining single coating protein on Ti6Al4V 
surface. Photographs were taken using Carl-Zeiss microscope (Carl Zeiss Ltd, Welwyn 
Garden City, UK) with x50 and 100x objective lenses. Focal adhesion vinculin markers and 
the cell area were calculated using Axiovision Image Analysis software (Axioimage 4.4; 
Carl Zeiss, Gottingen, Germany). 
 
3.2.6 Surface Profilometry 
Polished, silanized, non-passivated and silanized, passivated discs (n=6) were tested for 
average surface roughness (Ra) using a Tesa-Rugosurf 90-G profilometer (TESA 
Technology, Switzerland), at an angle of incidence of 65◦over the range 300–1600 nm with 
a resolution of 5 nm. Three readings were obtained for each disc using same protocol 
outlined by Middleton et al., 2007; Gordon et al., 2008. 
 
3.2.7 Statistical Analysis 
SPSS statistical package for Mac (Version 18.0, SPSS Inc, USA) was used for data 
analysis. Using kappa statistics, kappa scores indicated almost perfect inter-observer 
reliability (>0.9). The data did not meet assumptions of parametric testing (Kolmogorov-
Smirnov p>0.05) and data were analysed using a non-parametric test. Mann-Whitney U 
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test was used to compare medians. Box plots showing median values, whole and 
interquartile ranges were plotted. Median values (with 95% CI) were expressed. Results 
were considered significant at p-value < 0.05 level. 
 
3.3 Results 
3.3.1 Box and Whisker Plots 
In the graphs, the box length represents the difference between the 25th and 75th 
percentiles. The horizontal line inside the box represents the median. The whiskers 
represent the largest and smallest values. 
3.3.2 Cell Area 
Cell area increased significantly between 1 to 4 and 4 to 24 hours (p<0.05) [Figures 3.1- 
3.3] on dual coated substrates compared to uncoated controls and single protein coatings 
(p<0.05) [Figures 3.4-3.6]. On adsorbed substrates, a 4, 3.7 and 3.3-fold increase was 
seen with AdFnLn compared with Pol substrate alone at 1, 4 and 24 hours, respectively. 
Cell area was observed to be 1.3-fold greater on AdFnLn than on AdFn at all time points. 
There was a 1.5, 1.5 and 1.4-fold increase was seen with AdFnLn compared with AdLn 
alone at 1, 4 and 24 hours, respectively. Cell area was observed to be 3, 1.3 and 1.4-fold 
greater on SiFnLn- compared with Si- alone at 1, 4 and 24 hours, respectively. In addition 
there was a 1.3, 1.2 and 1.2-fold greater on SiFnLn- than on SiFn- at 1, 4 and 24 hours, 
respectively. A 1.5, 1.3 and 1.4- fold increase was seen with SiFnLn- compared with SiLn-  
at 1, 4 and 24 hours, respectively. On silanized, passivated surfaces a 2, 1.8 and 1.8-fold 
increase with SiFnLn+ compared with Si+ substrate alone at 1, 4 and 24 hours, 
respectively. There was a 1.2-fold increase was seen with SiFnLn+ compared with SiFn+ 
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at 1 and 4 hours, respectively. In addition, a 1.4, 1.3 and 1.1-fold increase with SiFnLn+ 
compared with SiLn+ at 1, 4 and 24 hours, respectively. 
 
At all time points, for dual protein coated surfaces, cell area increased significantly in the 
order: Si+, Ad, Si-. At 1 hour, there was a 1.5 and 1.2-fold increase seen with SiFnLn- 
compared with SiFnLn+ and AdFnLn, respectively. At 4 hours, SiFnLn- showed a 1.6 and 
1.2-fold increase compared with SiFnLn- and AdFnLn, respectively. At 24 hours, there was 
a 1.9 and 1.2-fold increase seen with SiFnLn- compared with SiFLn+ and AdFnLn, 
respectively.  A similar pattern was observed for single protein coatings at all time points.  
 
 
 
 
Figure 3.1: Box Plot showing Cell Area (m
2
) at 1, 4 and 24 hours on adsorbed surfaces 
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Figure 3.2: Box Plot showing Cell Area (m
2
) at 1, 4 and 24 hours on silanized, non-
passivated surfaces  
 
 
Figure 3.3: Box Plot showing Cell Area (m
2
) at 1, 4 and 24 hours on silanized, passivated 
surfaces 
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Figure 3.4: Box Plot showing Cell Area (m2) at 1 hour on different surfaces 
 
 
 
Figure 3.5: Box Plot showing Cell Area (m
2
) at 4 hours on different surfaces 
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Figure 3.6: Box Plot showing Cell Area (m
2
) at 24 hours on different surfaces 
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13.5-fold greater on SiFnLn- compared with Si- alone at 1, 4 and 24 hours, respectively. In 
addition, there was a 1.7, 1.6 and 1.6-fold greater on SiFnLn- than on SiFn- at 1, 4 and 24 
hours, respectively. A 2.3, 2.1 and 2.1- fold increase was seen with SiFnLn- compared 
with SiLn-  at 1, 4 and 24 hours, respectively. On silanized, passivated surfaces a 9.8, 6.8 
and 6.8-fold increase with SiFnLn+ compared with Si+ substrate alone at 1, 4 and 24 
hours, respectively. There was a 1.9, 1.7 and 1.3-fold increase was seen with SiFnLn+ 
compared with SiFn+ at 1, 4 and 24 hours, respectively. In addition, a 2.7, 1.7 and 2.3-fold 
increase with SiFnLn+ compared with SiLn+ at 1, 4 and 24 hours, respectively. 
 
In addition to this, adsorbed dual coatings produced less vinculin than silanized, non-
passivated single coatings at all time points (p<0.05) [Figures 3.10-3.12].  
 
 
Figure 3.7: Box Plot showing Vinculin marker/Cell unit at 1, 4 and 24 hours on adsorbed 
surfaces 
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Figure 3.8: Box Plot showing Vinculin marker/Cell unit at 1, 4 and 24 hours on silanized, non-
passivated surfaces 
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Figure 3.10: Box Plot showing Vinculin marker/Cell unit at 1 hour on different surfaces 
 
 
 
Figure 3.11: Box Plot showing Vinculin marker/Cell unit at 4 hours on different surfaces 
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Figure 3.12: Box Plot showing Vinculin marker/Cell unit at 24 hours on different surfaces 
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and 1.6- fold increase was seen with SiFnLn- compared with SiLn-  at 1, 4 and 24 hours, 
respectively. On silanized, passivated surfaces a 4.7, 3.7 and 3.9-fold increase with 
SiFnLn+ compared with Si+ substrate alone at 1, 4 and 24 hours, respectively. There was 
a 1.6, 1.5 and 1.2-fold increase was seen with SiFnLn+ compared with SiFn+ at 1, 4 and 
24 hours, respectively. In addition, a 1.9, 1.3 and 2-fold increase with SiFnLn+ compared 
with SiLn+ at 1, 4 and 24 hours, respectively. 
 
Si- surfaces provide the best surface for vinculin per cell area followed by Ad then Si+ 
surfaces at all time intervals [Figures 3.16-3.21]. A 3.4, 3.3 and 5- fold increase was seen 
on SnFnLn- compared with SiFnLn+ at 1, 4 and 24 hours, respectively. In a similar pattern, 
there was a 12, 1.3 and 1.3-fold increase on SnFnLn- compared with AdFnLn at 1, 4 and 
24 hours, respectively.  
 
Figure 3.13: Box Plot showing Vinculin marker/Cell area at 1, 4 and 24 hours on adsorbed 
surfaces 
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Figure 3.14: Box Plot showing Vinculin marker/Cell area at 1, 4 and 24 hours on silanized, 
non-passivated surfaces 
 
 
Figure 3.15: Box Plot showing Vinculin marker/Cell area at 1, 4 and 24 hours on silanized, 
passivated surfaces 
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Figure 3.16: Box Plot showing Vinculin marker/Cell area at 1 hour on different surfaces 
 
 
 
Figure 3.17: Box Plot showing Vinculin marker/Cell area at 4 hours on different surfaces 
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Figure 3.18: Box Plot showing Vinculin marker/Cell area at 24 hours on different surfaces 
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Figure 3.19: Fibroblasts cultured at 1, 4 and 24 hrs on absorbed single and dual coating          
protein surfaces stained for focal adhesion plaques with anti- vinculin on polished surfaces 
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Figure 3.20: Fibroblasts cultured at 1, 4 and 24 hrs on non-passivated, silanized single and 
silanized dual coating protein surfaces stained for focal adhesion plaques with anti- vinculin 
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Figure 3.21: Fibroblasts cultured at 1, 4 and 24 hrs on single and dual coating protein 
surfaces stained for focal adhesion plaques with anti- vinculin on silanized, passivated 
surfaces 
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3.3.5 Surface Roughness of different Ti topographies 
Silanized, passivated Ti surfaces have the highest average surface roughness, followed by 
silanized, non-passivated, then polished surfaces (p<0.05) [Figure 3.22]. This suggests 
that surface roughness is a contributing factorto increased number of focal adhesion 
vinculin markers. . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.22: Box plot showing average surface roughness (Ra) on polished, silanized, non-
passivated,and silanized, passivated titanium surfaces 
 
3.4 Discussion 
In my work, I demonstrated that number of focal adhesion vinculin markers and cell 
spreading increase on dual coating protein surfaces compared with single coatings and 
controls at all time points. There may be a number of contributing factors that may have 
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influenced this finding. I postulate that in the presence of dual protein coatings on Ti 
surface, cells need less adaptation to suit their environment, by secreting ECM proteins, in 
order to remodel the surface for better attachment and spreading. This is supported by 
data of cell area, expression of vinculin markers and vinculin per cell area. Other research 
groups have shown similar findings with dual coatings. For example, Huang et al. (2010), 
showed that with dual conjugation of fibronectin and collagen I on a platform that 
supported lipid bilayers, improved fibroblast size and number was observed compared with 
single coatings alone. They suggested that this might be because fibroblasts did not need 
to produce endogenous fibronectin to remodel their microenvironment and that as a 
consequence of this ECM orientation and composition was more similar to that normally 
encounter by cells in vivo, thus energy required to re-organize and deposit ECM is would 
be reduced  allowing  earlier up-regulation of cell attachment. This is also supported by 
findings by Laflamme et al.(2008), who showed that dual coating proteins with BMP-
2/BMP-7 enhanced osteoblast adhesion and growth compared with single coatings with 
either BMP-2 or BMP-7. They suggested that this may be due to different BMPs acting 
synergistically to enhance bone regeneration, through improving the expression of type I 
collagen mRNA and interleukin-6 mRNA expression for which BMP-2 and BMP-7 have a 
major role in their formation, respectively.  
 
In addition to this, I also suggest that packing the surface with dual proteins produces a 
construct formed of different sized proteins that looks like a “choppy sea” as opposed to a 
uniform surface of a “mill pond”. More specifically, Biggs et al., 2010 showed that 
microgrooves greater than 70nm have a detrimental effect on focal contact formation. 
Hence, it is suggested that cell adhesion is affected when microgrooves are greater than 
70nm in height. This in turn, exposes more RGD sequences available for cell adhesion. 
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Sousa et al. (2008), found that pre-adsorbing equal ratios of fibronectin and albumin on 
titanium substrates provided better osteoblast adhesion than albumin, 10% plasma or 
albumin/ fibronectin in the ratio of 200:1. They suggested that the presence of albumin 
may improve presentation of fibronectin in a more integrin recognized confirmation and 
provide some degree of molecular packing that prevents loss of integrin binding activity. 
 
It is possible that the observations with fibroblasts on Fn and Ln are a cause of synergistic 
effect. Cells do not need to organize their matrix accordingly and its more akin to the in 
vivo situation so these cells upregulate expression of vinculin attachment earlier on dual 
coatings compared with single coatings. In order to prove this, one would need to further 
analyze the components of ECM produced by fibroblasts cultured on Ti over time. This 
would be possible by treating the cells with cycloheximide, which blocks the secretion of 
endogenous ECM proteins, then comparing the effect of treated and untreated cells on 
non-coated, single and dual coating protein surfaces. 
 
Van den Dolder et al. (2003), evaluated the effect of fibronectin and collagen I coatings on 
titanium fibre mesh on the proliferation and osteogenic differentiation of bone marrow rat 
cells in vitro. They compared single coatings with either fibronectin or collagen I to dual 
coatings with both over 16 days. Then, they ran a DNA quantification analysis, alkaline 
phosphatase, calcium and osteocalcin measurements. They found that proliferation of 
osteogenic cells was not stimulated by single or dual coating of fibronectin or collagen I on 
titanium fibre meshes. Their results may be different from mine because they did not study 
the effect of cell adhesion within the first few hours. Moreover, none of the protein added 
to the titanium was covalently bonded to the surface and the surface roughness was 
different. It may also be due to the difference in cell type studied. In order to prove the 
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case, one would need to study the effect of endogenous ECM in remodeling the 
environment prior to cell adhesion, by analyzing the protein expression by the cells using 
reverse-transcriptase polymerase reaction and quantification of this protein using Western 
blotting. 
 
Moreover, my work showed that dual coatings on silanized, non-passivated surface, 
improved cell attachment and growth significantly compared with those on adsorbed or 
silanized, passivated surfaces at all time points. This may be due to the surface roughness 
of Ti. Other research groups have produced similar results with different surface 
roughness. Lee et al.(2009), showed that surface microgrooves of 60m in width and 
10m in depth on acid-etched Ti improved proliferation of human gingival fibroblasts and 
increased expression of fibronectin and Rho A proteins, compared with shallower or 
deeper microgrooves. Interestingly, Walboomers et al. (1999), showed that fibroblast 
attachment to micro-grooved substrates decreased at 1 hour but increased at later time 
points. This may be because of absence of pre-coated proteins, which meant that the cells 
had to remodel the environment prior to cell adhesion to the surface. This is also evident 
from the up-regulation of 5 integrin gene expression and production of fibronectin. They 
suggested that the cells migrated into the microgrooves and formed focal adhesion points 
at the bottom. They postulated that the depth of the grooves were as important as the 
width, since microgrooves with 60m in width but 5m in depth showed significantly worse 
results.  
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3.5 Conclusion 
I have demonstrated that human dermal fibroblasts are capable of attaching to and 
growing on Ti6Al4V pre-coated with dual proteins in vitro. I have demonstrated that 
fibroblasts present significantly higher numbers of vinculin and are larger in size when 
Ti6Al4V is pre-coated with dual coating proteins when compared with single protein 
coatings and controls at all time points. I have demonstrated that Ti6Al4V surface 
topography influences cell attachment and growth. My results have shown that silanized, 
non-passivated Ti6Al4V re-coated with dual proteins fibronectin and laminin would be the 
best surface topography to incorporate into ITAP pins in order to promote a dermal seal at 
this level.
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4.1 Introduction 
4.1.1 Background 
Early epidermal attachment to titanium alloys allows early cell growth and adhesion (C 
Middleton et al., 2007). Keratinocytes’ ability to bond effectively to an inorganic surface 
prevents tissue retraction around the metal implant, marsupilization, wound down-growth, 
infection and subsequent failure (Heaney et al., 1996). In vitro studies investigated 
adhesion and growth of cells to the implant and interaction between the implant and the 
biological system. These studies determined a positive influence of fibronectin and laminin 
on epithelial cells’ attachment (Dean III et al, 1995). Distinct preference in adherence was 
found when fibronectin or laminin were added separately on the titanium surface, to 
fibroblasts and epithelial cells, respectively. They used adsorbed single coating fibronectin 
and laminin on substrates composed of plasma-sprayed titanium, hydroxyapatite-coated 
titanium, and machine finished titanium. They used protein adsorption technique similar to 
mine. They did not use highly polished titanium substrate as I did. They did not measure 
the average surface roughness on the substrates they used. Previous studies at our 
institute showed machine finished tinanium surfaces produced less vinculin markers and 
had less cell spreading compared with highly polished titanium surface (Gordon et al., 
2008).The main difference between their work and mine was the use of single coating 
proteins, the use of different substrates with different average surface roughness and 
comparing different covalent bonding to adsorption techniques. 
 
Application of dual coating proteins (FnLn) on titanium surfaces has not been investigated 
before. In chapter 3, I found that silanized dual coating protein without passivation 
 
 Chapter 4: Keratinocyte Spreading and Number of Focal Adhesion Vinculin Markers 
on Ti with Dual Coating Proteins 
 
111 
 
provides the optimum media required for fibroblast adhesion and growth in the early 
phase. The null hypothesis of this chapter is that there is no difference between silanized, 
non-passivated dual coating proteins (SiFnLn-) on early keratinocyte adhesion and growth 
compared with dual coating proteins, either silanized, passivated  (SiFnLn+), or adsorbed 
(AdFnLn), single coating Fn, either silanized, non-passivated (SiFn-), or silanized, 
passivated (SiFn+), or adsorbed (AdFn), or silanized, non-passivated Ln (SiLn-), silanized, 
passivated Ln (SiLn+) or adsorbed Ln (AdLn), or controls without protein coating (Pol, Si-, 
Si+). 
 
4.2 Materials and Methods 
4.2.1 Disc Preparation and Protein Addition 
The same protocol was used to prepare discs, silanized titanium and attach protein as 
outlined in chapter 3 (Section 3.2.1). 
 
4.2.2 Human Epidermal Keratinoctyes 
Human adult low Calcium elevated Temperature (HaCaTs) keratinocytes were given as a 
gift from Dr. Mee, Department of Dermatology, University College London,UK. This cell 
line was selected in previous studies in the institute to examine single coating laminin on 
Ti6Al4V (Gordon et al., 2008). They were compared to primary dermal keratinocytes to 
study the effect on cell spreading and number of vinculin markers. They produced similar 
results as primary cell line with no contact inhibition characteristics noted. This cell line 
was chosen due to ease of maintainance and more visible vinculin markers. They were 
stored in liquid nitrogen at -70  C. The cells were obtained from the periphery of an excised 
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melanoma from the back of a 62 year-old male. This cell line is immortal and has been 
used in experiments outlined in this chapter.  
 
4.2.2.1 Resuscitation, Monitoring, Trypsinization, Cell Counting 
 
The protocols for resuscitation, monitoring, trysinization and counting of HaCaTs were the 
same as those outlined in chapter 3 (Section 3.2.3). 
4.2.2.2 Cell Seeding 
 
20,000 keratinocytes in 50l droplet was dropped on the top surface of each disc to form a 
uniform layer covering the whole surface. The discs were carefully placed in a covered 24 
wells-plate, which were transferred into an incubator (Function Line Haraeus Instruments) 
at 370C and 5%CO2, for 1 hour, without disturbing the droplet from the disc top. The plate 
was removed into a sterile hood and the discs were submerged into 1 ml of Fetal Calf 
Serum. The well plates were incubated for 1, 4 and 24 hours before fixing with 10% formal 
saline. 
 
4.2.3 Antibody Detection Method 
 
The same protocol described in chapter 3 was implemented (Section 3.2.4). 
 
4.2.4 Cell Area Measurement and Vinculin Marker Counting 
The same technique detailed in chapter 3 (Section 3.2.5), was used to measure the cell 
surface area and count the immuno-labeled vinculin markers of HaCaT cells. 
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4.2.5 Statistical Analysis 
 SPSS statistical package for Mac (Version 18.0, SPSS Inc, USA) was used for data 
analysis. Kappa statistics indicated excellent inter-observer agreement (>0.9) for both 
observers.The data did not fit a normal distribution curve for parametric testing 
(Kolmogorov-Smirnov p> 0.05). Non-parametric Mann-Whitney U test was used to 
determine differences between individual medians on a pair-wise basis. Results were 
considered significant at p-value < 0.05. 
4.3 Results 
4.3.1 Box and Whisker Plots 
As previously outlined, the box length represents the difference between the 25th and 75th 
percentiles. The horizontal line inside the box represents the median. The whiskers 
represent the largest and smallest values. 
 
4.3.2 Cell Area 
The median cell area was significantly greater on dual coated protein surfaces compared 
with single coated protein surfaces and controls at all time points (p<0.05) [Figures 4.1 - 
4.3]. On adsorbed substrates, a 3, 3 and 2-fold increase was seen with AdFnLn compared 
with Pol substrate alone at 1, 4 and 24 hours, respectively. Cell area was observed to be 
1.5, 1.3 and 1.3-fold greater on AdFnLn than on AdFn at 1, 4 and 24 hours, respectively. 
There was a 2, 1.4 and 1.5-fold increase was seen with AdFnLn compared with AdLn 
alone at 1, 4 and 24 hours, respectively. Cell area was observed to be 3, 3 and 1.8-fold 
greater on SiFnLn- compared with Si- alone at 1, 4 and 24 hours, respectively. In addition, 
there was a 1.4, 1.5 and 1.4 fold greater on SiFnLn- than on SiFn- at 1, 4 and 24 hours, 
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respectively. A 1.7, 1.4 and 1.2  fold increase was seen with SiFnLn- compared with SiLn-  
at 1 , 4 and 24 hours, respectively. On silanized, passivated surfaces a 2.8, 3 and 2-fold 
increase was seen with SiFnLn+ compared with Si+ substrate alone at 1, 4 and 24 hours, 
respectively. There was a 2.8, 3 and 1.9-fold increase was seen with SiFnLn+ compared 
with SiFn+ at 1, 4 and 24 hours, respectively. In addition, a 1.8, 1.4 and 1.5-fold increase 
with SiFnLn+ compared with SiLn+ at 1, 4 and 24 hours, respectively. 
 
For single coating protein, cell area significantly increased on fibronectin-coated surfaces, 
compared with laminin-coated surfaces on different surface topography, at all time points 
(p<0.05) [Figures 4.4 - 4.6]. A 1.2, 1.1 and 1.1- fold increase was seen on SnFn- 
compared with SiLn- at 1, 4 and 24 hours, respectively. In addition there was a 1.1-fold 
increase on AdFn compared with AdLn at 1, 4 and 24 hours, respectively. In a similar 
pattern there was a 1.2, 1.1 and 1.2-fold increase with SiFn+ compared with SiLn+ at 1, 4 
and 24 hours, respectively. 
 
No significance in size was found between SiFnLn- and AdFnLn at 1 hour and 24 hours 
time points. For single coatings, there was no significance between AdLn and SiLn+ at 1 
hour. Again, no significance difference was found between SiFn- and SiFn+ at 1 hour. Si+ 
surfaces demonstrated a significantly reduced cell area compared to Si- and Ad surfaces. 
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Figure 4.1: Box Plot showing Cell Area (m
2
) at 1, 4 and 24 hours on adsorbed surfaces 
 
 
Figure 4.2: Box Plot showing Cell Area (m
2
) at 1, 4 and 24 hours on silanized, non-
passivated surfaces  
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Figure 4.3: Box Plot showing Cell Area (m
2
) at 1, 4 and 24 hours on silanized, passivated 
surfaces 
 
 
Figure 4.4: Box Plot showing Cell Area (m
2
) at 1 hour on different surfaces 
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Figure 4.5: Box Plot showing Cell Area (m
2
) at 4 hours on different surfaces 
 
 
 
Figure 4.6: Box Plot showing Cell Area (m
2
) at 24 hours on different surfaces 
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4.3.3 Focal Adhesion Markers Per Cell Unit 
At each time point, vinculin markers per cell unit were expressed in significantly greater 
numbers on dual coated protein surfaces compared with single coated surfaces or controls 
despite the surface topography (p<0.05). The only exception to this was SiFnLn+ 
compared with SiFn+ at 24 hours where there was no significant difference (p=0.869) 
[Figures 4.7- 4.9]. On adsorbed substrates, a 39.5, 35.3 and 23-fold increase was seen 
with AdFnLn compared with Pol substrate alone at 1, 4 and 24 hours, respectively. 
Vinculin markers were observed to be 7.2, 3 and 2.4-fold greater on AdFnLn than on AdFn 
at 1, 4 and 24 hours, respectively. There was a 3.8, 2.1 and 2.1-fold increase seen with 
AdFnLn compared with AdLn alone at 1, 4 and 24 hours, respectively. Vinculin markers 
were observed to be 40, 47.7 and 19.6-fold greater on SiFnLn- than on Si- at 1, 4 and 24 
hours, respectively. A 5.3, 2.4 and 2-fold increase was seen with SiFnLn- compared with 
SiFn at 1 , 4 and 24 hours, respectively. In addition, there was a 3.5, 2 and 1.8-fold 
increase seen with SiFnLn- compared with SiLn- at 1, 4 and 24 hours, respectively. On 
silanized, passivated surfaces a 39.5, 35.3 and 23-fold increase was seen  with SiFnLn+ 
compared with Si+ subtrate alone at 1, 4 and 24 hours, respectively. There was a 7.2, 1.7 
and 1.9-fold increase was seen with SiFnLn+ compared with SiFn+ at 1, 4 and 24 hours, 
respectively. There was a 2.9, 3.7 and 2.1-fold increase with SiFnLn+ compared with 
SiLn+ at 1, 4 and 24 hours, respectively. 
 
Keratinocytes showed a similar trend to fibroblasts, where vinculin produced by cells on 
silanized, non-passivated dual coated substrate was significantly greater  than adsorbed 
surfaces and silanized, passivated surfaces, at 4 hours and 24 hours time points (p<0.05). 
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During the first hour, more vinculin per cell unit was produced on silanized, non-passivated 
surfaces and adsorbed surfaces than on silanized, passivated surfaces.  
 
In contrast to the trend seen with cell area, for adsorbed and silanized, non-passivated 
surfaces, vinculin expression was significantly greater in cells on single coated laminin 
substrates than  on fibronectin coated substrates at all time points (p<0.05).  
 
 
 
Figure 4.7: Box Plot showing Vinculin marker/Cell unit at 1, 4 and 24 hours on adsorbed 
surfaces 
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Figure 4.8: Box Plot showing Vinculin marker/Cell unit at 1, 4 and 24 hours on silanized, non-
passivated surfaces 
 
 
Figure 4.9: Box Plot showing Vinculin marker/Cell unit at 1, 4 and 24 hours on silanized, 
passivated surfaces 
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Figure 4.10: Box Plot showing Vinculin marker/Cell unit at 1 hour on different surfaces 
 
 
 
 
Figure 4.11: Box Plot showing Vinculin marker/Cell unit at 4 hours on different surfaces 
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Figure 4.12: Box Plot showing Vinculin marker/Cell unit at 24 hours on different surfaces 
 
 
4.3.4 Vinculin Markers Per Cell Area 
 
There was greater vinculin per cell area produced on dual coated protein substrates 
compared with single coated protein on adsorbed and salinized, non-passivated 
substrates at all time points (p<0.05). As with fibroblasts, this suggests that in the first 24 
hours, keratinocytes produce more focal adhesion contacts per area on dual coatings 
substrates. A 13.2, 11.4 and 12.3-fold increase was seen with AdFnLn compared with Pol 
substrate alone at 1, 4 and 24 hours, respectively. Vinculin per cell area was observed to 
be 4.2, 2.3 and 1.8-fold greater on AdFnLn than on AdFn at 1, 4 and 24 hours, 
respectively. There was a 2, 1.5 and 1.4-fold increase seen with AdFnLn compared with 
AdLn alone at 1, 4 and 24 hours, respectively. Vinculin per cell area was observed to be 
14.6, 21.5 and 10.2-fold greater on SiFnLn- than on Si- at 1, 4 and 24 hours, respectively. 
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A 4, 2 and 1.7- fold increase was seen with SiFnLn- compared with SiFn-  at 1, 4 and 24 
hours, respectively. In addition, there was a 2, 1.5 and 1.4-fold increase seen with SiFnLn- 
compared with SiLn- at 1, 4 and 24 hours, respectively. On silanized, passivated surfaces 
a 2.9, 3.2 and 5.8-fold increase with SiFnLn+ compared with Si+ subtrate alone at 1, 4 and 
24 hours, respectively. There was a 2.2, 1.1-fold increase was seen with SiFnLn+ 
compared with SiFn+ at 1 and 4 hours, respectively. There was a 2.9, 2.4 and 1.4-fold 
increase was seen with SiFnLn+ compared with SiLn+ at 1, 4 and 24 hours, respectively.  
 
For surface topography, Si- surfaces provided the best surface for vinculin per cell area 
followed by Ad then Si+ surfaces at all time intervals [Figures 4.16-4.21]. This is in keeping 
with the results shown with the fibroblast study. 
 
For single coatings, laminin coated substrates expressed more vinculin markers per cell 
area than fibronectin at all time points on adsorbed and silanized, non-passivated surfaces 
independent of surface topography. 
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Figure 4.13: Box Plot showing Vinculin marker/Cell area at 1, 4 and 24 hours on adsorbed 
surfaces 
 
 
Figure 4.14: Box Plot showing Vinculin marker/Cell area at 1, 4 and 24 hours on silanized, 
non-passivated surfaces 
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Figure 4.15: Box Plot showing Vinculin marker/Cell area at 1, 4 and 24 hours on silanized, 
passivated surfaces 
 
 
Figure 4.16: Box Plot showing Vinculin marker/Cell area at 1 hour on different surfaces 
 
 Chapter 4: Keratinocyte Spreading and Number of Focal Adhesion Vinculin Markers 
on Ti with Dual Coating Proteins 
 
126 
 
 
Figure 4.17: Box Plot showing Vinculin marker/Cell area at 4 hours on different surfaces 
 
 
 
Figure 4.18: Box Plot showing Vinculin marker/Cell area at 24 hours on different surfaces 
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Figure 4.19: Keratinocytes cultured at 1, 4 and 24 hrs on single and dual coating protein 
surfaces stained for focal adhesion plaques with anti-vinculin on polished surfaces 
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Figure 4.20: Keratinocytes cultured at 1, 4 and 24 hrs on single and dual coating protein 
surfaces stained for focal adhesion plaques with anti- vinculin on salinized, non-passivated 
surfaces 
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Figure 4.21: Keratinocytes cultured at 1, 4 and 24 hrs on single and dual coating protein 
surfaces stained for focal adhesion plaques with anti-vinculin on silanized, passivated 
surfaces 
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4.4 Discussion 
Keratinocytes showed that silanized, non-passivated dual coating protein surface provided 
the best surface for cell attachment and growth at all time intervals. In addition to this, 
laminin provided a better coating compared to fibronectin when either adsorbed or 
silanized on non-passivated titanium alloy for epithelial cells adhesion and growth. 
 
Scheideler et al. (2007), studied effect of silanized fibronectin on titanium surfaces on 
keratinocyte adhesion and growth. Fibronectin was covalently coupled to titanium (Ti) 
surfaces via silanization using anthraquinone immobilizer. Impact of initial host-biomaterial 
keratinocyte adhesion and platelet interactions was studied. Keratinocyte adhesion was 
studied after 30, 60, 90 and 120 minutes of incubation in Epilife-Medium (TEBU, 
Offenbach, Germany) at 370C and 5% CO2. Adhering cells were stained using fluorescein 
diacetate (FDA). Cell surface areas were measured using an epifluorescence microscope 
equipped with a digital camera. Cell adhesion and spreading was assessed by 
determination of the mean area of sample surface covered by vital stained cells in each 
group. They found that covalently bonding fibronectin enhanced both cell adhesion and 
growth. 
 
Karecla et al. (1994), showed that keratinocytes attached to laminin at three integrin sites. 
They proved that keratinocytes had specific laminin receptor sites that ensured the binding 
of the cells to this glycoprotein. 21 is the receptor that mediates the binding to laminin 
and collagen, while 31 is responsible for binding laminin and Kalinin. On the other hand, 
51 is the keratinocyte fibronectin receptor. This shows that fibronectin and laminin could 
increase cell adhesion to the Ti surface independently since each has different receptor 
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sites, meaning they do not compete for receptor sites on keratinocytes, making it possible 
for the cells to bind to both fibronectin and laminin when found together on the surface. 
 
Another factor that may explain the superiority of silanized, non-passivated dual coating 
surface in providing a better coating for early cell attachment and growth is surface 
roughness. It is very difficult to control variation of surface roughness at nanoparticle level. 
This is because even when we silanized the controls, addition of protein will add to 
roughness that will be difficult to detect. This can be measured using atomic force 
microscopy but will still be an additional variant. Baharloo et al. (2005), demonstrated as 
surface roughness increased, epithelial cell surface area decreased. They compared 
smooth polished Ti surfaces, acid-etched surfaces, grit blasted surfaces. They defined 
smooth polished Ti surfaces at Ra 0.06 μm. They found that rough surfaces decreased the 
growth of cells compared with smooth surfaces in cultures up to 28 days. In general, rough 
surfaces decreased the spreading of cells, as assessed by cell area, with the most 
pronounced affect for the SLA surface. On the other hand, the strength of cells adhesion 
was investigated by immunofluorescence staining of vinculin in focal adhesions indicating  
that cells form a greater number and larger focal adhesions on the smooth polished 
surface compared with the rougher acid-etched surface. These findings are comparable to 
mine. We have treated our surfaces with silanization and omitted the passivation step to 
obtain a smoother surface. We found that this produced favourable results both in terms of 
cell adhesion and growth, compared with polished surfaces.   
 
Ohji et al. (1993), studied the effect of exogenous laminin and fibronectin on corneal 
epithelial cell attachment. They found that laminin provided a better medium for cell 
attachment than fibronectin. They labeled human corneal epithelial cells with 3H-thymidine 
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and seeded them onto plates coated with laminin or fibronectin. After incubation, the cells 
that remained attached were lysed with 1ml of 1% sodium dodecyl sulfate and radioactivity 
of each sample was measured by liquid scintillation counting. Attachment of cells was 
calculated by dividing the radioactivity in cells that remained attached by the total 
radioactivity in the original suspension.  69% of human corneal epithelial cells attached to 
plates coated with human laminin or human fibronectin, with 50% of cells attached to the 
wells coated with 40ng ml-1 of laminin and fibronectin, respectively (p < 0.001). These 
results are comparable to my findings on single coating proteins on adsorbed and 
silanized, non-passivated surfaces and prove that exogenous laminin is better for epithelial 
cells’ up-regulation than fibronectin. 
 
El-Ghannam et al. (1998), coated Laminin-5 on Ti6Al4V surface via adsorption and 
passivation. They showed there was significantly more hemidesmosomes on passivated 
laminin-5 Ti6Al4V surface than unpassivated laminin-5 coated surface. Hemidesmosomes 
are small structures found in the inner basal surface of keratinocytes in the epidermis. 
They act as cell adhesion between cells and extra-cellular matrix. Similar to our results, 
they showed there was rapid cell attachment and spreading. They suggested the increase 
in hemidesmosome assembly may reflect better integration between epithelial cells and 
titanium alloy and may be a predictor to long-term implant stability. 
 
Tamura et al.(1997), investigated epithelial cell attachment to titanium alloy coated with 
laminin-5. They showed that cells were able to assemble hemidesmoses within 24 hours 
on laminin-5 coated titanium alloy but not on controls of titanium alloy only. They 
suggested laminin-5 may have clinical applications as an implant coating that promoted 
the formation of a biological seal.  
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In 2008, Pendegrass et al. studied the effect of surface roughness of Ti6Al4V on 
keratinocyte proliferation and attachment. They compared smooth-polished, machine-
finished, sand-blasted and hydrofluoric acid-etched titanium surfaces. Smooth-polished 
Ti6Al4V surfaces showed significantly better keratinocyte proliferation and cell attachment 
with vinculin and hemidesmosomes compared with other surfaces. It also provided a 
substrate for larger more flattened cells compared with the other surfaces. Similar to our 
results, surface topography influences the morphology of the cells and cell attachment. 
Keratinocyte attachment was enhanced by addition of fibronectin (Bush et al., 2007). 
 
In conclusion, previous studies have identified addition of protein coating enhances cell 
spreading and focal contact numbers. Other studies that used dual coating bone 
morphogenetic proteins found they were superior to single coating on osteoblasts. I have 
shown that adding dual coating protein fibronectin and laminin improve keratinocyte 
spreading and number of focal adhesion vinculin markers in vitro. This can be validated by 
examining the effect of dual coating protein fibronectin and laminin on BP180, E-cadherins 
and hemidesmosomes. 
 
Further in vitro studies are required to determine whether hemidesmosome attachment 
would be enhanced using silanized dual coating fibronectin and laminin. In addition to this, 
there is a need for in vivo studies to determine whether there would be competitive binding 
from other extra-cellular protein to the covalently bound dual coating protein. This would 
be done by silanizing the ITAP prostheses, prior to implanting, with single coating 
fibronectin, single coating laminin and dual coating fibronectin and laminin and comparing 
these with controls of polished non-silanized prosthesis. After 21 days, histology slides of 
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ITAP would determine whether there was adequate bonding at the implant-transcutaneous 
interface and if there was any statistical difference favouring any particular surface, as the 
in vitro study has with non-passivated silanized dual coating fibronectin-laminin coating on 
Ti6Al4V surface. 
 
 
 
 135 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5  
 
 
Effect of Fibronectin- Hydroxyapatite 
Coatings on Fibroblast Focal Adhesion 
Vinculin Markers 
 
 
 
 
 
Chapter 5: Effect of Fibronectin-Hydroxyapatite Coating on Febroblast attachment 
 
136 
 
5.1 Introduction 
5.1.1 Background  
Synthetic hydroxyapatite (HA) coatings have been incorporated in ITAP design to 
enhance dermal attachment successfully in vivo (Pendegrass et al., 2006 (6); 
Pendegrass et al., 2008, Kang et al., 2010). On the other hand, biological coatings in 
the form of silanized fibronectin coating improved dermal attachment to titanium alloy in 
vitro (Middleton CA et al., 2007). Both substrates have independently shown promising 
results in forming a tight seal barrier at the skin-implant barrier, which is crucial for the 
success of ITAP. 
 
Hydroxyapatite is found abundantly in the bones and teeth, forming the main inorganic 
component of bone. The crystalline form of calcium apatite is the formula 
Ca10(PO4)6(OH)2.This composite is responsible for the mechanical strength and 
osteoconduction of bone (Fox et al., 2012). When hydroxyapatite is combined with type 
1 collagen fibres and extracellular matrix, it is able to provide support scaffold for bone 
and teeth (Stigter et al., 2002). Carbonated apatite crystals are the smallest crystals in 
the human body, with average sizes of 50 x 25 x 2-4nm in bone and 100 x 50 x 50nm 
in tooth enamel (Weiner et al., 1999). Although hydroxyapaptite has a good 
compressive strength, it is  weak in tension with a high modulus of elasticity. Collagen 
complements this by providing high tensile strength, hence allowing bone to be strong 
yet provide some deformation.  
 
Synthetic hydroxyapatite coating of endoprostheses has shown to enhance 
osseointegration (Cook et al.,1988) and several studies investigated the interaction 
between extracellular proteins with hydroxyapatite. Shen et al. (2008), investigated the 
interactions of the 10th type III module of fibronectin with hydroxyapatite surface. They 
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concluded that the charged –COO(-) and –NH(3)(+) are the strongest groups that 
interact with hydroxapatite. In addition to this, Dong et al.(2007), studied the bonding of 
bone morphogenetic protein 2 (BMP-2) on hydroxyapatite. They found three types of 
functional groups –OH, -NH2 and –COO(-) through which BMP-2 interacts with 
hydroxyapaptite.  
 
However despite these investigations, the nature of this interaction remains unclear. In 
this chapter, we investigated the release kinetics and durability of Fn on hydroxyapatite 
surface in order to establish the optimum Fn coating to improve fibroblast attachment. 
The second part of the chapter assesses the effect of Fn- functionalized HA on dermal 
fibroblast attachment in vitro. Dr. CJ Pendegrass, performed the cell bioassay 
experiment and kindly shared the results for use in this chapter. 
 
The hypothesis is that adsorption of Fn on compacted, sintered HA discs would 
enhance fibroblast attachment when compared with HA alone and Ti controls. 
 
5.2 Materials and Methods 
5.2.1 Disc preparation 
One gram of hydroxyapatite powder (Apatech, Elstree, UK) was placed into 12 mm 
casts with 1.5 tonnes of pressure applied over 2 hours at 1250OC (5OC ramp/min). 
Compacted HA discs 11.7 mm in diameter were compacted in a mould and heated to 
500OC. X-ray diffraction analysis (XRD) was performed to assess crystallinity and purity 
of HA, XRD patterns recorded using X’Pert Pro Diffractometer (PANalytical Ltd, 
Cambridge, UK) and discs with 95% purity were used. 
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5.2.2 Fibronectin coating and radiolabelling 
Human plasma fibronectin (F2006; Sigma-Aldrich, Gillingham, UK) was custom-
labelled by PerkinElmer Inc. (Wellesley, Massachusetts, USA) using the method 
outlined in chapter 2.2.2. HA discs were coated with 50l droplets of 125I-Fn, spread 
evenly on the  surface of discs. All techniques were performed at 210C under sterile 
conditions using aseptic technique.  
Gamma radiation from radiolabelled protein was detected using Tricarb 290TR liquid 
scintillation counter (PerkinElmer Inc., USA) as counts per minute (CPM). Discs were 
placed facing up in 5ml scintillant tubes and immersed in 4.5ml Ultima Gold XR 
scintillation liquid (PerkinElmer Inc., USA). QuantaSmart software (v.1.31, Packard 
Instrument, USA) connected to the counter, provided CPM with correction of 125I half-
life, at a count time of 1 minute. Each sample was counted thrice. Six replicates were 
used for all experiments. 
 
5.2.3 Calibration Curve 
A standard calibration curve was generated for 125I-Fn on HA discs against CPM. 50 
l droplets of 10 g, 100 g, 250 g, 500 g and 750 g of 125I-Fn protein were placed 
on HA discs and CPM was immediately measured thrice.  
 
5.2.4 Effect of quantity of 125I-Fn loading on HA discs 
In order to determine maximum possible coating concentration, 100ng, 250ng, 500ng, 
1000ng and 1500ng of 125I-Fn were placed on disc surfaces for 1 hour before 
analysis.  
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5.2.5 Effect of duration on 125I-Fn loading of HA discs 
Optimal time to leave 125I-Fn on HA discs was determined by placing 500ng of 125I-
Fn on disc surfaces for zero, half an hour, 1 and 2 hours before analysis. 
 
5.2.6 Durability of 125I-Fn on HA discs 
50l droplet of 1000ng 125I-Fn was added to HA discs. These were immersed in fetal 
calf serum (FCS) (First Link Ltd, Birmingham, UK). The discs were analysed 
immediately after 3washes in sterile PBS at time zero. Remaining discs were left 
immersed in FCS at 37oC for 1, 4, 8 and 24 hours. 
 
5.2.7 Disc preparation for dermal fibroblast attachment 
Ti6Al4V discs, 10 mm in diameter, were ground, polished and cleaned, to be used as 
controls (Pol group). Discs were sterilised in a 2100 Classic Clinical Autoclave 
(Prestige Medical, Blackburn, UK) for 11 minutes at 126°C and a pressure of 1.4 bar. 
Surface roughness (Ra), mean maximum height of the profile (Rz) and mean spacing 
of irregularities of the profile (Sm) were measured using a Mitutoyo Surftest SV-400 
Surface Profiler (Mitutoyo, War- wick, United Kingdom). Non-functionalised sintered HA 
discs were prepared as described in section 5.2.1 and represented HA group. 1000ng 
of Fn were applied to HA discs for 1hour and represented HAFn group.  
 
5.2.8 Fibroblast culture and seeding 
Fibroblasts (1BR.3.G cells, ECACC/Sigma-Aldrich) were cultured in Dulbecco’s 
Modified Eagle’s medium (DMEM; Sigma- Aldrich) with 4500 mg/l glucose, 1% non-
essential amino acids, 1% penicillin/streptomycin (Invitrogen Corporation, Paisley, UK) 
and 10% FCS (First Link) at 37°C with 5% CO2; 2500 cells per disc were seeded for 1, 
4 and 24 hours on Pol, HA and HAFn discs.  
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5.2.9 Fibroblast focal adhesion detection method 
The discs were washed in PBS and fixed in formal saline for 5minutes. Four five-
minute washes in PBS followed. Mouse monoclonal anti-human clone HUV-1 (V9131 
Sigma-Aldrich = Anti-vinculin) (1:100) and Triton X-100 (1:500) was added for 2 hours. 
After 3 washes in PBS the discs were incubated for 45 minutes with fluorescein 
isothiocyanate (FITC) conjugate in a secondary antibody solution (F2883 Sigma-
Aldrich; Anti-mouse) (1:168 in sterile PBS) and then washed 3 times in PBS before 
analysis. 
 
5.2.10 Fibroblast focal adhesion and cell area quantification  
After vinculin staining at 1, 4 and 24 hours, focal adhesion quantification was carried 
out using a Carl Zeiss microscope (Carl Zeiss Ltd, Welwyn Garden City, UK) with ×50, 
and ×100 objective lenses. For each disc 15 cells were analysed. A random field of 
view was selected and the vinculin markers on the cells were manually identified and 
counted by two independent observers who were blinded both to the test substrate and 
to one another.  
 
5.2.11 Statistical Analysis 
Using kappa statistics, kappa scores indicated almost perfect inter-observer agreement 
(> 0.90), and so the data presented are those of both observers combined. Cell areas 
were measured using Axiovision Image Analysis Software (Axioimage 4.4; Carl Zeiss, 
Gottingen, Germany). The number of vinculin markers per unit and cell area were 
calculated by dividing the number of vinculin counts by cell unit and cell area, 
respectively. The data did not fit the assumptions required for parametric testing and 
were analysed using Mann-Whitney U tests to compare medians. Box plots showing 
median values, whole and interquartile ranges and median values were expressed with 
95% confidence intervals (CI). All numerical data are stated as median values (with 
Chapter 5: Effect of Fibronectin-Hydroxyapatite Coating on Febroblast attachment 
 
141 
 
95% CI) unless otherwise stated. Results were considered significant when the p-value 
< 0.05. 
 
5.3 Results  
5.3.1 Calibration Curve 
A standard calibration curve was designed and used to determine the results for the 
loading and release kinetics experiments with correction for the half- life of 125I (R2 = 
0.995) (Figure 5.1). 
 
 
Figure 5.1: Calibration Curve for Correlating Counts Per Minute to 125I-Fn Quantity 
(nanograms) 
 
5.3.2 Optimisation of loading time for 125I-Fn coating on HA 
discs 
The optimal time for loading of Fn onto HA discs was 1 hour (Figure 5.2 and 5.3). The 
amount of Fn remaining on HA discs increased significantly between all time points up 
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to 1 hour (p<0.001), but there was no significant difference between 1 and 2 hours (p = 
0.691). The data show that there was no significant increase in the amount of protein 
retained on the discs after incubation for one hour. 
 
After 1 hour (optimal incubation duration as shown above) the median maximum 
amount of Fn bound was 255.26ng (95% CI: 253.74 to 264.26ng) from an initial load of 
500ng in 50μl. 
 
 
Figure 5.2: Box plot showing Counts Per Minute detected after initial loading with 500ng 
125I-Fn on HA discs over time 
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Figure 5.3: Box plot showing amount of 125I-Fn (ng) remaining, after initial loading with 
500ng 125I-Fn on HA discs over time 
 
 
5.3.3 Optimisation of 125I-Fn loading quanitity on HA discs 
As the quantity of 125I-Fn added increased (from 100ng to 250ng, and 500ng to 
1000ng), a significantly higher quantity of 125I-Fn remained on the discs (all p < 
0.001); 50μl droplets containing 1000ng and 1500ng did not produce proportionally 
more coupled protein (p = 0.085) (Figures 5.4 and 5.5). 
The optimal loading concentration and incubation time of 1000ng in 50μl for 1 hour was 
used to determine the optimum durability.  
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Figure 5.4: Box plot showing CPM detected on HA discs after initial loading between 
100ng and 1500ng Fn, incubation for 1 hour 
 
 
Figure 5.5: Box plot showing amount of 
125
I-Fn (ng) remaining on HA discs after initial 
loading between 100ng and 1500ng Fn, incubation for 1 hour 
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5.3.4: Durability kinetics of 125I-Fn on HA discs 
A significant decrease from a median of 249.91ng (95% CI 239.79 to 254.39) to 137.93 
ng (95% CI 135.89 to 142.72ng) of Fn coupled to HA was seen within the first hour of 
incubation in FCS (p < 0.001) (Figures 5.6 and 5.7). There was no further decrease 
between 1 and 4 hours (p = 0.233), or between four and eight hours (p = 0.1); 
however, the amount decreased significantly to one-fifth of its initial optimal loading 
concentration (median 49.99ng (95% CI 43.71 to 51.33)) by 24 hours (p < 0.001). 
These figures are equivalent to 3.2ng mm-2, 1.8 ng mm-2 and 0.6 ng mm-2 of Fn on 
HA at zero, 1 to 8, and 24 hours, respectively.  
 
 
 
Figure 5.6: Box plot showing CPM detected on HA discs with increasing incubation time 
(hours) after initial loading of 100 ng 125I-Fn in FCS 
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Figure 5.7: Box plot showing amount of125I-Fn (ng) remaining on HA discs with 
increasing incubation time (hours) after initial loading of 1000ng 125I-Fn in FCS 
 
5.3.5 Surface roughness experiments  
Median Ra, Rz and Sm values for Pol were 0.030μm (95% CI 0.011 to 0.048), 
0.120μm (95% CI 0.100 to 0.148) and 20.630μm (95% CI 9.804 to 32.701), 
respectively. The corresponding median values for HA were 0.039 μm (95% CI 0.121 
to 0.052), 0.131μm (95% CI 0.107 to 0.159) and 22.005 μm (95% CI 10.020 to 34.653). 
No statistically significant differences were observed between Pol and HA discs (p = 
0.650, p = 0.631 and p = 0.262 for Ra, Rz and Sm, respectively). 
 
5.3.6 Fibroblast focal adhesion and cell area quantification  
5.3.6.1 Number of vinculin markers per cell 
The number of vinculin markers per cell was significantly greater on HAFn than on the 
HA and Pol controls at all time-points (HAFn vs HA: p = 0.003, 0.004 and 0.004; HAFn 
vs Pol: p = 0.003, 0.004 and 0.004; at 1, 4 and 24 hours, respectively). A 15-, 19- and 
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12-fold increase was seen with HAFn compared with HA alone at 1, 4 and 24 hours, 
respectively. After one hour the number of vinculin markers per cell was significantly 
greater with HA than with Pol (p = 0.006), but by 4 and 24 hours the opposite was seen 
(p = 0.025 and 0.004, respectively). 
 
5.3.6.2 Cell area 
At 1 and 4 hours the cell area increased in the order HA < Pol < HAFn. The median cell 
area on HAFn was significantly greater than those on both HA and Pol controls (HAFn 
vs HA: p = 0.003 and 0.004; HAFn vs Pol: p = 0.003 and 0.004; at 1 and 4 hours, 
respectively). At 24 hours the cell areas on both HAFn and Pol were significantly 
greater than on HA (p = 0.01 and 0.004); there was no significant difference between 
them (p = 0.631). Cell area was observed to be 5-, 5.5- and 2-fold greater on HAFn 
than on HA at 1, 4 and 24 hours, respectively. 
 
5.3.6.3 Vinculin marker per cell area 
Vinculin adhesion markers were counted and divided by cell area. d . At 1 hour 
attachment increased significantly between Pol and HA (p = 0.004) and between HA 
and HAFn (p = 0.003) with a 14- and a three- fold increase, respectively (Fig. 5.8). 
 
A similar pattern was seen at 4 and 24 hours (Fig. 5.8); however, no significant 
difference was seen between Pol and HA (p = 0.055 and 0.150). Attachment was 
significantly greater on HAFn than on HA at four and 24 hours (p = 0.004): 4 and 7-fold 
increases were seen. 
 
On Pol substrates, vinculin per cell area increased significantly between 1 and 4 hours 
(p = 0.004), after which no significant difference was seen (p = 0.199). 
Chapter 5: Effect of Fibronectin-Hydroxyapatite Coating on Febroblast attachment 
 
148 
 
Attachment of cells on HA was not significantly different between  1 and  4 (p = 0.262) 
or  4 and 24 hours (p = 0.055); however, on HAFn attachment increased significantly 
between both time points (p = 0.038 and 0.004, respectively) (Figure 5.8). Figure 5.9 
shows vinculin staining in cells on Pol, HA and HAFn at 1, 4 and 24 hours. The images 
show increases in cell area and vinculin markers on HAFn substrates at all times 
compared to HA and Pol controls. Number of vinculin markers per unit cell area, on 
HAFn at 1 hour was 3.4 and 4.2 times greater than with HA and Pol at 24 hours (Fig. 
5.9). 
 
 
 
Figure 5.8: Graph showing median number of vinculin markers per unit cell area (count 
per m
2
) for polished (Pol), HA and HAFn substrates for 1, 4 and 24 hours 
 
Chapter 5: Effect of Fibronectin-Hydroxyapatite Coating on Febroblast attachment 
 
149 
 
 
Figure 5.9: Fluorescence microscopy showing appearance of fibroblasts on Pol, HA and 
HAFn substrates at 1, 4 and 24 hours 
 
5.4 Discussion 
In this chapter we have shown that Fn can be adsorbed on HA, and that this procedure 
increases dermal fibroblasts vincluin markers per unit area of the cell in vitro.  
 
Focal adhesions are crucial for cell attachment signalling and regulation (Petit and 
Thiery, 2000; Sastry and Burridge, 2000). Accurate quantification of cell attachment 
can be measured through calculating the number of vinculin markers per unit cell area; 
gives an accurate indication of the biophysical strength of cell attachment (Pendegrass 
et al.,2010). Previous studies have shown that protein augmentation can increase the 
attachment of cells in vitro (Middleton el al.,2007; El Ghannam et al.,1998), and 
1 hour 24 hours 4 hours 
Pol 
HA 
HaF
n 
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attempts to create durable coatings by silanisation have shown promising results 
(Gordon et al., 2010). My work in chapters 2, 3 and 4 show that silanized dual coating 
protein on Ti6Al4V is a a durable surface that improves keratinocyte and fibroblast 
attachment compared to uncoated controls and single coating proteins. Silanisation 
techniques create –CHO bonds for protein binding, but are laboratory based and 
subject to considerable variability. The process is time consuming and has a learning 
curve to master the steps. Protein absorption may be a more consistent technique and, 
unlike silanisation, could be performed at the time of surgery for ITAP. On HA discs, 
our findings show that after 1 hour of adsorption with an initial coating concentration of 
13 ng mm-2 (1000 ng per 10 mm diameter disc), HA substrates are optimally loaded 
with 3.2 ng mm-2, which significantly increases dermal fibroblast attachment in vitro. 
Given the duration of an ITAP surgical procedure, intra-operative implementation of our 
adsorption technique would be practicable. 
 
In 2010, Gordon et al., showed that keratinocyte attachment could be increased by a 
coating of 6 to 7ng/mm2 of silanised laminin-5.  My findings agree with this and show 
that between 3.2 and 0.6 ng mm-2 of Fn have a significant positive effect on fibroblast 
attachment. The maximum amount of Fn that could be adsorbed was 3.2 ng/mm2, 
although we accept that this may not give a maximal increase in the attachment 
strength of the dermal fibroblasts. In addition to this, in vivo studies are still needed to 
establish whether similar there is a increase in dermal attachment. I noted a decrease 
in adsorbed Fn on HA, only one-fifth of the initial load remaining by 24 hours. This 
shows that the stability of the coating is not as robust as that achieved with silanisation. 
Despite this, a 7-fold increase in fibroblast attachment on Fn-functionalised HA was 
seen at 24 hours. Further investigations are necessary to determine whether this is 
directly due to the Fn coating, or whether the initial coating influences the deposition 
rate and composition of the ECM, which in turn upregulates attachment. In a study 
assessing the influence of the competitive pre-adsorption of human serum albumin and 
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Fn on osteoblast adhesion and morphology, Sousa et al. (2008), concluded that the 
tissue response to implants is dependent on the initial attachment of cells to the 
substrate and that this is directly related to the ability of cells to interact with the protein 
layer absorbed on the implant surface. In 2008, Laflamme and Rouabhia showed that 
BMP-2 and -7 coatings promote osteoblast attachment to collagen scaffolds and 
concluded that this was due to the substrate mimicking the in vivo physiological 
conditions of the ECM more precisely than uncoated controls. I suggest that Fn-pre-
adsorbed HA resembles the adhesion protein component of the fibroblasts’ native ECM 
more closely, enabling them to become attached more quickly and more efficiently than 
uncoated controls.  
 
In conclusion, our results suggest that Fn-coated HA implants  increases vinculin 
adhesion markers per cell area to ITAP. An adsorption technique that applies Fn to 
HA-coated implants at the time of surgery may be enough to achieve this without the 
need for prolonged preparation, which might limit the application of these coatings. 
Further work is needed to determine whether increased concentrations of Fn result in 
further upregulation of dermal fibroblast attachment and whether these coatings elicit a 
similar effect on dermal tissue attachment around an ITAP in vivo. The hypothesis 
would be that Fn applied to HA- coated ITAP would bind to surrounding tissue with 
more surface area compared to controls on uncoated ITAP and HA coated ITAP 
without Fn. 
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6.1 Conclusions from this Thesis 
In my thesis, I investigated HaCaT keratinocytes and HDF fibroblasts grown on 
Ti6Al4V with the overall aim being to increase earlyvinculin markers and cell area.  My 
work aims to help cells form a barrier at the implant- tissue interface that is resistant to 
infection.This seal may help avoiding cell down-growth, marsupilization, infection and 
failure of metalwork. This improves longevity and effectiveness of percutaneous 
devices, which require this seal for their success. Intraosseous Transcutaneous 
Amputation Prosthesis (ITAP) is a novel percutaneous device that overcomes 
conventional stump-socket problems. By creating a soft tissue seal around the 
percutaneous portion of this permanent implant, the hope is that long-term survival can 
be achieved (Pendegrass et al., 2008). 
 
The overall hypothesis tested in this thesis was that by modifying both the 
chemical structure and the surface topography of Ti6Al4V, both keratinocyte and 
fibroblast vinculin markers and cell area would be enhanced. This has been 
supported. 
 
Since Branemark’s design of a percutaneous device for amputees, no attempt to deal 
with skin-implant interface down-growth and failure was investigated to improve its 
design. Our research group has attempted to improve this barrier by modifying the 
chemical structure of Ti6Al4V via covalently bonding laminin to the metal surface, or 
covalently bonding fibronectin and investigating the behaviour of keratinocytes and 
fibroblasts on the attachment respectively (Pendegrass et al., 2008). Further work 
identified that changing the surface topography through oxidation of Ti6Al4V prior to 
silanization can have a detrimental effect on cell attachment (Pendegrass et al., 2010) 
that provided the basis for my work. 
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In order to enhance HaCaT and HDF attachment to Ti6Al4V, I examined the effect of 
polished surfaces and silanized surfaces on cells. I also examined silanization with and 
without oxidation as methods to covalently link dual coating proteins of fibronectin and 
laminin to Ti6Al4V. These surfaces were tested in vitro to assess keratinocyte and 
fibroblast behaviour, including the expression of adhesion complexes and growth.  
 
In Chapter 2, I hypothesised that silanized dual coating proteins on Ti6Al4V surfaces 
bonded significantly more and were more durable than on adsorbed surfaces. I also 
hypothesized that there was non-competitive bonding between laminin and fibronectin 
when they were silanized on Ti6Al4V. I used radiolabeled protein to quantify the 
amount of laminin and fibronectin remaining on Ti6Al4V over time in a sensitive and 
accurate method. I showed that covalent bonding of dual coating proteins 125I-Fn and 
125I-Ln to Ti6Al4V through silanization (Weetall, 1993) demonstrated significantly larger 
amounts of both proteins remaining on the surface compared to adsorbed surfaces at 
all time periods. There was a 7-fold increase of silanized dual coating fibronectin 
remaining on Ti6Al4V at 72 hours compared to adsorbed dual coating fibronectin and a 
4 -fold increase of silanized dual coating laminin compared to adsorbed dual coating 
laminin at the same time period. I showed this increase happens in dual coating 
proteins as well as single coating protein. I also showed that there was non-competitive 
binding of these proteins on the surface on the substrate. The protocol outlined by 
Middleton et al. (2007), and Gordon et al.(2010), was implemented where maximum 
bonded laminin and fibronectin were used respectively, which was 6.366ng/mm2 for 
both proteins.  
 
In order to determine whether dual coating protein silanized to Ti6Al4V were sufficient 
to enhance early cell adhesion and growth, further experiments were required to 
culture cells on silanized dual coating proteins and test their adhesion properties and 
size using the same silanization protocols.  
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In chapter 3, I examined the behaviour of HaCATs on dual coating laminin and 
fibronectin and single coating laminin and fibronectin on Ti6Al4V surfaces. Silanization 
allows proteins to couple to metal alloy directly, the protocol outlined by Middleton et al. 
(2007), requiring metal to be passivated in order to provide a uniform layer of TiO2. 
However, passivation leads to creating a rough surface that may have negative effect 
on cell attachment. I compared dual coating protein on polished surfaces and silanized 
surfaces with and without passivation. I also ran the same experiments at the same 
time points using uncoated controls, adsorbed, silanized passivated, silanized non-
passivated single coating fibronectin and single coating laminin to determine if there 
was any significance between them or with dual coating proteins. Cell attachment was 
determined by measuring vinculin markers and cell growth by measuring cell size. I 
found that silanized dual coating protein provided the best surface for early cell 
attachment and growth. Gordon et al. (2008), showed that silanized passivated laminin 
supported smaller cell area than control discs. There were more vinculin markers per 
cell and per unit area than controls. However, vinculin markers per cell and cell area 
were not significantly more than adsorbed laminin at 24 hours. These are similar to my 
findings; this may be due to the rough surface formed by the passivation step of 
silanization. When this step is removed, silanized, non-passivated laminin surface 
supported more cell area, vinculin markers per cell and per unit area than silanized, 
passivated laminin surface and controls at all time points. No work has investigated 
silanized, non-passivated dual coating protein fibronectin and laminin. Further studies 
need to be conducted to validate my results.  
 
In chapter 4, I investigated the effect of dual coating protein fibronectin and laminin on 
HDF fibroblasts. I compared controls of polished uncoated surface; silanized, non-
passivated; silanized passivated, single coating laminin and fibronectin and dual 
coating protein. I found that silanized, non-passivated dual coating protein surface 
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expressed significantly more vinculin markers per cell unit and cell area. Middleton et 
al.(2007), investigated silanized, passivated and non-passivated single coating 
fibronectin, and concluded that silanized, non-passivated fibronectin surface expressed 
larger cell areas and vinculin markers at all time periods. No previous studies 
investigated silanized, non-passivated dual coating protein effect on HDFs.  
 
In chapter 5, I investigated the durability of fibronectin coating on HA discs. Fn 
attachment peaked at one hour of incubation and the maximum binding efficiency was 
achieved with a droplet of 1000ng. There was a significant increase in cell attachment 
at 1, 4 and 24 hours with Fn coating on HA discs to uncoated controls. 
 
6.2 Clinical Relevance of the Experiments 
The data presented in this thesis are highly relevant to clinical practice. Intra-osseous 
transcutaneous amputation prostheses is dependent on the presence of a tight seal at 
the skin-implant interface to avoiding epithelial downgrowth, marsupialisation, infection, 
subsequent loosening and failure of the metalwork.  
 
I developed a Ti6Al4V surface that enhances early epithelial attachment and is stable 
in vitro. By applying this surface in clinical practice, transcutaneous devices may form 
this barrier that improves the longevity and reduces morbidity in patients with these 
devices.  
 
This new surface can also be used to coat external pins in treatment of fractures and 
leg lengthening procedures. Although these devices are temporary, complications of 
pin site infections can be reduced by forming a seal around the metal alloy.  
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Research done in my thesis is a step to come closer to developing the ideal surface for 
ITAP. This will improve the transcutaneous portion of ITAP and will contribute to the 
ongoing development for this amputation prosthesis. 
 
6.3 Further Work 
In vivo, it is not just cell attachment that may be important in producing a seal at the 
skin-implant interface. Competitive binding from other components within the 
extracellular matrix such as albumin, cellular activity involved in wound healing in 
addition to the presence of many other cell types may affect my results in vivo.  
 
Wound healing is a dynamic process that may need other substrates to enhance this 
environment and may need to be triggered at different time points as the local pH 
changes. Addition of prophylactic local antibiotics may be necessary to help cells, in 
case bacteria and other microorganisms attempt to invade the skin-implant barrier and 
underlying tissues.  
 
Further work needs to investigate synthetic RGD sequences to compare them to dual 
coating fibronectin and laminin both in vitro and in vivo. The hypothesis would be 
synthetic cyclic RGD sequences coated to Ti6Al4V discs produce more vinculin 
markers and increased cell area on fibroblasts and keratinocytes compared with 
controls and dual coating FnLn. These would then be tested on animal studies to 
compare then to controls. Histopathological samples would be examinaed for the 
percentage of tissue binding to Ti alloy. The following step would be to test the effect of 
sterilization techniques such as gamma radiation, or ethylene oxide on protein coated 
ITAP. The hypothesis would be there would be no difference in the vinculin markers 
and cell area when discs are sterilized using different techniques. This would allow the 
protein coated implants to be used in operative procedures. The hope is that the 
Chapter 6: Conclusions From My Thesis 
 
158 
 
results gained from my studies provide evidence to support the long-term use of ITAP 
utilizing biomaterials similar to the ones I used in my thesis and to reach a practical, 
commercially available product that can be utilized in normal operating theatres. 
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7.1:Polished surfaces fibroblast cell area descriptives 
 
Polished 
Surface   Statistic 
Std. 
Error 
Cell Area 
(micrometres squared) 
Pol 1hr Mean 352.2083 18.44742 
95% Confidence 
Interval for Mean 
Lower Bound 304.7877   
Upper Bound 399.6289   
5% Trimmed Mean 353.3315   
Median 363.5650   
Variance 2041.844   
Std. Deviation 45.18677   
Minimum 288.67   
Maximum 395.53   
Range 106.86   
Interquartile Range 86.76   
Skewness -.507 .845 
Kurtosis -1.884 1.741 
Pol 4hrs Mean 487.0717 13.10684 
95% Confidence 
Interval for Mean 
Lower Bound 453.3795   
Upper Bound 520.7639   
5% Trimmed Mean 487.5363   
Median 491.1200   
Variance 1030.735   
Std. Deviation 32.10507   
Minimum 440.49   
Maximum 525.29   
Range 84.80   
Interquartile Range 60.85   
Skewness -.394 .845 
Kurtosis -1.089 1.741 
Pol 24hrs Mean 680.9733 15.59293 
95% Confidence Lower Bound 640.8904   
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Interval for Mean Upper Bound 721.0562   
5% Trimmed Mean 681.1165   
Median 676.0800   
Variance 1458.837   
Std. Deviation 38.19473   
Minimum 631.70   
Maximum 727.67   
Range 95.97   
Interquartile Range 71.82   
Skewness .067 .845 
Kurtosis -1.842 1.741 
AdFn 1hr Mean 1221.4433 10.80285 
95% Confidence 
Interval for Mean 
Lower Bound 1193.6737   
Upper Bound 1249.2129   
5% Trimmed Mean 1221.6787   
Median 1225.3900   
Variance 700.209   
Std. Deviation 26.46147   
Minimum 1186.56   
Maximum 1252.09   
Range 65.53   
Interquartile Range 54.73   
Skewness -.336 .845 
Kurtosis -1.619 1.741 
AdFn 4hrs Mean 1442.1417 24.17230 
95% Confidence 
Interval for Mean 
Lower Bound 1380.0048   
Upper Bound 1504.2785   
5% Trimmed Mean 1441.6330   
Median 1437.5350   
Variance 3505.801   
Std. Deviation 59.20980   
Minimum 1377.01   
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Maximum 1516.43   
Range 139.42   
Interquartile Range 127.95   
Skewness .193 .845 
Kurtosis -1.801 1.741 
AdFn 24hrs Mean 1759.4550 18.80587 
95% Confidence 
Interval for Mean 
Lower Bound 1711.1130   
Upper Bound 1807.7970   
5% Trimmed Mean 1758.7561   
Median 1756.8750   
Variance 2121.964   
Std. Deviation 46.06479   
Minimum 1698.16   
Maximum 1833.33   
Range 135.17   
Interquartile Range 72.77   
Skewness .484 .845 
Kurtosis .734 1.741 
AdLn 1hr Mean 1069.5200 28.87035 
95% Confidence 
Interval for Mean 
Lower Bound 995.3064   
Upper Bound 1143.7336   
5% Trimmed Mean 1065.2933   
Median 1036.4050   
Variance 5000.982   
Std. Deviation 70.71762   
Minimum 1016.59   
Maximum 1198.53   
Range 181.94   
Interquartile Range 106.51   
Skewness 1.592 .845 
Kurtosis 1.958 1.741 
AdLn 4hrs Mean 1199.7567 33.44907 
95% Confidence Lower Bound 1113.7731   
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Interval for Mean Upper Bound 1285.7403   
5% Trimmed Mean 1200.2396   
Median 1215.5300   
Variance 6713.044   
Std. Deviation 81.93317   
Minimum 1099.06   
Maximum 1291.76   
Range 192.70   
Interquartile Range 172.56   
Skewness -.375 .845 
Kurtosis -1.890 1.741 
AdLn 24hrs Mean 1587.3417 25.32817 
95% Confidence 
Interval for Mean 
Lower Bound 1522.2335   
Upper Bound 1652.4498   
5% Trimmed Mean 1588.3202   
Median 1609.5650   
Variance 3849.096   
Std. Deviation 62.04108   
Minimum 1506.12   
Maximum 1650.95   
Range 144.83   
Interquartile Range 125.18   
Skewness -.666 .845 
Kurtosis -1.834 1.741 
AdFn/Ln 1hr Mean 1572.7683 25.78516 
95% Confidence 
Interval for Mean 
Lower Bound 1506.4855   
Upper Bound 1639.0512   
5% Trimmed Mean 1572.2215   
Median 1571.2400   
Variance 3989.248   
Std. Deviation 63.16049   
Minimum 1499.19   
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Maximum 1656.19   
Range 157.00   
Interquartile Range 130.86   
Skewness .126 .845 
Kurtosis -1.584 1.741 
AdFn/Ln 4hrs Mean 1821.9600 28.40093 
95% Confidence 
Interval for Mean 
Lower Bound 1748.9531   
Upper Bound 1894.9669   
5% Trimmed Mean 1821.5611   
Median 1818.8900   
Variance 4839.677   
Std. Deviation 69.56778   
Minimum 1754.32   
Maximum 1896.78   
Range 142.46   
Interquartile Range 131.66   
Skewness .038 .845 
Kurtosis -3.169 1.741 
AdFn/Ln 24hrs Mean 2206.6517 20.90016 
95% Confidence 
Interval for Mean 
Lower Bound 2152.9261   
Upper Bound 2260.3772   
5% Trimmed Mean 2206.8607   
Median 2206.2350   
Variance 2620.899   
Std. Deviation 51.19472   
Minimum 2145.07   
Maximum 2264.47   
Range 119.40   
Interquartile Range 105.96   
Skewness -.013 .845 
Kurtosis -2.245 1.741 
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7.2: Polished surfaces fibroblast vinculin per cell 
descriptives 
 Polished Surface   Statistic Std. Error 
Vinculin/Cell Pol 1hr Mean 1.833 .4014 
95% Confidence 
Interval for Mean 
Lower Bound .802   
Upper Bound 2.865   
5% Trimmed Mean 1.815   
Median 1.500   
Variance .967   
Std. Deviation .9832   
Minimum 1.0   
Maximum 3.0   
Range 2.0   
Interquartile Range 2.0   
Skewness .456 .845 
Kurtosis -2.390 1.741 
Pol 4hrs Mean 5.333 .3333 
95% Confidence 
Interval for Mean 
Lower Bound 4.476   
Upper Bound 6.190   
5% Trimmed Mean 5.370   
Median 5.500   
Variance .667   
Std. Deviation .8165   
Minimum 4.0   
Maximum 6.0   
Range 2.0   
Interquartile Range 1.3   
Skewness -.857 .845 
Kurtosis -.300 1.741 
Pol 24hrs Mean 5.667 .2108 
95% Confidence Lower Bound 5.125   
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Interval for Mean Upper Bound 6.209   
5% Trimmed Mean 5.685   
Median 6.000   
Variance .267   
Std. Deviation .5164   
Minimum 5.0   
Maximum 6.0   
Range 1.0   
Interquartile Range 1.0   
Skewness -.968 .845 
Kurtosis -1.875 1.741 
AdFn 1hr Mean 56.167 2.2274 
95% Confidence 
Interval for Mean 
Lower Bound 50.441   
Upper Bound 61.892   
5% Trimmed Mean 56.185   
Median 56.500   
Variance 29.767   
Std. Deviation 5.4559   
Minimum 49.0   
Maximum 63.0   
Range 14.0   
Interquartile Range 11.0   
Skewness -.136 .845 
Kurtosis -1.449 1.741 
AdFn 4hrs Mean 80.833 3.1981 
95% Confidence 
Interval for Mean 
Lower Bound 72.612   
Upper Bound 89.054   
5% Trimmed Mean 80.926   
Median 80.500   
Variance 61.367   
Std. Deviation 7.8337   
Minimum 70.0   
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Maximum 90.0   
Range 20.0   
Interquartile Range 15.5   
Skewness -.100 .845 
Kurtosis -1.333 1.741 
AdFn 24hrs Mean 93.833 3.6462 
95% Confidence 
Interval for Mean 
Lower Bound 84.461   
Upper Bound 103.206   
5% Trimmed Mean 93.648   
Median 92.500   
Variance 79.767   
Std. Deviation 8.9312   
Minimum 84.0   
Maximum 107.0   
Range 23.0   
Interquartile Range 17.0   
Skewness .490 .845 
Kurtosis -1.187 1.741 
AdLn 1hr Mean 38.500 1.6073 
95% Confidence 
Interval for Mean 
Lower Bound 34.368   
Upper Bound 42.632   
5% Trimmed Mean 38.500   
Median 38.500   
Variance 15.500   
Std. Deviation 3.9370   
Minimum 34.0   
Maximum 43.0   
Range 9.0   
Interquartile Range 7.5   
Skewness .000 .845 
Kurtosis -2.758 1.741 
AdLn 4hrs Mean 40.333 2.0276 
95% Confidence Lower Bound 35.121   
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Interval for Mean Upper Bound 45.545   
5% Trimmed Mean 40.370   
Median 41.000   
Variance 24.667   
Std. Deviation 4.9666   
Minimum 34.0   
Maximum 46.0   
Range 12.0   
Interquartile Range 10.5   
Skewness -.298 .845 
Kurtosis -1.736 1.741 
AdLn 24hrs Mean 81.667 2.9963 
95% Confidence 
Interval for Mean 
Lower Bound 73.964   
Upper Bound 89.369   
5% Trimmed Mean 81.852   
Median 85.000   
Variance 53.867   
Std. Deviation 7.3394   
Minimum 71.0   
Maximum 89.0   
Range 18.0   
Interquartile Range 13.5   
Skewness -.830 .845 
Kurtosis -1.419 1.741 
AdFn/Ln 1hr Mean 93.500 2.3488 
95% Confidence 
Interval for Mean 
Lower Bound 87.462   
Upper Bound 99.538   
5% Trimmed Mean 93.778   
Median 94.500   
Variance 33.100   
Std. Deviation 5.7533   
Minimum 83.0   
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Maximum 99.0   
Range 16.0   
Interquartile Range 8.5   
Skewness -1.418 .845 
Kurtosis 2.369 1.741 
AdFn/Ln 4hrs Mean 130.833 2.5615 
95% Confidence 
Interval for Mean 
Lower Bound 124.249   
Upper Bound 137.418   
5% Trimmed Mean 130.704   
Median 129.500   
Variance 39.367   
Std. Deviation 6.2743   
Minimum 124.0   
Maximum 140.0   
Range 16.0   
Interquartile Range 11.5   
Skewness .512 .845 
Kurtosis -1.409 1.741 
AdFn/Ln 24hrs Mean 153.333 2.8245 
95% Confidence 
Interval for Mean 
Lower Bound 146.073   
Upper Bound 160.594   
5% Trimmed Mean 153.426   
Median 154.000   
Variance 47.867   
Std. Deviation 6.9186   
Minimum 144.0   
Maximum 161.0   
Range 17.0   
Interquartile Range 12.5   
Skewness -.242 .845 
Kurtosis -2.131 1.741 
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7.3: Polished surfaces fibroblast vinculin per cell area 
descriptives 
 Polished Surface   Statistic Std. Error 
Vinculin/Cell Area Pol 1hr Mean .00513 .001038 
95% Confidence 
Interval for Mean 
Lower Bound .00246   
Upper Bound .00779   
5% Trimmed Mean .00507   
Median .00426   
Variance .000   
Std. Deviation .002543   
Minimum .003   
Maximum .009   
Range .006   
Interquartile Range .005   
Skewness .660 .845 
Kurtosis -1.658 1.741 
Pol 4hrs Mean .01092 .000505 
95% Confidence 
Interval for Mean 
Lower Bound .00962   
Upper Bound .01222   
5% Trimmed Mean .01098   
Median .01139   
Variance .000   
Std. Deviation .001238   
Minimum .009   
Maximum .012   
Range .003   
Interquartile Range .002   
Skewness -1.471 .845 
Kurtosis 1.873 1.741 
Pol 24hrs Mean .00834 .000350 
95% Confidence Lower Bound .00744   
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Interval for Mean Upper Bound .00924   
5% Trimmed Mean .00834   
Median .00829   
Variance .000   
Std. Deviation .000857   
Minimum .007   
Maximum .009   
Range .002   
Interquartile Range .002   
Skewness .113 .845 
Kurtosis -1.136 1.741 
AdFn 1hr Mean .04598 .001751 
95% Confidence 
Interval for Mean 
Lower Bound .04148   
Upper Bound .05048   
5% Trimmed Mean .04602   
Median .04687   
Variance .000   
Std. Deviation .004290   
Minimum .041   
Maximum .051   
Range .010   
Interquartile Range .009   
Skewness -.394 .845 
Kurtosis -2.043 1.741 
AdFn 4hrs Mean .05608 .002184 
95% Confidence 
Interval for Mean 
Lower Bound .05046   
Upper Bound .06169   
5% Trimmed Mean .05590   
Median .05460   
Variance .000   
Std. Deviation .005351   
Minimum .051   
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Maximum .064   
Range .014   
Interquartile Range .009   
Skewness .759 .845 
Kurtosis -.771 1.741 
AdFn 24hrs Mean .05340 .002362 
95% Confidence 
Interval for Mean 
Lower Bound .04733   
Upper Bound .05947   
5% Trimmed Mean .05318   
Median .05192   
Variance .000   
Std. Deviation .005787   
Minimum .048   
Maximum .063   
Range .015   
Interquartile Range .010   
Skewness .953 .845 
Kurtosis .102 1.741 
AdLn 1hr Mean .03697 .001605 
95% Confidence 
Interval for Mean 
Lower Bound .03285   
Upper Bound .04110   
5% Trimmed Mean .03722   
Median .03920   
Variance .000   
Std. Deviation .003931   
Minimum .030   
Maximum .039   
Range .009   
Interquartile Range .006   
Skewness -1.457 .845 
Kurtosis 1.045 1.741 
AdLn 4hrs Mean .03358 .001236 
95% Confidence Lower Bound .03040   
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Interval for Mean Upper Bound .03675   
5% Trimmed Mean .03352   
Median .03205   
Variance .000   
Std. Deviation .003027   
Minimum .031   
Maximum .037   
Range .007   
Interquartile Range .006   
Skewness .850 .845 
Kurtosis -1.838 1.741 
AdLn 24hrs Mean .05149 .001926 
95% Confidence 
Interval for Mean 
Lower Bound .04654   
Upper Bound .05644   
5% Trimmed Mean .05156   
Median .05226   
Variance .000   
Std. Deviation .004717   
Minimum .045   
Maximum .057   
Range .012   
Interquartile Range .009   
Skewness -.437 .845 
Kurtosis -1.412 1.741 
AdFn/Ln 1hr Mean .05948 .001405 
95% Confidence 
Interval for Mean 
Lower Bound .05586   
Upper Bound .06309   
5% Trimmed Mean .05951   
Median .06040   
Variance .000   
Std. Deviation .003441   
Minimum .055   
Appendix 
 
193 
 
Maximum .063   
Range .008   
Interquartile Range .007   
Skewness -.508 .845 
Kurtosis -1.711 1.741 
AdFn/Ln 4hrs Mean .07180 .000596 
95% Confidence 
Interval for Mean 
Lower Bound .07026   
Upper Bound .07333   
5% Trimmed Mean .07178   
Median .07204   
Variance .000   
Std. Deviation .001461   
Minimum .070   
Maximum .074   
Range .004   
Interquartile Range .003   
Skewness -.045 .845 
Kurtosis -1.196 1.741 
AdFn/Ln 24hrs Mean .06951 .001416 
95% Confidence 
Interval for Mean 
Lower Bound .06587   
Upper Bound .07315   
5% Trimmed Mean .06947   
Median .06853   
Variance .000   
Std. Deviation .003469   
Minimum .066   
Maximum .074   
Range .007   
Interquartile Range .007   
Skewness .473 .845 
Kurtosis -2.272 1.741 
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7.4: Silanized non-passivated fibroblast cell area 
descriptives 
 
Silanized, non-
Passivated 
Surface   Statistic 
Std. 
Error 
Cell Area (m
2
) Si- 1hr Mean 605.4150 21.64380 
    95% Confidence Interval for Mean Lower 
Bound 
549.7778   
      Upper 
Bound 
661.0522   
    5% Trimmed Mean 605.3728   
    Median 593.8750   
    Variance 2810.724   
    Std. Deviation 53.01627   
    Minimum 534.21   
    Maximum 677.38   
    Range 143.17   
    Interquartile Range 95.44   
    Skewness .227 .845 
    Kurtosis -.928 1.741 
  Si-4 hrs Mean 757.1700 19.03333 
    95% Confidence Interval for Mean Lower 
Bound 
708.2433   
      Upper 
Bound 
806.0967   
    5% Trimmed Mean 755.0406   
    Median 735.5450   
    Variance 2173.606   
    Std. Deviation 46.62195   
    Minimum 721.03   
    Maximum 831.64   
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    Range 110.61   
    Interquartile Range 84.01   
    Skewness 1.038 .845 
    Kurtosis -.663 1.741 
  Si- 24hrs Mean 945.3100 24.21491 
    95% Confidence Interval for Mean Lower 
Bound 
883.0636   
      Upper 
Bound 
1007.5564   
    5% Trimmed Mean 945.8389   
    Median 955.1500   
    Variance 3518.170   
    Std. Deviation 59.31417   
    Minimum 863.01   
    Maximum 1018.09   
    Range 155.08   
    Interquartile Range 114.79   
    Skewness -.351 .845 
    Kurtosis -1.271 1.741 
  SiFn- 1hr Mean 1387.1367 22.92987 
    95% Confidence Interval for Mean Lower 
Bound 
1328.1936   
      Upper 
Bound 
1446.0798   
    5% Trimmed Mean 1387.0774   
    Median 1384.0650   
    Variance 3154.674   
    Std. Deviation 56.16648   
    Minimum 1322.45   
    Maximum 1452.89   
    Range 130.44   
    Interquartile Range 100.93   
    Skewness .028 .845 
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    Kurtosis -2.740 1.741 
  SiFn- 4hrs Mean 1686.7350 16.56526 
    95% Confidence Interval for Mean Lower 
Bound 
1644.1527   
      Upper 
Bound 
1729.3173   
    5% Trimmed Mean 1687.8594   
    Median 1705.5950   
    Variance 1646.446   
    Std. Deviation 40.57642   
    Minimum 1632.96   
    Maximum 1720.27   
    Range 87.31   
    Interquartile Range 83.23   
    Skewness -.869 .845 
    Kurtosis -1.849 1.741 
  SiFn- 24hrs Mean 1990.4117 27.45996 
    95% Confidence Interval for Mean Lower 
Bound 
1919.8236   
      Upper 
Bound 
2060.9997   
    5% Trimmed Mean 1992.0157   
    Median 1999.8500   
    Variance 4524.296   
    Std. Deviation 67.26289   
    Minimum 1894.52   
    Maximum 2057.43   
    Range 162.91   
    Interquartile Range 120.92   
    Skewness -.403 .845 
    Kurtosis -1.873 1.741 
  SiLn- 1hr Mean 1183.4950 23.52899 
    95% Confidence Interval for Mean Lower 1123.0118   
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Bound 
      Upper 
Bound 
1243.9782   
    5% Trimmed Mean 1183.7317   
    Median 1185.2500   
    Variance 3321.681   
    Std. Deviation 57.63403   
    Minimum 1115.22   
    Maximum 1247.51   
    Range 132.29   
    Interquartile Range 103.89   
    Skewness -.052 .845 
    Kurtosis -2.808 1.741 
  SiLn- 4hrs Mean 1550.7567 43.04557 
    95% Confidence Interval for Mean Lower 
Bound 
1440.1045   
      Upper 
Bound 
1661.4088   
    5% Trimmed Mean 1549.6452   
    Median 1566.2800   
    Variance 11117.528   
    Std. Deviation 105.43969   
    Minimum 1428.04   
    Maximum 1693.48   
    Range 265.44   
    Interquartile Range 202.53   
    Skewness -.036 .845 
    Kurtosis -1.450 1.741 
  SiLn- 24hrs Mean 1810.3583 22.91183 
    95% Confidence Interval for Mean Lower 
Bound 
1751.4616   
      Upper 
Bound 
1869.2551   
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    5% Trimmed Mean 1810.8698   
    Median 1824.0300   
    Variance 3149.712   
    Std. Deviation 56.12230   
    Minimum 1726.54   
    Maximum 1884.97   
    Range 158.43   
    Interquartile Range 93.86   
    Skewness -.409 .845 
    Kurtosis -.242 1.741 
  SiFnLn- 1hr Mean 1780.9733 25.78016 
    95% Confidence Interval for 
Mean 
Lower 
Bound 
1714.7033   
      Upper 
Bound 
1847.2433   
    5% Trimmed Mean 1779.8093   
    Median 1769.8350   
    Variance 3987.699   
    Std. Deviation 63.14823   
    Minimum 1700.75   
    Maximum 1882.15   
    Range 181.40   
    Interquartile Range 103.29   
    Skewness .621 .845 
    Kurtosis .385 1.741 
  SiFnLn- 4hrs Mean 2061.8400 25.53214 
    95% Confidence Interval for Mean Lower 
Bound 
1996.2075   
      Upper 
Bound 
2127.4725   
    5% Trimmed Mean 2060.4933   
    Median 2049.8350   
    Variance 3911.342   
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    Std. Deviation 62.54072   
    Minimum 1997.11   
    Maximum 2150.81   
    Range 153.70   
    Interquartile Range 116.85   
    Skewness .450 .845 
    Kurtosis -1.761 1.741 
  SiFnLn- 24hrs Mean 2456.8950 33.79463 
    95% Confidence Interval for Mean Lower 
Bound 
2370.0231   
      Upper 
Bound 
2543.7669   
    5% Trimmed Mean 2456.8683   
    Median 2477.9100   
    Variance 6852.461   
    Std. Deviation 82.77959   
    Minimum 2355.84   
    Maximum 2558.43   
    Range 202.59   
    Interquartile Range 159.52   
    Skewness -.301 .845 
    Kurtosis -1.775 1.741 
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7.5: Silanized non-passivated fibroblast vinculin per 
cell descriptives 
 
Silanized, non-
Passivated Surface   Statistic Std. Error 
Vinculin/Cell Si- 1hr Mean 6.500 .7188 
95% Confidence 
Interval for Mean 
Lower Bound 4.652   
Upper Bound 8.348   
5% Trimmed Mean 6.444   
Median 6.000   
Variance 3.100   
Std. Deviation 1.7607   
Minimum 5.0   
Maximum 9.0   
Range 4.0   
Interquartile Range 3.3   
Skewness .495 .845 
Kurtosis -1.925 1.741 
Si-4 hrs Mean 10.667 .3333 
95% Confidence 
Interval for Mean 
Lower Bound 9.810   
Upper Bound 11.524   
5% Trimmed Mean 10.630   
Median 10.500   
Variance .667   
Std. Deviation .8165   
Minimum 10.0   
Maximum 12.0   
Range 2.0   
Interquartile Range 1.3   
Skewness .857 .845 
Kurtosis -.300 1.741 
Si- 24hrs Mean 16.333 1.5202 
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95% Confidence 
Interval for Mean 
Lower Bound 12.425   
Upper Bound 20.241   
5% Trimmed Mean 16.259   
Median 15.000   
Variance 13.867   
Std. Deviation 3.7238   
Minimum 13.0   
Maximum 21.0   
Range 8.0   
Interquartile Range 8.0   
Skewness .723 .845 
Kurtosis -1.875 1.741 
SiFn- 1hr Mean 77.667 2.7406 
95% Confidence 
Interval for Mean 
Lower Bound 70.622   
Upper Bound 84.712   
5% Trimmed Mean 77.519   
Median 77.000   
Variance 45.067   
Std. Deviation 6.7132   
Minimum 70.0   
Maximum 88.0   
Range 18.0   
Interquartile Range 12.0   
Skewness .531 .845 
Kurtosis -.634 1.741 
SiFn- 4hrs Mean 103.333 3.5182 
95% Confidence 
Interval for Mean 
Lower Bound 94.289   
Upper Bound 112.377   
5% Trimmed Mean 103.370   
Median 101.500   
Variance 74.267   
Std. Deviation 8.6178   
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Minimum 92.0   
Maximum 114.0   
Range 22.0   
Interquartile Range 16.8   
Skewness .232 .845 
Kurtosis -1.298 1.741 
SiFn- 24hrs Mean 132.333 5.3583 
95% Confidence 
Interval for Mean 
Lower Bound 118.559   
Upper Bound 146.107   
5% Trimmed Mean 132.648   
Median 136.000   
Variance 172.267   
Std. Deviation 13.1250   
Minimum 114.0   
Maximum 145.0   
Range 31.0   
Interquartile Range 25.0   
Skewness -.518 .845 
Kurtosis -1.920 1.741 
SiLn- 1hr Mean 56.833 2.6257 
95% Confidence 
Interval for Mean 
Lower Bound 50.084   
Upper Bound 63.583   
5% Trimmed Mean 56.926   
Median 57.000   
Variance 41.367   
Std. Deviation 6.4317   
Minimum 47.0   
Maximum 65.0   
Range 18.0   
Interquartile Range 9.8   
Skewness -.392 .845 
Kurtosis -.389 1.741 
SiLn- 4hrs Mean 78.000 2.6331 
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95% Confidence 
Interval for Mean 
Lower Bound 71.231   
Upper Bound 84.769   
5% Trimmed Mean 77.889   
Median 79.000   
Variance 41.600   
Std. Deviation 6.4498   
Minimum 70.0   
Maximum 88.0   
Range 18.0   
Interquartile Range 10.5   
Skewness .322 .845 
Kurtosis -.011 1.741 
SiLn- 24hrs Mean 104.500 2.6677 
95% Confidence 
Interval for Mean 
Lower Bound 97.642   
Upper Bound 111.358   
5% Trimmed Mean 104.389   
Median 103.500   
Variance 42.700   
Std. Deviation 6.5345   
Minimum 97.0   
Maximum 114.0   
Range 17.0   
Interquartile Range 12.5   
Skewness .452 .845 
Kurtosis -1.191 1.741 
SiFnLn- 1hr Mean 129.333 2.6034 
95% Confidence 
Interval for Mean 
Lower Bound 122.641   
Upper Bound 136.026   
5% Trimmed Mean 129.426   
Median 130.500   
Variance 40.667   
Std. Deviation 6.3770   
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Minimum 120.0   
Maximum 137.0   
Range 17.0   
Interquartile Range 11.8   
Skewness -.455 .845 
Kurtosis -1.011 1.741 
SiFnLn- 4hrs Mean 162.000 3.4351 
95% Confidence 
Interval for Mean 
Lower Bound 153.170   
Upper Bound 170.830   
5% Trimmed Mean 161.944   
Median 163.500   
Variance 70.800   
Std. Deviation 8.4143   
Minimum 151.0   
Maximum 174.0   
Range 23.0   
Interquartile Range 14.8   
Skewness -.012 .845 
Kurtosis -.691 1.741 
SiFnLn- 24hrs Mean 220.167 3.4100 
95% Confidence 
Interval for Mean 
Lower Bound 211.401   
Upper Bound 228.932   
5% Trimmed Mean 219.963   
Median 219.500   
Variance 69.767   
Std. Deviation 8.3526   
Minimum 211.0   
Maximum 233.0   
Range 22.0   
Interquartile Range 14.5   
Skewness .535 .845 
Kurtosis -.823 1.741 
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7.6: Silanized non-passivated fibroblast vinculin per 
cell area descriptives 
 
Silanized, non-
Passivated Surface   Statistic 
Std. 
Error 
Vinculin/Cell 
Area 
Si- 1hr Mean .01076 .001188 
95% Confidence 
Interval for Mean 
Lower Bound .00771   
Upper Bound .01382   
5% Trimmed Mean .01071   
Median .00985   
Variance .000   
Std. Deviation .002911   
Minimum .008   
Maximum .015   
Range .007   
Interquartile Range .006   
Skewness .662 .845 
Kurtosis -1.382 1.741 
Si-4 hrs Mean .01416 .000666 
95% Confidence 
Interval for Mean 
Lower Bound .01244   
Upper Bound .01587   
5% Trimmed Mean .01417   
Median .01452   
Variance .000   
Std. Deviation .001632   
Minimum .012   
Maximum .016   
Range .004   
Interquartile Range .003   
Skewness -.296 .845 
Kurtosis -1.933 1.741 
Si- 24hrs Mean .01725 .001500 
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95% Confidence 
Interval for Mean 
Lower Bound .01340   
Upper Bound .02111   
5% Trimmed Mean .01713   
Median .01510   
Variance .000   
Std. Deviation .003674   
Minimum .015   
Maximum .022   
Range .008   
Interquartile Range .007   
Skewness .961 .845 
Kurtosis -1.846 1.741 
SiFn- 1hr Mean .05597 .001580 
95% Confidence 
Interval for Mean 
Lower Bound .05191   
Upper Bound .06003   
5% Trimmed Mean .05597   
Median .05611   
Variance .000   
Std. Deviation .003871   
Minimum .051   
Maximum .061   
Range .011   
Interquartile Range .007   
Skewness -.048 .845 
Kurtosis -.625 1.741 
SiFn- 4hrs Mean .06123 .001754 
95% Confidence 
Interval for Mean 
Lower Bound .05672   
Upper Bound .06573   
5% Trimmed Mean .06122   
Median .06052   
Variance .000   
Std. Deviation .004296   
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Minimum .056   
Maximum .066   
Range .010   
Interquartile Range .009   
Skewness .295 .845 
Kurtosis -2.020 1.741 
SiFn- 24hrs Mean .06645 .002340 
95% Confidence 
Interval for Mean 
Lower Bound .06043   
Upper Bound .07246   
5% Trimmed Mean .06651   
Median .06798   
Variance .000   
Std. Deviation .005731   
Minimum .059   
Maximum .073   
Range .014   
Interquartile Range .011   
Skewness -.501 .845 
Kurtosis -1.710 1.741 
SiLn- 1hr Mean .04806 .002209 
95% Confidence 
Interval for Mean 
Lower Bound .04238   
Upper Bound .05374   
5% Trimmed Mean .04810   
Median .04841   
Variance .000   
Std. Deviation .005412   
Minimum .042   
Maximum .053   
Range .011   
Interquartile Range .010   
Skewness -.046 .845 
Kurtosis -3.170 1.741 
SiLn- 4hrs Mean .05043 .001881 
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95% Confidence 
Interval for Mean 
Lower Bound .04560   
Upper Bound .05527   
5% Trimmed Mean .05049   
Median .05073   
Variance .000   
Std. Deviation .004607   
Minimum .044   
Maximum .056   
Range .012   
Interquartile Range .009   
Skewness -.285 .845 
Kurtosis -1.154 1.741 
SiLn- 24hrs Mean .05781 .001959 
95% Confidence 
Interval for Mean 
Lower Bound .05278   
Upper Bound .06285   
5% Trimmed Mean .05765   
Median .05655   
Variance .000   
Std. Deviation .004798   
Minimum .053   
Maximum .066   
Range .014   
Interquartile Range .007   
Skewness 1.047 .845 
Kurtosis .975 1.741 
SiFnLn- 1hr Mean .07267 .001603 
95% Confidence 
Interval for Mean 
Lower Bound .06855   
Upper Bound .07679   
5% Trimmed Mean .07263   
Median .07274   
Variance .000   
Std. Deviation .003926   
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Minimum .069   
Maximum .078   
Range .009   
Interquartile Range .007   
Skewness .102 .845 
Kurtosis -2.564 1.741 
SiFnLn- 4hrs Mean .07855 .001018 
95% Confidence 
Interval for Mean 
Lower Bound .07593   
Upper Bound .08116   
5% Trimmed Mean .07859   
Median .07895   
Variance .000   
Std. Deviation .002494   
Minimum .075   
Maximum .081   
Range .006   
Interquartile Range .005   
Skewness -.384 .845 
Kurtosis -1.897 1.741 
SiFnLn- 24hrs Mean .08963 .001033 
95% Confidence 
Interval for Mean 
Lower Bound .08697   
Upper Bound .09229   
5% Trimmed Mean .08964   
Median .08952   
Variance .000   
Std. Deviation .002531   
Minimum .086   
Maximum .093   
Range .007   
Interquartile Range .005   
Skewness -.035 .845 
Kurtosis -.805 1.741 
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7.7: Silanized passivated fibroblast cell area 
descriptives 
 
Silanized, 
Passivated 
Surface   Statistic 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Si+ 1hr Mean 536.2733 18.22227 
95% Confidence 
Interval for Mean 
Lower Bound 489.4315   
Upper Bound 583.1152   
5% Trimmed Mean 535.8537   
Median 529.7450   
Variance 1992.308   
Std. Deviation 44.63527   
Minimum 491.27   
Maximum 588.83   
Range 97.56   
Interquartile Range 95.15   
Skewness .263 .845 
Kurtosis -2.336 1.741 
Si+ 4hrs Mean 707.1800 8.21385 
95% Confidence 
Interval for Mean 
Lower Bound 686.0656   
Upper Bound 728.2944   
5% Trimmed Mean 707.0961   
Median 702.1500   
Variance 404.804   
Std. Deviation 20.11974   
Minimum 684.26   
Maximum 731.61   
Range 47.35   
Interquartile Range 41.11   
Skewness .420 .845 
Kurtosis -1.905 1.741 
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Si+ 24hrs Mean 742.7583 11.71889 
95% Confidence 
Interval for Mean 
Lower Bound 712.6340   
Upper Bound 772.8827   
5% Trimmed Mean 741.9031   
Median 728.6650   
Variance 823.994   
Std. Deviation 28.70530   
Minimum 719.40   
Maximum 781.51   
Range 62.11   
Interquartile Range 56.59   
Skewness .826 .845 
Kurtosis -1.875 1.741 
SiFn+ 1hr Mean 978.3817 26.84955 
95% Confidence 
Interval for Mean 
Lower Bound 909.3627   
Upper Bound 1047.4006   
5% Trimmed Mean 978.1185   
Median 976.2750   
Variance 4325.391   
Std. Deviation 65.76770   
Minimum 907.57   
Maximum 1053.93   
Range 146.36   
Interquartile Range 136.82   
Skewness .060 .845 
Kurtosis -2.524 1.741 
SiFn+ 4hrs Mean 1120.0800 22.83380 
95% Confidence 
Interval for Mean 
Lower Bound 1061.3838   
Upper Bound 1178.7762   
5% Trimmed Mean 1120.0289   
Median 1131.4550   
Variance 3128.296   
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Std. Deviation 55.93117   
Minimum 1049.84   
Maximum 1191.24   
Range 141.40   
Interquartile Range 103.53   
Skewness -.172 .845 
Kurtosis -1.723 1.741 
SiFn+ 24hrs Mean 1267.4967 18.06021 
95% Confidence 
Interval for Mean 
Lower Bound 1221.0714   
Upper Bound 1313.9219   
5% Trimmed Mean 1268.0319   
Median 1275.8800   
Variance 1957.027   
Std. Deviation 44.23830   
Minimum 1210.11   
Maximum 1315.25   
Range 105.14   
Interquartile Range 83.33   
Skewness -.281 .845 
Kurtosis -2.300 1.741 
SiLn+ 1hr Mean 829.3567 19.68192 
95% Confidence 
Interval for Mean 
Lower Bound 778.7627   
Upper Bound 879.9507   
5% Trimmed Mean 828.4530   
Median 813.4000   
Variance 2324.269   
Std. Deviation 48.21067   
Minimum 774.53   
Maximum 900.45   
Range 125.92   
Interquartile Range 86.95   
Skewness .649 .845 
Kurtosis -1.096 1.741 
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SiLn+ 4hrs Mean 993.4333 22.35985 
95% Confidence 
Interval for Mean 
Lower Bound 935.9555   
Upper Bound 1050.9112   
5% Trimmed Mean 994.5509   
Median 1004.4250   
Variance 2999.779   
Std. Deviation 54.77023   
Minimum 923.45   
Maximum 1043.30   
Range 119.85   
Interquartile Range 102.80   
Skewness -.259 .845 
Kurtosis -2.610 1.741 
SiLn+ 24hrs Mean 1169.9000 29.02984 
95% Confidence 
Interval for Mean 
Lower Bound 1095.2764   
Upper Bound 1244.5236   
5% Trimmed Mean 1166.9044   
Median 1150.4900   
Variance 5056.390   
Std. Deviation 71.10830   
Minimum 1101.89   
Maximum 1291.83   
Range 189.94   
Interquartile Range 117.36   
Skewness 1.127 .845 
Kurtosis .734 1.741 
SiFnLn+ 1hr Mean 1152.8983 10.67110 
95% Confidence 
Interval for Mean 
Lower Bound 1125.4674   
Upper Bound 1180.3293   
5% Trimmed Mean 1151.8193   
Median 1144.0300   
Variance 683.234   
Appendix 
 
214 
 
Std. Deviation 26.13875   
Minimum 1128.83   
Maximum 1196.39   
Range 67.56   
Interquartile Range 46.43   
Skewness 1.086 .845 
Kurtosis .101 1.741 
SiFnLn+ 4hrs Mean 1249.9650 16.71188 
95% Confidence 
Interval for Mean 
Lower Bound 1207.0057   
Upper Bound 1292.9243   
5% Trimmed Mean 1250.4822   
Median 1249.7450   
Variance 1675.723   
Std. Deviation 40.93559   
Minimum 1190.63   
Maximum 1299.99   
Range 109.36   
Interquartile Range 76.87   
Skewness -.226 .845 
Kurtosis -.926 1.741 
SiFnLn+ 24hrs Mean 1286.2583 24.86839 
95% Confidence 
Interval for Mean 
Lower Bound 1222.3321   
Upper Bound 1350.1846   
5% Trimmed Mean 1285.8276   
Median 1278.9650   
Variance 3710.622   
Std. Deviation 60.91487   
Minimum 1213.63   
Maximum 1366.64   
Range 153.01   
Interquartile Range 116.92   
Skewness .220 .845 
Kurtosis -1.869 1.741 
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7.8: Silanized passivated fibroblast vinculin per cell 
descriptives 
 
Silanized, 
Passivated Surface   Statistic Std. Error 
Vinculin/Cell Si+ 1hr Mean 2.500 .2236 
95% Confidence 
Interval for Mean 
Lower Bound 1.925   
Upper Bound 3.075   
5% Trimmed Mean 2.500   
Median 2.500   
Variance .300   
Std. Deviation .5477   
Minimum 2.0   
Maximum 3.0   
Range 1.0   
Interquartile Range 1.0   
Skewness .000 .845 
Kurtosis -3.333 1.741 
Si+ 4hrs Mean 4.500 .4282 
95% Confidence 
Interval for Mean 
Lower Bound 3.399   
Upper Bound 5.601   
5% Trimmed Mean 4.500   
Median 4.500   
Variance 1.100   
Std. Deviation 1.0488   
Minimum 3.0   
Maximum 6.0   
Range 3.0   
Interquartile Range 1.5   
Skewness .000 .845 
Kurtosis -.248 1.741 
Si+ 24hrs Mean 3.833 .7491 
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95% Confidence 
Interval for Mean 
Lower Bound 1.908   
Upper Bound 5.759   
5% Trimmed Mean 3.815   
Median 3.500   
Variance 3.367   
Std. Deviation 1.8348   
Minimum 2.0   
Maximum 6.0   
Range 4.0   
Interquartile Range 4.0   
Skewness .362 .845 
Kurtosis -2.103 1.741 
SiFn+ 1hr Mean 13.000 .5774 
95% Confidence 
Interval for Mean 
Lower Bound 11.516   
Upper Bound 14.484   
5% Trimmed Mean 13.000   
Median 13.000   
Variance 2.000   
Std. Deviation 1.4142   
Minimum 11.0   
Maximum 15.0   
Range 4.0   
Interquartile Range 2.5   
Skewness .000 .845 
Kurtosis -.300 1.741 
SiFn+ 4hrs Mean 15.500 1.7654 
95% Confidence 
Interval for Mean 
Lower Bound 10.962   
Upper Bound 20.038   
5% Trimmed Mean 15.611   
Median 17.500   
Variance 18.700   
Std. Deviation 4.3243   
Appendix 
 
217 
 
Minimum 10.0   
Maximum 19.0   
Range 9.0   
Interquartile Range 9.0   
Skewness -.846 .845 
Kurtosis -1.897 1.741 
SiFn+ 24hrs Mean 17.333 1.9264 
95% Confidence 
Interval for Mean 
Lower Bound 12.381   
Upper Bound 22.285   
5% Trimmed Mean 17.426   
Median 19.000   
Variance 22.267   
Std. Deviation 4.7188   
Minimum 11.0   
Maximum 22.0   
Range 11.0   
Interquartile Range 9.5   
Skewness -.673 .845 
Kurtosis -1.840 1.741 
SiLn+ 1hr Mean 9.333 .4216 
95% Confidence 
Interval for Mean 
Lower Bound 8.249   
Upper Bound 10.417   
5% Trimmed Mean 9.315   
Median 9.000   
Variance 1.067   
Std. Deviation 1.0328   
Minimum 8.0   
Maximum 11.0   
Range 3.0   
Interquartile Range 1.5   
Skewness .666 .845 
Kurtosis .586 1.741 
SiLn+ 4hrs Mean 16.500 1.4549 
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95% Confidence 
Interval for Mean 
Lower Bound 12.760   
Upper Bound 20.240   
5% Trimmed Mean 16.556   
Median 18.000   
Variance 12.700   
Std. Deviation 3.5637   
Minimum 12.0   
Maximum 20.0   
Range 8.0   
Interquartile Range 7.3   
Skewness -.776 .845 
Kurtosis -1.826 1.741 
SiLn+ 24hrs Mean 10.667 1.5846 
95% Confidence 
Interval for Mean 
Lower Bound 6.593   
Upper Bound 14.740   
5% Trimmed Mean 10.630   
Median 10.500   
Variance 15.067   
Std. Deviation 3.8816   
Minimum 6.0   
Maximum 16.0   
Range 10.0   
Interquartile Range 7.8   
Skewness .193 .845 
Kurtosis -1.354 1.741 
SiFnLn+ 1hr Mean 24.833 2.0235 
95% Confidence 
Interval for Mean 
Lower Bound 19.632   
Upper Bound 30.035   
5% Trimmed Mean 24.815   
Median 24.500   
Variance 24.567   
Std. Deviation 4.9565   
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Minimum 19.0   
Maximum 31.0   
Range 12.0   
Interquartile Range 10.5   
Skewness .149 .845 
Kurtosis -1.770 1.741 
SiFnLn+ 4hrs Mean 29.667 1.5846 
95% Confidence 
Interval for Mean 
Lower Bound 25.593   
Upper Bound 33.740   
5% Trimmed Mean 29.685   
Median 30.500   
Variance 15.067   
Std. Deviation 3.8816   
Minimum 25.0   
Maximum 34.0   
Range 9.0   
Interquartile Range 8.3   
Skewness -.423 .845 
Kurtosis -1.847 1.741 
SiFnLn+ 24hrs Mean 24.500 1.3844 
95% Confidence 
Interval for Mean 
Lower Bound 20.941   
Upper Bound 28.059   
5% Trimmed Mean 24.444   
Median 24.000   
Variance 11.500   
Std. Deviation 3.3912   
Minimum 21.0   
Maximum 29.0   
Range 8.0   
Interquartile Range 7.3   
Skewness .369 .845 
Kurtosis -1.696 1.741 
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7.9: Silanized passivated- fibroblast vinculin per cell 
area descriptives 
 
Silanized, 
Passivated 
Surface   Statistic Std. Error 
Vinculin/Cell 
Area 
Si+ 1hr Mean .00466 .000383 
95% Confidence 
Interval for Mean 
Lower Bound .00367   
Upper Bound .00564   
5% Trimmed Mean .00463   
Median .00458   
Variance .000   
Std. Deviation .000938   
Minimum .004   
Maximum .006   
Range .002   
Interquartile Range .002   
Skewness .562 .845 
Kurtosis -.951 1.741 
Si+ 4hrs Mean .00635 .000590 
95% Confidence 
Interval for Mean 
Lower Bound .00484   
Upper Bound .00787   
5% Trimmed Mean .00635   
Median .00631   
Variance .000   
Std. Deviation .001445   
Minimum .004   
Maximum .008   
Range .004   
Interquartile Range .002   
Skewness .175 .845 
Kurtosis -.332 1.741 
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Si+ 24hrs Mean .00521 .001065 
95% Confidence 
Interval for Mean 
Lower Bound .00247   
Upper Bound .00795   
5% Trimmed Mean .00518   
Median .00464   
Variance .000   
Std. Deviation .002609   
Minimum .003   
Maximum .008   
Range .006   
Interquartile Range .006   
Skewness .415 .845 
Kurtosis -2.140 1.741 
SiFn+ 1hr Mean .01327 .000363 
95% Confidence 
Interval for Mean 
Lower Bound .01234   
Upper Bound .01420   
5% Trimmed Mean .01328   
Median .01315   
Variance .000   
Std. Deviation .000889   
Minimum .012   
Maximum .014   
Range .002   
Interquartile Range .002   
Skewness .039 .845 
Kurtosis -1.451 1.741 
SiFn+ 4hrs Mean .01382 .001539 
95% Confidence 
Interval for Mean 
Lower Bound .00987   
Upper Bound .01778   
5% Trimmed Mean .01393   
Median .01534   
Variance .000   
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Std. Deviation .003769   
Minimum .009   
Maximum .017   
Range .008   
Interquartile Range .008   
Skewness -.784 .845 
Kurtosis -1.801 1.741 
SiFn+ 24hrs Mean .01368 .001505 
95% Confidence 
Interval for Mean 
Lower Bound .00981   
Upper Bound .01755   
5% Trimmed Mean .01376   
Median .01527   
Variance .000   
Std. Deviation .003688   
Minimum .009   
Maximum .017   
Range .008   
Interquartile Range .008   
Skewness -.755 .845 
Kurtosis -1.970 1.741 
SiLn+ 1hr Mean .01096 .000351 
95% Confidence 
Interval for Mean 
Lower Bound .01006   
Upper Bound .01186   
5% Trimmed Mean .01096   
Median .01115   
Variance .000   
Std. Deviation .000859   
Minimum .010   
Maximum .012   
Range .002   
Interquartile Range .001   
Skewness -.128 .845 
Kurtosis .140 1.741 
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SiLn+ 4hrs Mean .01676 .001706 
95% Confidence 
Interval for Mean 
Lower Bound .01237   
Upper Bound .02114   
5% Trimmed Mean .01680   
Median .01840   
Variance .000   
Std. Deviation .004178   
Minimum .012   
Maximum .021   
Range .010   
Interquartile Range .008   
Skewness -.696 .845 
Kurtosis -1.766 1.741 
SiLn+ 24hrs Mean .00923 .001496 
95% Confidence 
Interval for Mean 
Lower Bound .00538   
Upper Bound .01307   
5% Trimmed Mean .00918   
Median .00880   
Variance .000   
Std. Deviation .003664   
Minimum .005   
Maximum .014   
Range .009   
Interquartile Range .007   
Skewness .289 .845 
Kurtosis -1.816 1.741 
SiFnLn+ 1hr Mean .02147 .001562 
95% Confidence 
Interval for Mean 
Lower Bound .01746   
Upper Bound .02549   
5% Trimmed Mean .02149   
Median .02141   
Variance .000   
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Std. Deviation .003826   
Minimum .017   
Maximum .026   
Range .009   
Interquartile Range .008   
Skewness .007 .845 
Kurtosis -1.798 1.741 
SiFnLn+ 4hrs Mean .02373 .001246 
95% Confidence 
Interval for Mean 
Lower Bound .02053   
Upper Bound .02694   
5% Trimmed Mean .02375   
Median .02357   
Variance .000   
Std. Deviation .003053   
Minimum .020   
Maximum .027   
Range .008   
Interquartile Range .006   
Skewness .060 .845 
Kurtosis -1.661 1.741 
SiFnLn+ 24hrs Mean .01911 .001246 
95% Confidence 
Interval for Mean 
Lower Bound .01591   
Upper Bound .02231   
5% Trimmed Mean .01908   
Median .01799   
Variance .000   
Std. Deviation .003052   
Minimum .016   
Maximum .023   
Range .007   
Interquartile Range .006   
Skewness .592 .845 
Kurtosis -1.644 1.741 
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7.10: Fibroblast cell area descriptives on different 
surfaces at 1 hour 
 
Surface at One 
Hour   Statistic 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Pol 1hr Mean 352.2083 18.44742 
95% Confidence 
Interval for Mean 
Lower Bound 304.7877   
Upper Bound 399.6289   
5% Trimmed Mean 353.3315   
Median 363.5650   
Variance 2041.844   
Std. Deviation 45.18677   
Minimum 288.67   
Maximum 395.53   
Range 106.86   
Interquartile Range 86.76   
Skewness -.507 .845 
Kurtosis -1.884 1.741 
AdFn 1hr Mean 1221.4433 10.80285 
95% Confidence 
Interval for Mean 
Lower Bound 1193.6737   
Upper Bound 1249.2129   
5% Trimmed Mean 1221.6787   
Median 1225.3900   
Variance 700.209   
Std. Deviation 26.46147   
Minimum 1186.56   
Maximum 1252.09   
Range 65.53   
Interquartile Range 54.73   
Skewness -.336 .845 
Kurtosis -1.619 1.741 
AdLn 1hr Mean 1069.5200 28.87035 
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95% Confidence 
Interval for Mean 
Lower Bound 995.3064   
Upper Bound 1143.7336   
5% Trimmed Mean 1065.2933   
Median 1036.4050   
Variance 5000.982   
Std. Deviation 70.71762   
Minimum 1016.59   
Maximum 1198.53   
Range 181.94   
Interquartile Range 106.51   
Skewness 1.592 .845 
Kurtosis 1.958 1.741 
AdFnLn 1hr Mean 1572.7683 25.78516 
95% Confidence 
Interval for Mean 
Lower Bound 1506.4855   
Upper Bound 1639.0512   
5% Trimmed Mean 1572.2215   
Median 1571.2400   
Variance 3989.248   
Std. Deviation 63.16049   
Minimum 1499.19   
Maximum 1656.19   
Range 157.00   
Interquartile Range 130.86   
Skewness .126 .845 
Kurtosis -1.584 1.741 
Si- 1hr Mean 605.4150 21.64380 
95% Confidence 
Interval for Mean 
Lower Bound 549.7778   
Upper Bound 661.0522   
5% Trimmed Mean 605.3728   
Median 593.8750   
Variance 2810.724   
Std. Deviation 53.01627   
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Minimum 534.21   
Maximum 677.38   
Range 143.17   
Interquartile Range 95.44   
Skewness .227 .845 
Kurtosis -.928 1.741 
SiFn- 1hr Mean 1387.1367 22.92987 
95% Confidence 
Interval for Mean 
Lower Bound 1328.1936   
Upper Bound 1446.0798   
5% Trimmed Mean 1387.0774   
Median 1384.0650   
Variance 3154.674   
Std. Deviation 56.16648   
Minimum 1322.45   
Maximum 1452.89   
Range 130.44   
Interquartile Range 100.93   
Skewness .028 .845 
Kurtosis -2.740 1.741 
SiLn- 1hr Mean 1183.4950 23.52899 
95% Confidence 
Interval for Mean 
Lower Bound 1123.0118   
Upper Bound 1243.9782   
5% Trimmed Mean 1183.7317   
Median 1185.2500   
Variance 3321.681   
Std. Deviation 57.63403   
Minimum 1115.22   
Maximum 1247.51   
Range 132.29   
Interquartile Range 103.89   
Skewness -.052 .845 
Kurtosis -2.808 1.741 
SiFnLn- 1hr Mean 1780.9733 25.78016 
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95% Confidence 
Interval for Mean 
Lower Bound 1714.7033   
Upper Bound 1847.2433   
5% Trimmed Mean 1779.8093   
Median 1769.8350   
Variance 3987.699   
Std. Deviation 63.14823   
Minimum 1700.75   
Maximum 1882.15   
Range 181.40   
Interquartile Range 103.29   
Skewness .621 .845 
Kurtosis .385 1.741 
Si+ 1hr Mean 536.2733 18.22227 
95% Confidence 
Interval for Mean 
Lower Bound 489.4315   
Upper Bound 583.1152   
5% Trimmed Mean 535.8537   
Median 529.7450   
Variance 1992.308   
Std. Deviation 44.63527   
Minimum 491.27   
Maximum 588.83   
Range 97.56   
Interquartile Range 95.15   
Skewness .263 .845 
Kurtosis -2.336 1.741 
SiFn+ 1hr Mean 978.3817 26.84955 
95% Confidence 
Interval for Mean 
Lower Bound 909.3627   
Upper Bound 1047.4006   
5% Trimmed Mean 978.1185   
Median 976.2750   
Variance 4325.391   
Std. Deviation 65.76770   
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Minimum 907.57   
Maximum 1053.93   
Range 146.36   
Interquartile Range 136.82   
Skewness .060 .845 
Kurtosis -2.524 1.741 
SiLn+ 1hr Mean 829.3567 19.68192 
95% Confidence 
Interval for Mean 
Lower Bound 778.7627   
Upper Bound 879.9507   
5% Trimmed Mean 828.4530   
Median 813.4000   
Variance 2324.269   
Std. Deviation 48.21067   
Minimum 774.53   
Maximum 900.45   
Range 125.92   
Interquartile Range 86.95   
Skewness .649 .845 
Kurtosis -1.096 1.741 
SiFnLn+ 1hr Mean 1152.8983 10.67110 
95% Confidence 
Interval for Mean 
Lower Bound 1125.4674   
Upper Bound 1180.3293   
5% Trimmed Mean 1151.8193   
Median 1144.0300   
Variance 683.234   
Std. Deviation 26.13875   
Minimum 1128.83   
Maximum 1196.39   
Range 67.56   
Interquartile Range 46.43   
Skewness 1.086 .845 
Kurtosis .101 1.741 
 
Appendix 
 
230 
 
7.11: Fibroblast vinculin per cell descriptives at 1 hour 
 Surface at One Hour   Statistic Std. Error 
Vinculin/Cell Pol 1hr Mean 1.833 .4014 
95% Confidence 
Interval for Mean 
Lower Bound .802   
Upper Bound 2.865   
5% Trimmed Mean 1.815   
Median 1.500   
Variance .967   
Std. Deviation .9832   
Minimum 1.0   
Maximum 3.0   
Range 2.0   
Interquartile Range 2.0   
Skewness .456 .845 
Kurtosis -2.390 1.741 
AdFn 1hr Mean 56.167 2.2274 
95% Confidence 
Interval for Mean 
Lower Bound 50.441   
Upper Bound 61.892   
5% Trimmed Mean 56.185   
Median 56.500   
Variance 29.767   
Std. Deviation 5.4559   
Minimum 49.0   
Maximum 63.0   
Range 14.0   
Interquartile Range 11.0   
Skewness -.136 .845 
Kurtosis -1.449 1.741 
AdLn 1hr Mean 38.500 1.6073 
95% Confidence 
Interval for Mean 
Lower Bound 34.368   
Upper Bound 42.632   
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5% Trimmed Mean 38.500   
Median 38.500   
Variance 15.500   
Std. Deviation 3.9370   
Minimum 34.0   
Maximum 43.0   
Range 9.0   
Interquartile Range 7.5   
Skewness .000 .845 
Kurtosis -2.758 1.741 
AdFnLn 1hr Mean 93.500 2.3488 
95% Confidence 
Interval for Mean 
Lower Bound 87.462   
Upper Bound 99.538   
5% Trimmed Mean 93.778   
Median 94.500   
Variance 33.100   
Std. Deviation 5.7533   
Minimum 83.0   
Maximum 99.0   
Range 16.0   
Interquartile Range 8.5   
Skewness -1.418 .845 
Kurtosis 2.369 1.741 
Si- 1hr Mean 6.500 .7188 
95% Confidence 
Interval for Mean 
Lower Bound 4.652   
Upper Bound 8.348   
5% Trimmed Mean 6.444   
Median 6.000   
Variance 3.100   
Std. Deviation 1.7607   
Minimum 5.0   
Maximum 9.0   
Range 4.0   
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Interquartile Range 3.3   
Skewness .495 .845 
Kurtosis -1.925 1.741 
SiFn- 1hr Mean 77.667 2.7406 
95% Confidence 
Interval for Mean 
Lower Bound 70.622   
Upper Bound 84.712   
5% Trimmed Mean 77.519   
Median 77.000   
Variance 45.067   
Std. Deviation 6.7132   
Minimum 70.0   
Maximum 88.0   
Range 18.0   
Interquartile Range 12.0   
Skewness .531 .845 
Kurtosis -.634 1.741 
SiLn- 1hr Mean 56.833 2.6257 
95% Confidence 
Interval for Mean 
Lower Bound 50.084   
Upper Bound 63.583   
5% Trimmed Mean 56.926   
Median 57.000   
Variance 41.367   
Std. Deviation 6.4317   
Minimum 47.0   
Maximum 65.0   
Range 18.0   
Interquartile Range 9.8   
Skewness -.392 .845 
Kurtosis -.389 1.741 
SiFnLn- 1hr Mean 129.333 2.6034 
95% Confidence 
Interval for Mean 
Lower Bound 122.641   
Upper Bound 136.026   
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5% Trimmed Mean 129.426   
Median 130.500   
Variance 40.667   
Std. Deviation 6.3770   
Minimum 120.0   
Maximum 137.0   
Range 17.0   
Interquartile Range 11.8   
Skewness -.455 .845 
Kurtosis -1.011 1.741 
Si+ 1hr Mean 2.500 .2236 
95% Confidence 
Interval for Mean 
Lower Bound 1.925   
Upper Bound 3.075   
5% Trimmed Mean 2.500   
Median 2.500   
Variance .300   
Std. Deviation .5477   
Minimum 2.0   
Maximum 3.0   
Range 1.0   
Interquartile Range 1.0   
Skewness .000 .845 
Kurtosis -3.333 1.741 
SiFn+ 1hr Mean 13.000 .5774 
95% Confidence 
Interval for Mean 
Lower Bound 11.516   
Upper Bound 14.484   
5% Trimmed Mean 13.000   
Median 13.000   
Variance 2.000   
Std. Deviation 1.4142   
Minimum 11.0   
Maximum 15.0   
Range 4.0   
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Interquartile Range 2.5   
Skewness .000 .845 
Kurtosis -.300 1.741 
SiLn+ 1hr Mean 9.333 .4216 
95% Confidence 
Interval for Mean 
Lower Bound 8.249   
Upper Bound 10.417   
5% Trimmed Mean 9.315   
Median 9.000   
Variance 1.067   
Std. Deviation 1.0328   
Minimum 8.0   
Maximum 11.0   
Range 3.0   
Interquartile Range 1.5   
Skewness .666 .845 
Kurtosis .586 1.741 
SiFnLn+ 1hr Mean 24.833 2.0235 
95% Confidence 
Interval for Mean 
Lower Bound 19.632   
Upper Bound 30.035   
5% Trimmed Mean 24.815   
Median 24.500   
Variance 24.567   
Std. Deviation 4.9565   
Minimum 19.0   
Maximum 31.0   
Range 12.0   
Interquartile Range 10.5   
Skewness .149 .845 
Kurtosis -1.770 1.741 
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7.12: Fibroblast vinculin per cell area descriptives at  1 
hour 
 
Surface at One 
Hour   Statistic Std. Error 
Vinculin/Cell 
Area 
Pol 1hr Mean .00513 .001038 
95% Confidence 
Interval for Mean 
Lower Bound .00246   
Upper Bound .00779   
5% Trimmed Mean .00507   
Median .00426   
Variance .000   
Std. Deviation .002543   
Minimum .003   
Maximum .009   
Range .006   
Interquartile Range .005   
Skewness .660 .845 
Kurtosis -1.658 1.741 
AdFn 1hr Mean .04598 .001751 
95% Confidence 
Interval for Mean 
Lower Bound .04148   
Upper Bound .05048   
5% Trimmed Mean .04602   
Median .04687   
Variance .000   
Std. Deviation .004290   
Minimum .041   
Maximum .051   
Range .010   
Interquartile Range .009   
Skewness -.394 .845 
Kurtosis -2.043 1.741 
AdLn 1hr Mean .03697 .001605 
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95% Confidence 
Interval for Mean 
Lower Bound .03285   
Upper Bound .04110   
5% Trimmed Mean .03722   
Median .03920   
Variance .000   
Std. Deviation .003931   
Minimum .030   
Maximum .039   
Range .009   
Interquartile Range .006   
Skewness -1.457 .845 
Kurtosis 1.045 1.741 
AdFnLn 1hr Mean .05948 .001405 
95% Confidence 
Interval for Mean 
Lower Bound .05586   
Upper Bound .06309   
5% Trimmed Mean .05951   
Median .06040   
Variance .000   
Std. Deviation .003441   
Minimum .055   
Maximum .063   
Range .008   
Interquartile Range .007   
Skewness -.508 .845 
Kurtosis -1.711 1.741 
Si- 1hr Mean .01076 .001188 
95% Confidence 
Interval for Mean 
Lower Bound .00771   
Upper Bound .01382   
5% Trimmed Mean .01071   
Median .00985   
Variance .000   
Std. Deviation .002911   
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Minimum .008   
Maximum .015   
Range .007   
Interquartile Range .006   
Skewness .662 .845 
Kurtosis -1.382 1.741 
SiFn- 1hr Mean .05597 .001580 
95% Confidence 
Interval for Mean 
Lower Bound .05191   
Upper Bound .06003   
5% Trimmed Mean .05597   
Median .05611   
Variance .000   
Std. Deviation .003871   
Minimum .051   
Maximum .061   
Range .011   
Interquartile Range .007   
Skewness -.048 .845 
Kurtosis -.625 1.741 
SiLn- 1hr Mean .04806 .002209 
95% Confidence 
Interval for Mean 
Lower Bound .04238   
Upper Bound .05374   
5% Trimmed Mean .04810   
Median .04841   
Variance .000   
Std. Deviation .005412   
Minimum .042   
Maximum .053   
Range .011   
Interquartile Range .010   
Skewness -.046 .845 
Kurtosis -3.170 1.741 
SiFnLn- 1hr Mean .07267 .001603 
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95% Confidence 
Interval for Mean 
Lower Bound .06855   
Upper Bound .07679   
5% Trimmed Mean .07263   
Median .07274   
Variance .000   
Std. Deviation .003926   
Minimum .069   
Maximum .078   
Range .009   
Interquartile Range .007   
Skewness .102 .845 
Kurtosis -2.564 1.741 
Si+ 1hr Mean .00466 .000383 
95% Confidence 
Interval for Mean 
Lower Bound .00367   
Upper Bound .00564   
5% Trimmed Mean .00463   
Median .00458   
Variance .000   
Std. Deviation .000938   
Minimum .004   
Maximum .006   
Range .002   
Interquartile Range .002   
Skewness .562 .845 
Kurtosis -.951 1.741 
SiFn+ 1hr Mean .01327 .000363 
95% Confidence 
Interval for Mean 
Lower Bound .01234   
Upper Bound .01420   
5% Trimmed Mean .01328   
Median .01315   
Variance .000   
Std. Deviation .000889   
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Minimum .012   
Maximum .014   
Range .002   
Interquartile Range .002   
Skewness .039 .845 
Kurtosis -1.452 1.741 
SiLn+ 1hr Mean .01096 .000351 
95% Confidence 
Interval for Mean 
Lower Bound .01006   
Upper Bound .01186   
5% Trimmed Mean .01096   
Median .01115   
Variance .000   
Std. Deviation .000859   
Minimum .010   
Maximum .012   
Range .002   
Interquartile Range .001   
Skewness -.128 .845 
Kurtosis .140 1.741 
SiFnLn+ 1hr Mean .02147 .001562 
95% Confidence 
Interval for Mean 
Lower Bound .01746   
Upper Bound .02549   
5% Trimmed Mean .02149   
Median .02141   
Variance .000   
Std. Deviation .003826   
Minimum .017   
Maximum .026   
Range .009   
Interquartile Range .008   
Skewness .007 .845 
Kurtosis -1.798 1.741 
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7.13: Fibroblast cell area descriptives on different 
surfaces at 4 hours 
 
Surface at Four 
Hours   Statistic 
Std. 
Error 
Cell Area (m
2
) Pol 4hrs Mean 487.0717 13.10684 
    95% Confidence 
Interval for Mean 
Lower Bound 
453.3795   
      Upper Bound 520.7639   
    5% Trimmed Mean 487.5363   
    Median 491.1200   
    Variance 1030.735   
    Std. Deviation 32.10507   
    Minimum 440.49   
    Maximum 525.29   
    Range 84.80   
    Interquartile Range 60.85   
    Skewness -.394 .845 
    Kurtosis -1.089 1.741 
  AdFn 4hrs Mean 1442.1417 24.17230 
    95% Confidence 
Interval for Mean 
Lower Bound 
1380.0048   
      Upper Bound 1504.2785   
    5% Trimmed Mean 1441.6330   
    Median 1437.5350   
    Variance 3505.801   
    Std. Deviation 59.20980   
    Minimum 1377.01   
    Maximum 1516.43   
    Range 139.42   
    Interquartile Range 127.95   
    Skewness .193 .845 
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    Kurtosis -1.801 1.741 
  AdLn 4hrs Mean 1199.7567 33.44907 
    95% Confidence 
Interval for Mean 
Lower Bound 
1113.7731   
      Upper Bound 1285.7403   
    5% Trimmed Mean 1200.2396   
    Median 1215.5300   
    Variance 6713.044   
    Std. Deviation 81.93317   
    Minimum 1099.06   
    Maximum 1291.76   
    Range 192.70   
    Interquartile Range 172.56   
    Skewness -.375 .845 
    Kurtosis -1.890 1.741 
  AdFnLn 4hrs Mean 1821.9600 28.40093 
    95% Confidence 
Interval for Mean 
Lower Bound 
1748.9531   
      Upper Bound 1894.9669   
    5% Trimmed Mean 1821.5611   
    Median 1818.8900   
    Variance 4839.677   
    Std. Deviation 69.56778   
    Minimum 1754.32   
    Maximum 1896.78   
    Range 142.46   
    Interquartile Range 131.66   
    Skewness .038 .845 
    Kurtosis -3.169 1.741 
  Si- 4hrs Mean 757.1700 19.03333 
    95% Confidence 
Interval for Mean 
Lower Bound 
708.2433   
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      Upper Bound 806.0967   
    5% Trimmed Mean 755.0406   
    Median 735.5450   
    Variance 2173.606   
    Std. Deviation 46.62195   
    Minimum 721.03   
    Maximum 831.64   
    Range 110.61   
    Interquartile Range 84.01   
    Skewness 1.038 .845 
    Kurtosis -.663 1.741 
  SiFn- 4hrs Mean 1686.7350 16.56526 
    95% Confidence 
Interval for Mean 
Lower Bound 
1644.1527   
      Upper Bound 1729.3173   
    5% Trimmed Mean 1687.8594   
    Median 1705.5950   
    Variance 1646.446   
    Std. Deviation 40.57642   
    Minimum 1632.96   
    Maximum 1720.27   
    Range 87.31   
    Interquartile Range 83.23   
    Skewness -.869 .845 
    Kurtosis -1.849 1.741 
  SiLn- 4hrs Mean 1550.7567 43.04557 
    95% Confidence 
Interval for Mean 
Lower Bound 
1440.1045   
      Upper Bound 1661.4088   
    5% Trimmed Mean 1549.6452   
    Median 1566.2800   
    Variance 11117.528   
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    Std. Deviation 105.43969   
    Minimum 1428.04   
    Maximum 1693.48   
    Range 265.44   
    Interquartile Range 202.53   
    Skewness -.036 .845 
    Kurtosis -1.450 1.741 
  SiFnLn- 4hrs Mean 2061.8400 25.53214 
    95% Confidence 
Interval for Mean 
Lower Bound 
1996.2075   
      Upper Bound 2127.4725   
    5% Trimmed Mean 2060.4933   
    Median 2049.8350   
    Variance 3911.342   
    Std. Deviation 62.54072   
    Minimum 1997.11   
    Maximum 2150.81   
    Range 153.70   
    Interquartile Range 116.85   
    Skewness .450 .845 
    Kurtosis -1.761 1.741 
  Si+ 4hrs Mean 707.1800 8.21385 
    95% Confidence 
Interval for Mean 
Lower Bound 
686.0656   
      Upper Bound 728.2944   
    5% Trimmed Mean 707.0961   
    Median 702.1500   
    Variance 404.804   
    Std. Deviation 20.11974   
    Minimum 684.26   
    Maximum 731.61   
    Range 47.35   
    Interquartile Range 41.11   
Appendix 
 
244 
 
    Skewness .420 .845 
    Kurtosis -1.905 1.741 
  SiFn+ 4hrs Mean 1120.0800 22.83380 
    95% Confidence 
Interval for Mean 
Lower Bound 
1061.3838   
      Upper Bound 1178.7762   
    5% Trimmed Mean 1120.0289   
    Median 1131.4550   
    Variance 3128.296   
    Std. Deviation 55.93117   
    Minimum 1049.84   
    Maximum 1191.24   
    Range 141.40   
    Interquartile Range 103.53   
    Skewness -.172 .845 
    Kurtosis -1.723 1.741 
  SiLn+ 4hrs Mean 993.4333 22.35985 
    95% Confidence 
Interval for Mean 
Lower Bound 
935.9555   
      Upper Bound 1050.9112   
    5% Trimmed Mean 994.5509   
    Median 1004.4250   
    Variance 2999.779   
    Std. Deviation 54.77023   
    Minimum 923.45   
    Maximum 1043.30   
    Range 119.85   
    Interquartile Range 102.80   
    Skewness -.259 .845 
    Kurtosis -2.610 1.741 
  SiFnLn+ 4hrs Mean 1249.9650 16.71188 
    95% Confidence 
Interval for Mean 
Lower Bound 
1207.0057   
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      Upper Bound 1292.9243   
    5% Trimmed Mean 1250.4822   
    Median 1249.7450   
    Variance 1675.723   
    Std. Deviation 40.93559   
    Minimum 1190.63   
    Maximum 1299.99   
    Range 109.36   
    Interquartile Range 76.87   
    Skewness -.226 .845 
    Kurtosis -.926 1.741 
 
7.14: Fibroblast vinculin per cell descriptives at  
4 hours 
 
Surface at Four 
Hours   Statistic Std. Error 
Vinculin/Cell Pol 4hrs Mean 5.333 .3333 
95% Confidence 
Interval for Mean 
Lower Bound 4.476   
Upper Bound 6.190   
5% Trimmed Mean 5.370   
Median 5.500   
Variance .667   
Std. Deviation .8165   
Minimum 4.0   
Maximum 6.0   
Range 2.0   
Interquartile Range 1.3   
Skewness -.857 .845 
Kurtosis -.300 1.741 
AdFn 4hrs Mean 80.833 3.1981 
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95% Confidence 
Interval for Mean 
Lower Bound 72.612   
Upper Bound 89.054   
5% Trimmed Mean 80.926   
Median 80.500   
Variance 61.367   
Std. Deviation 7.8337   
Minimum 70.0   
Maximum 90.0   
Range 20.0   
Interquartile Range 15.5   
Skewness -.100 .845 
Kurtosis -1.333 1.741 
AdLn 4hrs Mean 40.333 2.0276 
95% Confidence 
Interval for Mean 
Lower Bound 35.121   
Upper Bound 45.545   
5% Trimmed Mean 40.370   
Median 41.000   
Variance 24.667   
Std. Deviation 4.9666   
Minimum 34.0   
Maximum 46.0   
Range 12.0   
Interquartile Range 10.5   
Skewness -.298 .845 
Kurtosis -1.736 1.741 
AdFnLn 4hrs Mean 130.833 2.5615 
95% Confidence 
Interval for Mean 
Lower Bound 124.249   
Upper Bound 137.418   
5% Trimmed Mean 130.704   
Median 129.500   
Variance 39.367   
Std. Deviation 6.2743   
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Minimum 124.0   
Maximum 140.0   
Range 16.0   
Interquartile Range 11.5   
Skewness .512 .845 
Kurtosis -1.409 1.741 
Si- 4hrs Mean 10.667 .3333 
95% Confidence 
Interval for Mean 
Lower Bound 9.810   
Upper Bound 11.524   
5% Trimmed Mean 10.630   
Median 10.500   
Variance .667   
Std. Deviation .8165   
Minimum 10.0   
Maximum 12.0   
Range 2.0   
Interquartile Range 1.3   
Skewness .857 .845 
Kurtosis -.300 1.741 
SiFn- 4hrs Mean 103.333 3.5182 
95% Confidence 
Interval for Mean 
Lower Bound 94.289   
Upper Bound 112.377   
5% Trimmed Mean 103.370   
Median 101.500   
Variance 74.267   
Std. Deviation 8.6178   
Minimum 92.0   
Maximum 114.0   
Range 22.0   
Interquartile Range 16.8   
Skewness .232 .845 
Kurtosis -1.298 1.741 
SiLn- 4hrs Mean 78.000 2.6331 
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95% Confidence 
Interval for Mean 
Lower Bound 71.231   
Upper Bound 84.769   
5% Trimmed Mean 77.889   
Median 79.000   
Variance 41.600   
Std. Deviation 6.4498   
Minimum 70.0   
Maximum 88.0   
Range 18.0   
Interquartile Range 10.5   
Skewness .322 .845 
Kurtosis -.011 1.741 
SiFnLn- 4hrs Mean 162.000 3.4351 
95% Confidence 
Interval for Mean 
Lower Bound 153.170   
Upper Bound 170.830   
5% Trimmed Mean 161.944   
Median 163.500   
Variance 70.800   
Std. Deviation 8.4143   
Minimum 151.0   
Maximum 174.0   
Range 23.0   
Interquartile Range 14.8   
Skewness -.012 .845 
Kurtosis -.691 1.741 
Si+ 4hrs Mean 4.500 .4282 
95% Confidence 
Interval for Mean 
Lower Bound 3.399   
Upper Bound 5.601   
5% Trimmed Mean 4.500   
Median 4.500   
Variance 1.100   
Std. Deviation 1.0488   
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Minimum 3.0   
Maximum 6.0   
Range 3.0   
Interquartile Range 1.5   
Skewness .000 .845 
Kurtosis -.248 1.741 
SiFn+ 4hrs Mean 15.500 1.7654 
95% Confidence 
Interval for Mean 
Lower Bound 10.962   
Upper Bound 20.038   
5% Trimmed Mean 15.611   
Median 17.500   
Variance 18.700   
Std. Deviation 4.3243   
Minimum 10.0   
Maximum 19.0   
Range 9.0   
Interquartile Range 9.0   
Skewness -.846 .845 
Kurtosis -1.897 1.741 
SiLn+ 4hrs Mean 16.500 1.4549 
95% Confidence 
Interval for Mean 
Lower Bound 12.760   
Upper Bound 20.240   
5% Trimmed Mean 16.556   
Median 18.000   
Variance 12.700   
Std. Deviation 3.5637   
Minimum 12.0   
Maximum 20.0   
Range 8.0   
Interquartile Range 7.3   
Skewness -.776 .845 
Kurtosis -1.826 1.741 
SiFnLn+ 4hrs Mean 29.667 1.5846 
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95% Confidence 
Interval for Mean 
Lower Bound 25.593   
Upper Bound 33.740   
5% Trimmed Mean 29.685   
Median 30.500   
Variance 15.067   
Std. Deviation 3.8816   
Minimum 25.0   
Maximum 34.0   
Range 9.0   
Interquartile Range 8.3   
Skewness -.423 .845 
Kurtosis -1.847 1.741 
 
7.15: Fibroblast vinculin per cell area descriptives at  4 
hours 
 
Surface at Four 
Hours   Statistic Std. Error 
Vinculin/Cell 
Area 
Pol 4hrs Mean .01092 .000505 
95% Confidence 
Interval for Mean 
Lower Bound .00962   
Upper Bound .01222   
5% Trimmed Mean .01098   
Median .01139   
Variance .000   
Std. Deviation .001238   
Minimum .009   
Maximum .012   
Range .003   
Interquartile Range .002   
Skewness -1.471 .845 
Kurtosis 1.873 1.741 
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AdFn 4hrs Mean .05608 .002184 
95% Confidence 
Interval for Mean 
Lower Bound .05046   
Upper Bound .06169   
5% Trimmed Mean .05590   
Median .05460   
Variance .000   
Std. Deviation .005351   
Minimum .051   
Maximum .064   
Range .014   
Interquartile Range .009   
Skewness .759 .845 
Kurtosis -.771 1.741 
AdLn 4hrs Mean .03358 .001236 
95% Confidence 
Interval for Mean 
Lower Bound .03040   
Upper Bound .03675   
5% Trimmed Mean .03352   
Median .03205   
Variance .000   
Std. Deviation .003027   
Minimum .031   
Maximum .037   
Range .007   
Interquartile Range .006   
Skewness .850 .845 
Kurtosis -1.838 1.741 
AdFnLn 4hrs Mean .07180 .000596 
95% Confidence 
Interval for Mean 
Lower Bound .07026   
Upper Bound .07333   
5% Trimmed Mean .07178   
Median .07204   
Variance .000   
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Std. Deviation .001461   
Minimum .070   
Maximum .074   
Range .004   
Interquartile Range .003   
Skewness -.045 .845 
Kurtosis -1.196 1.741 
Si- 4hrs Mean .01416 .000666 
95% Confidence 
Interval for Mean 
Lower Bound .01244   
Upper Bound .01587   
5% Trimmed Mean .01417   
Median .01452   
Variance .000   
Std. Deviation .001632   
Minimum .012   
Maximum .016   
Range .004   
Interquartile Range .003   
Skewness -.296 .845 
Kurtosis -1.933 1.741 
SiFn- 4hrs Mean .06123 .001754 
95% Confidence 
Interval for Mean 
Lower Bound .05672   
Upper Bound .06573   
5% Trimmed Mean .06122   
Median .06052   
Variance .000   
Std. Deviation .004296   
Minimum .056   
Maximum .066   
Range .010   
Interquartile Range .009   
Skewness .295 .845 
Kurtosis -2.020 1.741 
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SiLn- 4hrs Mean .05043 .001881 
95% Confidence 
Interval for Mean 
Lower Bound .04560   
Upper Bound .05527   
5% Trimmed Mean .05049   
Median .05073   
Variance .000   
Std. Deviation .004607   
Minimum .044   
Maximum .056   
Range .012   
Interquartile Range .009   
Skewness -.285 .845 
Kurtosis -1.154 1.741 
SiFnLn- 4hrs Mean .07855 .001018 
95% Confidence 
Interval for Mean 
Lower Bound .07593   
Upper Bound .08116   
5% Trimmed Mean .07859   
Median .07895   
Variance .000   
Std. Deviation .002494   
Minimum .075   
Maximum .081   
Range .006   
Interquartile Range .005   
Skewness -.384 .845 
Kurtosis -1.897 1.741 
Si+ 4hrs Mean .00635 .000590 
95% Confidence 
Interval for Mean 
Lower Bound .00484   
Upper Bound .00787   
5% Trimmed Mean .00635   
Median .00631   
Variance .000   
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Std. Deviation .001445   
Minimum .004   
Maximum .008   
Range .004   
Interquartile Range .002   
Skewness .175 .845 
Kurtosis -.332 1.741 
SiFn+ 4hrs Mean .01382 .001539 
95% Confidence 
Interval for Mean 
Lower Bound .00987   
Upper Bound .01778   
5% Trimmed Mean .01393   
Median .01534   
Variance .000   
Std. Deviation .003769   
Minimum .009   
Maximum .017   
Range .008   
Interquartile Range .008   
Skewness -.784 .845 
Kurtosis -1.801 1.741 
SiLn+ 4hrs Mean .01676 .001706 
95% Confidence 
Interval for Mean 
Lower Bound .01237   
Upper Bound .02114   
5% Trimmed Mean .01680   
Median .01840   
Variance .000   
Std. Deviation .004178   
Minimum .012   
Maximum .021   
Range .010   
Interquartile Range .008   
Skewness -.696 .845 
Kurtosis -1.766 1.741 
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SiFnLn+ 4hrs Mean .02373 .001246 
95% Confidence 
Interval for Mean 
Lower Bound .02053   
Upper Bound .02694   
5% Trimmed Mean .02375   
Median .02357   
Variance .000   
Std. Deviation .003053   
Minimum .020   
Maximum .027   
Range .008   
Interquartile Range .006   
Skewness .060 .845 
Kurtosis -1.661 1.741 
 
7.16: Fibroblast cell area descriptives at 24 hours 
 
Surface at 
Twenty Four 
Hours   Statistic 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Pol 24hrs Mean 680.9733 15.59293 
95% Confidence 
Interval for Mean 
Lower Bound 640.8904   
Upper Bound 721.0562   
5% Trimmed Mean 681.1165   
Median 676.0800   
Variance 1458.837   
Std. Deviation 38.19473   
Minimum 631.70   
Maximum 727.67   
Range 95.97   
Interquartile Range 71.82   
Skewness .067 .845 
Kurtosis -1.842 1.741 
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AdFn 24hrs Mean 1759.4550 18.80587 
95% Confidence 
Interval for Mean 
Lower Bound 1711.1130   
Upper Bound 1807.7970   
5% Trimmed Mean 1758.7561   
Median 1756.8750   
Variance 2121.964   
Std. Deviation 46.06479   
Minimum 1698.16   
Maximum 1833.33   
Range 135.17   
Interquartile Range 72.77   
Skewness .484 .845 
Kurtosis .734 1.741 
AdLn 24hrs Mean 1587.3417 25.32817 
95% Confidence 
Interval for Mean 
Lower Bound 1522.2335   
Upper Bound 1652.4498   
5% Trimmed Mean 1588.3202   
Median 1609.5650   
Variance 3849.096   
Std. Deviation 62.04108   
Minimum 1506.12   
Maximum 1650.95   
Range 144.83   
Interquartile Range 125.18   
Skewness -.666 .845 
Kurtosis -1.834 1.741 
AdFnLn 24hrs Mean 2206.6517 20.90016 
95% Confidence 
Interval for Mean 
Lower Bound 2152.9261   
Upper Bound 2260.3772   
5% Trimmed Mean 2206.8607   
Median 2206.2350   
Variance 2620.899   
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Std. Deviation 51.19472   
Minimum 2145.07   
Maximum 2264.47   
Range 119.40   
Interquartile Range 105.96   
Skewness -.013 .845 
Kurtosis -2.245 1.741 
Si- 24hrs Mean 945.3100 24.21491 
95% Confidence 
Interval for Mean 
Lower Bound 883.0636   
Upper Bound 1007.5564   
5% Trimmed Mean 945.8389   
Median 955.1500   
Variance 3518.170   
Std. Deviation 59.31417   
Minimum 863.01   
Maximum 1018.09   
Range 155.08   
Interquartile Range 114.79   
Skewness -.351 .845 
Kurtosis -1.271 1.741 
SiFn- 24hrs Mean 1990.4117 27.45996 
95% Confidence 
Interval for Mean 
Lower Bound 1919.8236   
Upper Bound 2060.9997   
5% Trimmed Mean 1992.0157   
Median 1999.8500   
Variance 4524.296   
Std. Deviation 67.26289   
Minimum 1894.52   
Maximum 2057.43   
Range 162.91   
Interquartile Range 120.92   
Skewness -.403 .845 
Kurtosis -1.873 1.741 
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SiLn- 24hrs Mean 1810.3583 22.91183 
95% Confidence 
Interval for Mean 
Lower Bound 1751.4616   
Upper Bound 1869.2551   
5% Trimmed Mean 1810.8698   
Median 1824.0300   
Variance 3149.712   
Std. Deviation 56.12230   
Minimum 1726.54   
Maximum 1884.97   
Range 158.43   
Interquartile Range 93.86   
Skewness -.409 .845 
Kurtosis -.242 1.741 
SiFnLn- 24hrs Mean 2456.8950 33.79463 
95% Confidence 
Interval for Mean 
Lower Bound 2370.0231   
Upper Bound 2543.7669   
5% Trimmed Mean 2456.8683   
Median 2477.9100   
Variance 6852.461   
Std. Deviation 82.77959   
Minimum 2355.84   
Maximum 2558.43   
Range 202.59   
Interquartile Range 159.52   
Skewness -.301 .845 
Kurtosis -1.775 1.741 
Si+ 24hrs Mean 742.7583 11.71889 
95% Confidence 
Interval for Mean 
Lower Bound 712.6340   
Upper Bound 772.8827   
5% Trimmed Mean 741.9031   
Median 728.6650   
Variance 823.994   
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Std. Deviation 28.70530   
Minimum 719.40   
Maximum 781.51   
Range 62.11   
Interquartile Range 56.59   
Skewness .826 .845 
Kurtosis -1.875 1.741 
SiFn+ 24hrs Mean 1267.4967 18.06021 
95% Confidence 
Interval for Mean 
Lower Bound 1221.0714   
Upper Bound 1313.9219   
5% Trimmed Mean 1268.0319   
Median 1275.8800   
Variance 1957.027   
Std. Deviation 44.23830   
Minimum 1210.11   
Maximum 1315.25   
Range 105.14   
Interquartile Range 83.33   
Skewness -.281 .845 
Kurtosis -2.300 1.741 
SiLn+ 24hrs Mean 1169.9000 29.02984 
95% Confidence 
Interval for Mean 
Lower Bound 1095.2764   
Upper Bound 1244.5236   
5% Trimmed Mean 1166.9044   
Median 1150.4900   
Variance 5056.390   
Std. Deviation 71.10830   
Minimum 1101.89   
Maximum 1291.83   
Range 189.94   
Interquartile Range 117.36   
Skewness 1.127 .845 
Kurtosis .734 1.741 
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SiFnLn+ 24hrs Mean 1286.2583 24.86839 
95% Confidence 
Interval for Mean 
Lower Bound 1222.3321   
Upper Bound 1350.1846   
5% Trimmed Mean 1285.8276   
Median 1278.9650   
Variance 3710.622   
Std. Deviation 60.91487   
Minimum 1213.63   
Maximum 1366.64   
Range 153.01   
Interquartile Range 116.92   
Skewness .220 .845 
Kurtosis -1.869 1.741 
 
7.17: Fibroblast vinculin per cell descriptives at 
24 hours 
 
Surface at Twenty 
Four Hours   Statistic Std. Error 
Vinculin/Cell Pol 24hrs Mean 5.667 .2108 
95% Confidence 
Interval for Mean 
Lower Bound 5.125   
Upper Bound 6.209   
5% Trimmed Mean 5.685   
Median 6.000   
Variance .267   
Std. Deviation .5164   
Minimum 5.0   
Maximum 6.0   
Range 1.0   
Interquartile Range 1.0   
Skewness -.968 .845 
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Kurtosis -1.875 1.741 
AdFn 24hrs Mean 93.833 3.6462 
95% Confidence 
Interval for Mean 
Lower Bound 84.461   
Upper Bound 103.206   
5% Trimmed Mean 93.648   
Median 92.500   
Variance 79.767   
Std. Deviation 8.9312   
Minimum 84.0   
Maximum 107.0   
Range 23.0   
Interquartile Range 17.0   
Skewness .490 .845 
Kurtosis -1.187 1.741 
AdLn 24hrs Mean 81.667 2.9963 
95% Confidence 
Interval for Mean 
Lower Bound 73.964   
Upper Bound 89.369   
5% Trimmed Mean 81.852   
Median 85.000   
Variance 53.867   
Std. Deviation 7.3394   
Minimum 71.0   
Maximum 89.0   
Range 18.0   
Interquartile Range 13.5   
Skewness -.830 .845 
Kurtosis -1.419 1.741 
AdFnLn 24hrs Mean 153.333 2.8245 
95% Confidence 
Interval for Mean 
Lower Bound 146.073   
Upper Bound 160.594   
5% Trimmed Mean 153.426   
Median 154.000   
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Variance 47.867   
Std. Deviation 6.9186   
Minimum 144.0   
Maximum 161.0   
Range 17.0   
Interquartile Range 12.5   
Skewness -.242 .845 
Kurtosis -2.131 1.741 
Si- 24hrs Mean 16.333 1.5202 
95% Confidence 
Interval for Mean 
Lower Bound 12.425   
Upper Bound 20.241   
5% Trimmed Mean 16.259   
Median 15.000   
Variance 13.867   
Std. Deviation 3.7238   
Minimum 13.0   
Maximum 21.0   
Range 8.0   
Interquartile Range 8.0   
Skewness .723 .845 
Kurtosis -1.875 1.741 
SiFn- 24hrs Mean 132.333 5.3583 
95% Confidence 
Interval for Mean 
Lower Bound 118.559   
Upper Bound 146.107   
5% Trimmed Mean 132.648   
Median 136.000   
Variance 172.267   
Std. Deviation 13.1250   
Minimum 114.0   
Maximum 145.0   
Range 31.0   
Interquartile Range 25.0   
Skewness -.518 .845 
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Kurtosis -1.920 1.741 
SiLn- 24hrs Mean 104.500 2.6677 
95% Confidence 
Interval for Mean 
Lower Bound 97.642   
Upper Bound 111.358   
5% Trimmed Mean 104.389   
Median 103.500   
Variance 42.700   
Std. Deviation 6.5345   
Minimum 97.0   
Maximum 114.0   
Range 17.0   
Interquartile Range 12.5   
Skewness .452 .845 
Kurtosis -1.191 1.741 
SiFnLn- 24hrs Mean 220.167 3.4100 
95% Confidence 
Interval for Mean 
Lower Bound 211.401   
Upper Bound 228.932   
5% Trimmed Mean 219.963   
Median 219.500   
Variance 69.767   
Std. Deviation 8.3526   
Minimum 211.0   
Maximum 233.0   
Range 22.0   
Interquartile Range 14.5   
Skewness .535 .845 
Kurtosis -.823 1.741 
Si+ 24hrs Mean 3.833 .7491 
95% Confidence 
Interval for Mean 
Lower Bound 1.908   
Upper Bound 5.759   
5% Trimmed Mean 3.815   
Median 3.500   
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Variance 3.367   
Std. Deviation 1.8348   
Minimum 2.0   
Maximum 6.0   
Range 4.0   
Interquartile Range 4.0   
Skewness .362 .845 
Kurtosis -2.103 1.741 
SiFn+ 24hrs Mean 17.333 1.9264 
95% Confidence 
Interval for Mean 
Lower Bound 12.381   
Upper Bound 22.285   
5% Trimmed Mean 17.426   
Median 19.000   
Variance 22.267   
Std. Deviation 4.7188   
Minimum 11.0   
Maximum 22.0   
Range 11.0   
Interquartile Range 9.5   
Skewness -.673 .845 
Kurtosis -1.840 1.741 
SiLn+ 24hrs Mean 10.667 1.5846 
95% Confidence 
Interval for Mean 
Lower Bound 6.593   
Upper Bound 14.740   
5% Trimmed Mean 10.630   
Median 10.500   
Variance 15.067   
Std. Deviation 3.8816   
Minimum 6.0   
Maximum 16.0   
Range 10.0   
Interquartile Range 7.8   
Skewness .193 .845 
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Kurtosis -1.354 1.741 
SiFnLn+ 24hrs Mean 24.500 1.3844 
95% Confidence 
Interval for Mean 
Lower Bound 20.941   
Upper Bound 28.059   
5% Trimmed Mean 24.444   
Median 24.000   
Variance 11.500   
Std. Deviation 3.3912   
Minimum 21.0   
Maximum 29.0   
Range 8.0   
Interquartile Range 7.3   
Skewness .369 .845 
Kurtosis -1.696 1.741 
 
7.18: Fibroblast vinculin per cell area descriptives at 24 
hours 
 
Surface at 
Twenty Four 
Hours   Statistic Std. Error 
Vinculin/Cell 
Area 
Pol 24hrs Mean .00834 .000350 
95% Confidence 
Interval for Mean 
Lower Bound .00744   
Upper Bound .00924   
5% Trimmed Mean .00834   
Median .00829   
Variance .000   
Std. Deviation .000857   
Minimum .007   
Maximum .009   
Range .002   
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Interquartile Range .002   
Skewness .113 .845 
Kurtosis -1.136 1.741 
AdFn 24hrs Mean .05340 .002362 
95% Confidence 
Interval for Mean 
Lower Bound .04733   
Upper Bound .05947   
5% Trimmed Mean .05318   
Median .05192   
Variance .000   
Std. Deviation .005787   
Minimum .048   
Maximum .063   
Range .015   
Interquartile Range .010   
Skewness .953 .845 
Kurtosis .102 1.741 
AdLn 24hrs Mean .05149 .001926 
95% Confidence 
Interval for Mean 
Lower Bound .04654   
Upper Bound .05644   
5% Trimmed Mean .05156   
Median .05226   
Variance .000   
Std. Deviation .004717   
Minimum .045   
Maximum .057   
Range .012   
Interquartile Range .009   
Skewness -.437 .845 
Kurtosis -1.412 1.741 
AdFnLn 24hrs Mean .06951 .001416 
95% Confidence 
Interval for Mean 
Lower Bound .06587   
Upper Bound .07315   
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5% Trimmed Mean .06947   
Median .06853   
Variance .000   
Std. Deviation .003469   
Minimum .066   
Maximum .074   
Range .007   
Interquartile Range .007   
Skewness .473 .845 
Kurtosis -2.272 1.741 
Si- 24hrs Mean .01725 .001500 
95% Confidence 
Interval for Mean 
Lower Bound .01340   
Upper Bound .02111   
5% Trimmed Mean .01713   
Median .01510   
Variance .000   
Std. Deviation .003674   
Minimum .015   
Maximum .022   
Range .008   
Interquartile Range .007   
Skewness .961 .845 
Kurtosis -1.846 1.741 
SiFn- 24hrs Mean .06645 .002340 
95% Confidence 
Interval for Mean 
Lower Bound .06043   
Upper Bound .07246   
5% Trimmed Mean .06651   
Median .06798   
Variance .000   
Std. Deviation .005731   
Minimum .059   
Maximum .073   
Range .014   
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Interquartile Range .011   
Skewness -.501 .845 
Kurtosis -1.710 1.741 
SiLn- 24hrs Mean .05781 .001959 
95% Confidence 
Interval for Mean 
Lower Bound .05278   
Upper Bound .06285   
5% Trimmed Mean .05765   
Median .05655   
Variance .000   
Std. Deviation .004798   
Minimum .053   
Maximum .066   
Range .014   
Interquartile Range .007   
Skewness 1.047 .845 
Kurtosis .975 1.741 
SiFnLn- 24hrs Mean .08963 .001033 
95% Confidence 
Interval for Mean 
Lower Bound .08697   
Upper Bound .09229   
5% Trimmed Mean .08964   
Median .08952   
Variance .000   
Std. Deviation .002531   
Minimum .086   
Maximum .093   
Range .007   
Interquartile Range .005   
Skewness -.035 .845 
Kurtosis -.805 1.741 
Si+ 24hrs Mean .00521 .001065 
95% Confidence 
Interval for Mean 
Lower Bound .00247   
Upper Bound .00795   
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5% Trimmed Mean .00518   
Median .00464   
Variance .000   
Std. Deviation .002609   
Minimum .003   
Maximum .008   
Range .006   
Interquartile Range .006   
Skewness .415 .845 
Kurtosis -2.140 1.741 
SiFn+ 24hrs Mean .01368 .001505 
95% Confidence 
Interval for Mean 
Lower Bound .00981   
Upper Bound .01755   
5% Trimmed Mean .01376   
Median .01527   
Variance .000   
Std. Deviation .003688   
Minimum .009   
Maximum .017   
Range .008   
Interquartile Range .008   
Skewness -.755 .845 
Kurtosis -1.970 1.741 
SiLn+ 24hrs Mean .00923 .001496 
95% Confidence 
Interval for Mean 
Lower Bound .00538   
Upper Bound .01307   
5% Trimmed Mean .00918   
Median .00880   
Variance .000   
Std. Deviation .003664   
Minimum .005   
Maximum .014   
Range .009   
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Interquartile Range .007   
Skewness .289 .845 
Kurtosis -1.816 1.741 
SiFnLn+ 24hrs Mean .01911 .001246 
95% Confidence 
Interval for Mean 
Lower Bound .01591   
Upper Bound .02231   
5% Trimmed Mean .01908   
Median .01799   
Variance .000   
Std. Deviation .003052   
Minimum .016   
Maximum .023   
Range .007   
Interquartile Range .006   
Skewness .592 .845 
Kurtosis -1.644 1.741 
 
7.19: p values for fibroblast bioassay-cell area 1 hour 
 
 
 
 
 
 Pol 
1hr 
AdF
n 
1hr 
AdL
n 
1hr 
AdFn
Ln 1hr 
Si- 
1hr 
SiFn
- 1hr 
SiLn
- 1hr 
SiFnL
n- 1hr 
Si+ 
1hr 
SiFn
+ 1hr 
SiLn
+ 1hr 
SiFnL
n+ 1hr 
Pol 
1hr 
 - 0.00
4 
0.00
4 
0.004 0.0
04 
0.00
4 
0.00
4 
0.004 0.0
04 
0.00
4 
0.00
4 
0.004 
AdFn 
1hr 
 - -  0.01 0.004 0.0
04 
0.00
4 
0.42
3 
0.004 0.0
04 
0.00
4 
0.00
4 
0.01 
AdLn 
1hr 
 - -  -  0.004 0.0
04 
0.00
4 
0.01
6 
0.004 0.0
04 
0.10
9 
0.00
4 
0.055 
AdFn
Ln 1hr 
 -  - -   - 0.0
04 
0.00
4 
0.00
4 
0.004 0.0
04 
0.00
4 
0.00
4 
0.004 
Si- 
1hr 
 -  -  -  -  - 0.00
4 
0.00
4 
0.004 0.0
78 
0.00
4 
0.00
4 
0.004 
SiFn- 
1hr 
 -  -  -  -  -  - 0.00
4 
0.004 4 0.00
4 
0.00
4 
0.004 
SiLn- 
1hr 
 -  -  -  -  -  -  - 0.004 0.0
04 
0.00
4 
0.00
4 
0.423 
SiFnL
n- 1hr 
 -  -  -  -  -  -  -  - 0.0
04 
0.00
4 
0.00
4 
0.004 
Si+ 
1hr 
 -  -  -  -  -  -  -  -  - 0.00
4 
0.00
4 
0.004 
SiFn+ 
1hr 
 -  -  -  - -   -  -  -  - - 0.00
4 
0.004 
SiLn+ 
1hr 
 - -   - -   -  -   - -   - -   - 0.004 
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7.20: p values for fibroblast- vinculin per cell 1 hour 
 
 
7.21: p values for fibroblast bioassay-vinculin per cell 
area 1 hour 
  
Po
l 
1h
r 
AdF
n 
1hr 
AdL
n 
1hr 
AdFnL
n 1hr 
Si- 
1hr 
SiFn
- 1hr 
SiLn
- 1hr 
SiFnL
n- 1hr 
Si+ 
1hr 
SiFn
+ 
1hr 
SiLn
+ 
1hr 
SiFnLn
+ 1hr 
Pol 
1hr  - 
0.00
4 
0.00
4 0.004 
0.01
6 
0.00
6 
0.00
4 0.004 
0.63
1 
0.00
4 
0.00
4 0.004 
AdFn 
1hr  -  - 
0.00
4 0.004 
0.00
4 
0.00
4 
0.33
7 0.004 
0.00
4 
0.00
4 
0.00
4 0.004 
AdLn 
1hr  -  -  - 0.004 
0.00
4 
0.00
4 
0.00
4 0.004 
0.00
4 
0.00
4 
0.00
4 0.004 
AdFnL
n 1hr  -  -  -  - 
0.00
4 0.2 
0.00
4 0.004 
0.00
4 
0.00
4 
0.00
4 0.004 
Si- 1hr  -  -  -  -  - 
0.00
4 
0.00
4 0.004 
0.00
4 0.2 
0.52
2 0.004 
SiFn- 
1hr  -  -  -  -  -  - 
0.02
5 0.004 
0.00
4 
0.00
4 
0.00
4 0.004 
SiLn- 
1hr  -  -  -  -  -  -  - 0.004 
0.00
4 
0.00
4 
0.00
4 0.004 
SiFnL
n- 1hr  -  -  -  -  -  -  -  - 
0.00
4 
0.00
4 
0.00
4 0.004 
Si+ 
1hr  -  -  -  -  -  -  -  - -  
0.00
4 
0.00
4 0.004 
SiFn+ 
1hr  -  -  -  -  -  -  -  -  -  - 
0.00
6 0.004 
SiLn+ 
1hr  - -   - -   - -   - -   - -    0.004 
 
Pol 
1hr 
AdF
n 1hr 
AdL
n 1hr 
AdFnL
n 1hr 
Si- 
1hr 
SiFn
- 1hr 
SiLn- 
1hr 
SiFnL
n- 1hr 
Si+ 
1hr 
SiFn
+ 1hr 
SiL
n+ 
1hr 
SiFn
Ln+ 
1hr 
Pol 1hr 
 - 
0.00
4 
0.00
4 0.004 
0.0
03 
0.0
04 0.004 0.004 
0.2
01 
0.00
4 
0.00
3 
0.00
4 
AdFn 1hr 
 -  - 
0.00
4 0.004 
0.0
04 
0.0
04 0.936 0.004 
0.0
03 
0.00
4 
0.00
4 
0.00
4 
AdLn 1hr 
 -  -  - 0.004 
0.0
04 
0.0
04 0.004 0.004 
0.0
03 
0.00
4 
0.00
4 
0.00
4 
AdFnLn 
1hr  -  -  - -  
0.0
04 
0.0
06 0.004 0.004 
0.0
03 
0.00
4 
0.00
4 
0.00
4 
Si- 1hr 
 -  -  -  -  - 
0.0
04 0.004 0.004 
0.0
03 
0.00
4 
0.01
4 
0.00
4 
SiFn- 1hr 
 -  -  -  -  -  - 0.004 0.004 
0.0
03 
0.00
4 
0.00
4 
0.00
4 
SiLn- 1hr 
 -  -  -  -  -  -  - 0.004 
0.0
03 
0.00
4 
0.00
4 
0.00
4 
SiFnLn- 
1hr  -  -  -  -  -  -  -  - 
0.0
03 
0.00
4 
0.00
4 
0.00
4 
Si+ 1hr 
 -  -  -  -  -  -  -  -  - 
0.00
3 
0.00
3 
0.00
3 
SiFn+ 
1hr  -  -  -  -  -  -  -  -  -  - 
0.00
4 
0.00
4 
SiLn+ 
1hr  -  - -   - -   - -   - -   - -  
0.00
4 
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7.22: p values for fibroblast bioassay-cell area 4 hours 
  
Pol 
4hr
s 
AdF
n 
4hrs 
AdL
n 
4hrs 
AdFn
Ln 
4hrs 
Si- 
4hr
s 
SiFn
- 
4hrs 
SiLn
- 
4hrs 
SiFnL
n- 
4hrs 
Si+ 
4hr
s 
SiFn
+ 
4hrs 
SiLn
+ 
4hrs 
SiFnL
n+ 
4hrs 
Pol 
4hrs  - 
0.00
4 
0.00
4 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
AdFn 
4hrs  -  - 
0.00
4 0.004 
0.0
04 
0.00
4 
0.07
8 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
AdLn 
4hrs  -  -  - 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 
0.10
9 
0.00
4 0.337 
AdFn
Ln 
4hrs  -  -  -  - 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
Si- 
4hrs  -  -  -  -  - 
0.00
4 
0.00
4 0.004 
0.0
55 
0.00
4 
0.00
4 0.004 
SiFn- 
4hrs  -  -  -  -  -  - 0.01 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
SiLn- 
4hrs  -  -  -  -  -  -  - 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
SiFnL
n- 
4hrs  -  -  -  -  -  -  -  - 
0.0
04 
0.00
4 
0.00
4 0.004 
Si+ 
4hrs  -  -  -  -  -  -  -  -  - 
0.00
4 
0.00
4 0.004 
SiFn+ 
4hrs  -  -  -  -  -  -  -  -  -  - 
0.00
4 0.006 
SiLn+ 
4hrs  - -   - -   - -   - -   - -   - 0.004 
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7.23: p values for fibroblast bioassay-vinculin 4 hours 
  
Pol 
4hr
s 
AdF
n 
4hrs 
AdL
n 
4hrs 
AdFn
Ln 
4hrs 
Si- 
4hr
s 
SiFn
- 
4hrs 
SiLn
- 
4hrs 
SiFnL
n- 
4hrs 
Si+ 
4hr
s 
SiFn
+ 
4hrs 
SiLn
+ 
4hrs 
SiFnL
n+ 
4hrs 
Pol 
4hrs  - 
0.00
4 
0.00
4 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
AdFn 
4hrs  -  - 
0.00
4 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
AdLn 
4hrs  -  -  - 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
AdFn
Ln 
4hrs  -  -  -  - 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
Si- 
4hrs  -  -  -  -  - 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
SiFn- 
4hrs  -  -  -  -  -  - 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
SiLn- 
4hrs  -  -  -  -  -  -  - 0.004 
0.0
04 0.004 0.004 0.004 
SiFnL
n- 
4hrs  -  -  -  -  -  -  -  - 
0.0
04 0.004 0.004 0.004 
Si+ 
4hrs  -  -  -  -  -  -  -  -  - 0.004 0.004 0.004 
SiFn+ 
4hrs  -  -  -  -  -  -  -  -  -  - 0.004 0.004 
SiLn+ 
4hrs  - -   - -   - -   - -   - -   - 0.004 
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7.24: p values for fibroblast bioassay-vinculin per cell 
area 4 hours 
  
Pol 
4hr
s 
AdF
n 
4hrs 
AdL
n 
4hrs 
AdFn
Ln 
4hrs 
Si- 
4hr
s 
SiFn
- 
4hrs 
SiLn
- 
4hrs 
SiFnL
n- 
4hrs 
Si+ 
4hr
s 
SiFn
+ 
4hrs 
SiLn
+ 
4hrs 
SiFnL
n+ 
4hrs 
Pol 
4hrs  - 
0.00
4 
0.00
4 0.004 
0.0
06 
0.00
4 
0.00
4 0.004 
0.0
04 0.262 0.025 0.004 
AdFn 
4hrs  -  - 
0.00
4 0.004 
0.0
04 
0.10
9 
0.07
8 0.004 
0.0
04 0.004 0.004 0.004 
AdLn 
4hrs  -  -  - 0.004 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
AdFn
Ln 
4hrs  -  -  -  - 
0.0
04 
0.00
4 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
Si- 
4hrs  -  -  -  -  - 
0.00
4 
0.00
4 0.004 
0.0
04 0.749 0.337 0.004 
SiFn- 
4hrs  -  -  -  -  -  - 
0.00
4 0.004 
0.0
04 0.004 0.004 0.004 
SiLn- 
4hrs  -  -  -  -  -  -  - 0.004 
0.0
04 0.004 0.004 0.004 
SiFnL
n- 
4hrs  -  -  -  -  -  -  -  - 
0.0
04 0.004 0.004 0.004 
Si+ 
4hrs  -  -  -  -  -  -  -  -  - 0.004 0.004 0.004 
SiFn+ 
4hrs  -  -  -  -  -  -  - -   -  - 0.109 0.004 
SiLn+ 
4hrs  - -   - -   - -   -  -  -  - -  0.004 
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7.25: p values for fibroblast bioassay- cell area  
24 hours 
  
Pol 
24hr
s 
AdFn 
24hrs 
AdLn 
24hrs 
AdFnL
n 
24hrs 
Si- 
24hr
s 
SiFn- 
24hrs 
SiLn- 
24hrs 
SiFnL
n- 
24hrs 
Si+ 
24hr
s 
SiFn+ 
24hrs 
SiLn+ 
24hrs 
SiFnLn
+ 
24hrs 
Pol 
24hrs  - 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
0.01
6 0.004 0.004 0.004 
AdFn 
24hrs  -  - 0.004 0.004 
0.00
4 0.004 0.15 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
24hrs  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 
24hrs  -  -  -  - 
0.00
4 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
Si- 
24hrs  -  -  -  -  - 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
SiFn- 
24hrs  -  -  -  -  -  - 0.004 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
24hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnL
n- 
24hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
24hrs  -  -  -  -  -  -  -  -  - 0.004 0.004 0.004 
SiFn+ 
24hrs  -  -  -  -  -  -  - -   -  - 0.016 0.423 
SiLn+ 
24hrs  - -   - -   - -   -  -  - -   - 0.016 
 
7.26: p values for fibroblast bioassay-vinculin 
24 hours 
  
Pol 
24hr
s 
AdFn 
24hrs 
AdLn 
24hrs 
AdFnL
n 
24hrs 
Si- 
24hr
s 
SiFn- 
24hrs 
SiLn- 
24hrs 
SiFnL
n- 
24hrs 
Si+ 
24hr
s 
SiFn+ 
24hrs 
SiLn+ 
24hrs 
SiFnLn
+ 
24hrs 
Pol 
24hrs  - 0.003 0.003 0.003 
0.00
3 0.003 0.003 0.003 
0.08
6 0.003 0.008 0.003 
AdFn 
24hrs  -  - 0.043 0.004 
0.00
4 0.004 0.055 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
24hrs  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 
24hrs  -  -  -  - 
0.00
4 0.006 0.004 0.004 
0.00
4 0.004 0.004 0.004 
Si- 
24hrs  -  -  -  -  - 0.004 0.004 0.004 
0.00
4 0.871 0.053 0.009 
SiFn- 
24hrs  -  -  -  -  -  - 0.005 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
24hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnL
n- 
24hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
24hrs  -  -  -  -  -  -  -  -  - 0.004 0.006 0.004 
SiFn+ 
24hrs  -  -  -  -  -  -  -  -  -  - 0.03 0.015 
SiLn+ 
24hrs  - -   - -   - -   - -   - -   - 0.004 
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7.27: p values for fibroblast bioassay-vinculin per cell 
area 24 hours 
  
Pol 
24hr
s 
AdFn 
24hrs 
AdLn 
24hrs 
AdFnL
n 
24hrs 
Si- 
24hr
s 
SiFn- 
24hrs 
SiLn- 
24hrs 
SiFnL
n- 
24hrs 
Si+ 
24hr
s 
SiFn+ 
24hrs 
SiLn+ 
24hrs 
SiFnLn
+ 
24hrs 
Pol 
24hrs  - 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
0.05
4 0.016 0.749 0.004 
AdFn 
24hrs  -  - 0.631 0.004 
0.00
4 0.01 0.15 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
24hrs  -  -  - 0.004 
0.00
4 0.004 0.078 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 
24hrs  -  -  -  - 
0.00
4 0.423 0.004 0.004 
0.00
4 0.004 0.004 0.004 
Si- 
24hrs  -  -  -  -  - 0.004 0.004 0.004 
0.00
4 0.337 0.004 0.109 
SiFn- 
24hrs  -  -  -  -  -  - 0.025 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
24hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnL
n- 
24hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
24hrs  -  -  -  -  -  -  -  -  - 0.004 0.078 0.004 
SiFn+ 
24hrs  -  -  - -   -  -  -  -  -  - 0.055 0.016 
SiLn+ 
24hrs  - -   -  -  - -   - -   - -   - 0.004 
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7.28: Keratinocyte cell area 1hour descriptives on 
different surfaces 
  
Surface at One 
Hour   Statistic 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Pol 1hr Mean 306.6867 11.75370 
95% Confidence 
Interval for Mean 
Lower Bound 276.4728   
Upper Bound 336.9005   
5% Trimmed Mean 306.3991   
Median 303.5550   
Variance 828.897   
Std. Deviation 28.79057   
Minimum 272.02   
Maximum 346.53   
Range 74.51   
Interquartile Range 56.23   
Skewness .287 .845 
Kurtosis -1.396 1.741 
AdFn 1hr Mean 524.1333 13.26125 
95% Confidence 
Interval for Mean 
Lower Bound 490.0442   
Upper Bound 558.2225   
5% Trimmed Mean 522.5770   
Median 520.1300   
Variance 1055.165   
Std. Deviation 32.48330   
Minimum 494.27   
Maximum 582.01   
Range 87.74   
Interquartile Range 48.76   
Skewness 1.260 .845 
Kurtosis 1.706 1.741 
AdLn 1hr Mean 462.9733 23.73728 
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95% Confidence 
Interval for Mean 
Lower Bound 401.9547   
Upper Bound 523.9920   
5% Trimmed Mean 461.9231   
Median 473.3650   
Variance 3380.751   
Std. Deviation 58.14423   
Minimum 394.29   
Maximum 550.56   
Range 156.27   
Interquartile Range 101.78   
Skewness .194 .845 
Kurtosis -.382 1.741 
AdFnLn 1hr Mean 856.0100 16.74587 
95% Confidence 
Interval for Mean 
Lower Bound 812.9634   
Upper Bound 899.0566   
5% Trimmed Mean 855.3189   
Median 846.5050   
Variance 1682.544   
Std. Deviation 41.01883   
Minimum 813.70   
Maximum 910.76   
Range 97.06   
Interquartile Range 85.67   
Skewness .512 .845 
Kurtosis -1.779 1.741 
Si- 1hr Mean 289.4967 10.06019 
95% Confidence 
Interval for Mean 
Lower Bound 263.6361   
Upper Bound 315.3572   
5% Trimmed Mean 289.4446   
Median 287.3700   
Variance 607.245   
Std. Deviation 24.64234   
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Minimum 255.76   
Maximum 324.17   
Range 68.41   
Interquartile Range 40.20   
Skewness .086 .845 
Kurtosis -.767 1.741 
SiFn- 1hr Mean 585.8100 13.64070 
95% Confidence 
Interval for Mean 
Lower Bound 550.7455   
Upper Bound 620.8745   
5% Trimmed Mean 585.8156   
Median 585.9400   
Variance 1116.412   
Std. Deviation 33.41274   
Minimum 541.99   
Maximum 629.53   
Range 87.54   
Interquartile Range 64.28   
Skewness -.007 .845 
Kurtosis -1.404 1.741 
SiLn- 1hr Mean 467.8117 6.97137 
95% Confidence 
Interval for Mean 
Lower Bound 449.8912   
Upper Bound 485.7321   
5% Trimmed Mean 468.1135   
Median 471.2200   
Variance 291.600   
Std. Deviation 17.07629   
Minimum 440.48   
Maximum 489.71   
Range 49.23   
Interquartile Range 26.66   
Skewness -.601 .845 
Kurtosis .398 1.741 
SiFnLn- 1hr Mean 810.4000 23.41552 
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95% Confidence 
Interval for Mean 
Lower Bound 750.2085   
Upper Bound 870.5915   
5% Trimmed Mean 810.4061   
Median 821.0850   
Variance 3289.718   
Std. Deviation 57.35607   
Minimum 743.04   
Maximum 877.65   
Range 134.61   
Interquartile Range 112.54   
Skewness -.211 .845 
Kurtosis -2.234 1.741 
Si+ 1hr Mean 399.1367 9.08381 
95% Confidence 
Interval for Mean 
Lower Bound 375.7860   
Upper Bound 422.4873   
5% Trimmed Mean 398.0819   
Median 387.7700   
Variance 495.094   
Std. Deviation 22.25070   
Minimum 381.14   
Maximum 436.12   
Range 54.98   
Interquartile Range 37.58   
Skewness 1.204 .845 
Kurtosis -.088 1.741 
SiFn+ 1hr Mean 533.4133 16.11953 
95% Confidence 
Interval for Mean 
Lower Bound 491.9768   
Upper Bound 574.8499   
5% Trimmed Mean 533.2037   
Median 531.3300   
Variance 1559.035   
Std. Deviation 39.48461   
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Minimum 490.96   
Maximum 579.64   
Range 88.68   
Interquartile Range 82.35   
Skewness .099 .845 
Kurtosis -2.445 1.741 
SiLn+ 1hr Mean 463.5100 23.79811 
95% Confidence 
Interval for Mean 
Lower Bound 402.3350   
Upper Bound 524.6850   
5% Trimmed Mean 461.6294   
Median 449.3900   
Variance 3398.101   
Std. Deviation 58.29323   
Minimum 405.83   
Maximum 555.04   
Range 149.21   
Interquartile Range 111.26   
Skewness .800 .845 
Kurtosis -.588 1.741 
SiFnLn+ 1hr Mean 582.5183 11.28956 
95% Confidence 
Interval for Mean 
Lower Bound 553.4976   
Upper Bound 611.5391   
5% Trimmed Mean 583.3237   
Median 593.5200   
Variance 764.725   
Std. Deviation 27.65366   
Minimum 541.29   
Maximum 609.25   
Range 67.96   
Interquartile Range 52.10   
Skewness -.842 .845 
Kurtosis -1.277 1.741 
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7.29: Keratinocyte Vinculin per cell descriptives on 
different surfaces 
  Surface at One Hour   Statistic Std. Error 
Vinculin/Cell Pol 1hr Mean 1.0000 .36515 
95% Confidence 
Interval for Mean 
Lower Bound .0614   
Upper Bound 1.9386   
5% Trimmed Mean 1.0000   
Median 1.0000   
Variance .800   
Std. Deviation .89443   
Minimum .00   
Maximum 2.00   
Range 2.00   
Interquartile Range 2.00   
Skewness .000 .845 
Kurtosis -1.875 1.741 
AdFn 1hr Mean 6.0000 .51640 
95% Confidence 
Interval for Mean 
Lower Bound 4.6726   
Upper Bound 7.3274   
5% Trimmed Mean 5.9444   
Median 5.5000   
Variance 1.600   
Std. Deviation 1.26491   
Minimum 5.00   
Maximum 8.00   
Range 3.00   
Interquartile Range 2.25   
Skewness .889 .845 
Kurtosis -.781 1.741 
AdLn 1hr Mean 10.5000 .42817 
95% Confidence Lower Bound 9.3993   
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Interval for Mean Upper Bound 11.6007   
5% Trimmed Mean 10.5000   
Median 10.5000   
Variance 1.100   
Std. Deviation 1.04881   
Minimum 9.00   
Maximum 12.00   
Range 3.00   
Interquartile Range 1.50   
Skewness .000 .845 
Kurtosis -.248 1.741 
AdFnLn 1hr Mean 39.0000 1.46059 
95% Confidence 
Interval for Mean 
Lower Bound 35.2454   
Upper Bound 42.7546   
5% Trimmed Mean 39.0000   
Median 39.5000   
Variance 12.800   
Std. Deviation 3.57771   
Minimum 34.00   
Maximum 44.00   
Range 10.00   
Interquartile Range 6.25   
Skewness -.118 .845 
Kurtosis -.491 1.741 
Si- 1hr Mean .6667 .21082 
95% Confidence 
Interval for Mean 
Lower Bound .1247   
Upper Bound 1.2086   
5% Trimmed Mean .6852   
Median 1.0000   
Variance .267   
Std. Deviation .51640   
Minimum .00   
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Maximum 1.00   
Range 1.00   
Interquartile Range 1.00   
Skewness -.968 .845 
Kurtosis -1.875 1.741 
SiFn- 1hr Mean 7.5000 .42817 
95% Confidence 
Interval for Mean 
Lower Bound 6.3993   
Upper Bound 8.6007   
5% Trimmed Mean 7.5000   
Median 7.5000   
Variance 1.100   
Std. Deviation 1.04881   
Minimum 6.00   
Maximum 9.00   
Range 3.00   
Interquartile Range 1.50   
Skewness .000 .845 
Kurtosis -.248 1.741 
SiLn- 1hr Mean 11.6667 .66667 
95% Confidence 
Interval for Mean 
Lower Bound 9.9529   
Upper Bound 13.3804   
5% Trimmed Mean 11.6296   
Median 11.5000   
Variance 2.667   
Std. Deviation 1.63299   
Minimum 10.00   
Maximum 14.00   
Range 4.00   
Interquartile Range 3.25   
Skewness .383 .845 
Kurtosis -1.481 1.741 
SiFnLn- 1hr Mean 40.1667 .94575 
95% Confidence Lower Bound 37.7355   
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Interval for Mean Upper Bound 42.5978   
5% Trimmed Mean 40.1296   
Median 40.0000   
Variance 5.367   
Std. Deviation 2.31661   
Minimum 37.00   
Maximum 44.00   
Range 7.00   
Interquartile Range 3.25   
Skewness .568 .845 
Kurtosis 1.499 1.741 
Si+ 1hr Mean .8333 .30732 
95% Confidence 
Interval for Mean 
Lower Bound .0433   
Upper Bound 1.6233   
5% Trimmed Mean .8148   
Median 1.0000   
Variance .567   
Std. Deviation .75277   
Minimum .00   
Maximum 2.00   
Range 2.00   
Interquartile Range 1.25   
Skewness .313 .845 
Kurtosis -.104 1.741 
SiFn+ 1hr Mean 1.5000 .22361 
95% Confidence 
Interval for Mean 
Lower Bound .9252   
Upper Bound 2.0748   
5% Trimmed Mean 1.5000   
Median 1.5000   
Variance .300   
Std. Deviation .54772   
Minimum 1.00   
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Maximum 2.00   
Range 1.00   
Interquartile Range 1.00   
Skewness .000 .845 
Kurtosis -3.333 1.741 
SiLn+ 1hr Mean .8333 .30732 
95% Confidence 
Interval for Mean 
Lower Bound .0433   
Upper Bound 1.6233   
5% Trimmed Mean .8148   
Median 1.0000   
Variance .567   
Std. Deviation .75277   
Minimum .00   
Maximum 2.00   
Range 2.00   
Interquartile Range 1.25   
Skewness .313 .845 
Kurtosis -.104 1.741 
SiFnLn+ 1hr Mean 3.6667 .33333 
95% Confidence 
Interval for Mean 
Lower Bound 2.8098   
Upper Bound 4.5235   
5% Trimmed Mean 3.6296   
Median 3.5000   
Variance .667   
Std. Deviation .81650   
Minimum 3.00   
Maximum 5.00   
Range 2.00   
Interquartile Range 1.25   
Skewness .857 .845 
Kurtosis -.300 1.741 
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7.30: Keratinocyte vinculin per cell area descriptives on 
different surfaces at 1 hour 
  
Surface at One 
Hour   Statistic Std. Error 
Vinculin/Cell 
Area 
Pol 1hr Mean .00323 .001143 
95% Confidence 
Interval for Mean 
Lower Bound .00029   
Upper Bound .00617   
5% Trimmed Mean .00323   
Median .00345   
Variance .000   
Std. Deviation .002799   
Minimum .000   
Maximum .006   
Range .006   
Interquartile Range .006   
Skewness -.166 .845 
Kurtosis -1.841 1.741 
AdFn 1hr Mean .01143 .000864 
95% Confidence 
Interval for Mean 
Lower Bound .00920   
Upper Bound .01365   
5% Trimmed Mean .01139   
Median .01093   
Variance .000   
Std. Deviation .002116   
Minimum .009   
Maximum .014   
Range .005   
Interquartile Range .004   
Skewness .426 .845 
Kurtosis -2.214 1.741 
AdLn 1hr Mean .02280 .000790 
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95% Confidence 
Interval for Mean 
Lower Bound .02077   
Upper Bound .02483   
5% Trimmed Mean .02284   
Median .02296   
Variance .000   
Std. Deviation .001935   
Minimum .020   
Maximum .025   
Range .005   
Interquartile Range .004   
Skewness -.392 .845 
Kurtosis -1.075 1.741 
AdFnLn 1hr Mean .04553 .001272 
95% Confidence 
Interval for Mean 
Lower Bound .04226   
Upper Bound .04880   
5% Trimmed Mean .04557   
Median .04558   
Variance .000   
Std. Deviation .003116   
Minimum .042   
Maximum .049   
Range .007   
Interquartile Range .006   
Skewness -.108 .845 
Kurtosis -2.175 1.741 
Si- 1hr Mean .00240 .000764 
95% Confidence 
Interval for Mean 
Lower Bound .00044   
Upper Bound .00436   
5% Trimmed Mean .00245   
Median .00343   
Variance .000   
Std. Deviation .001871   
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Minimum .000   
Maximum .004   
Range .004   
Interquartile Range .004   
Skewness -.916 .845 
Kurtosis -1.877 1.741 
SiFn- 1hr Mean .01281 .000687 
95% Confidence 
Interval for Mean 
Lower Bound .01104   
Upper Bound .01457   
5% Trimmed Mean .01277   
Median .01258   
Variance .000   
Std. Deviation .001684   
Minimum .011   
Maximum .015   
Range .004   
Interquartile Range .003   
Skewness .378 .845 
Kurtosis -1.679 1.741 
SiLn- 1hr Mean .02500 .001612 
95% Confidence 
Interval for Mean 
Lower Bound .02085   
Upper Bound .02914   
5% Trimmed Mean .02484   
Median .02461   
Variance .000   
Std. Deviation .003948   
Minimum .021   
Maximum .032   
Range .011   
Interquartile Range .007   
Skewness 1.009 .845 
Kurtosis 1.058 1.741 
SiFnLn- 1hr Mean .04970 .001376 
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95% Confidence 
Interval for Mean 
Lower Bound .04616   
Upper Bound .05323   
5% Trimmed Mean .04971   
Median .05001   
Variance .000   
Std. Deviation .003369   
Minimum .046   
Maximum .054   
Range .008   
Interquartile Range .006   
Skewness -.122 .845 
Kurtosis -2.488 1.741 
Si+ 1hr Mean .00174 .000622 
95% Confidence 
Interval for Mean 
Lower Bound .00015   
Upper Bound .00334   
5% Trimmed Mean .00172   
Median .00206   
Variance .000   
Std. Deviation .001523   
Minimum .000   
Maximum .004   
Range .004   
Interquartile Range .003   
Skewness .039 .845 
Kurtosis -.733 1.741 
SiFn+ 1hr Mean .00276 .000342 
95% Confidence 
Interval for Mean 
Lower Bound .00189   
Upper Bound .00364   
5% Trimmed Mean .00276   
Median .00274   
Variance .000   
Std. Deviation .000837   
Appendix 
 
291 
 
Minimum .002   
Maximum .004   
Range .002   
Interquartile Range .002   
Skewness .019 .845 
Kurtosis -3.243 1.741 
SiLn+ 1hr Mean .00185 .000684 
95% Confidence 
Interval for Mean 
Lower Bound .00009   
Upper Bound .00361   
5% Trimmed Mean .00181   
Median .00210   
Variance .000   
Std. Deviation .001675   
Minimum .000   
Maximum .004   
Range .004   
Interquartile Range .003   
Skewness .310 .845 
Kurtosis -.220 1.741 
SiFnLn+ 1hr Mean .00628 .000517 
95% Confidence 
Interval for Mean 
Lower Bound .00495   
Upper Bound .00761   
5% Trimmed Mean .00622   
Median .00605   
Variance .000   
Std. Deviation .001266   
Minimum .005   
Maximum .008   
Range .003   
Interquartile Range .002   
Skewness 1.162 .845 
Kurtosis 1.234 1.741 
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7.31: Keratinocyte cell area descriptives on different 
surfaces at 4 hours  
 
 
Surface at Four Hours 
Statistic Std. Error 
Cell Area 
(micrometres 
squared) 
Pol 4hrs Mean 367.9600 17.44037 
95% Confidence Interval 
for Mean 
Lower 
Bound 
323.1281  
Upper 
Bound 
412.7919  
5% Trimmed Mean 369.0250 
 
Median 376.0200 
 
Variance 1825.000 
 
Std. Deviation 42.72002 
 
Minimum 300.98 
 
Maximum 415.77 
 
Range 114.79 
 
Interquartile Range 78.59 
 
Skewness -.692 .845 
Kurtosis -.398 1.741 
AdFn 4hrs Mean 860.9650 18.21252 
95% Confidence Interval 
for Mean 
Lower 
Bound 
814.1482  
Upper 
Bound 
907.7818  
5% Trimmed Mean 861.6528 
 
Median 864.4200 
 
Variance 1990.175 
 
Std. Deviation 44.61137 
 
Minimum 804.81 
 
Maximum 904.74 
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Range 99.93 
 
Interquartile Range 85.72 
 
Skewness -.169 .845 
Kurtosis -2.632 1.741 
AdLn 4hrs Mean 799.4717 18.87334 
95% Confidence Interval 
for Mean 
Lower 
Bound 
750.9562  
Upper 
Bound 
847.9871  
5% Trimmed Mean 800.1763 
 
Median 801.7100 
 
Variance 2137.217 
 
Std. Deviation 46.23005 
 
Minimum 725.02 
 
Maximum 861.24 
 
Range 136.22 
 
Interquartile Range 71.95 
 
Skewness -.489 .845 
Kurtosis .834 1.741 
AdFnLn 4hrs Mean 1120.7217 26.36353 
95% Confidence Interval 
for Mean 
Lower 
Bound 
1052.9520  
Upper 
Bound 
1188.4913  
5% Trimmed Mean 1121.9235 
 
Median 1132.1400 
 
Variance 4170.215 
 
Std. Deviation 64.57720 
 
Minimum 1023.77 
 
Maximum 1196.04 
 
Range 172.27 
 
Interquartile Range 120.87 
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Skewness -.542 .845 
Kurtosis -.809 1.741 
Si- 4hrs Mean 412.2250 8.86341 
95% Confidence Interval 
for Mean 
Lower 
Bound 
389.4409  
Upper 
Bound 
435.0091  
5% Trimmed Mean 412.6306 
 
Median 412.9400 
 
Variance 471.360 
 
Std. Deviation 21.71084 
 
Minimum 382.27 
 
Maximum 434.88 
 
Range 52.61 
 
Interquartile Range 42.72 
 
Skewness -.236 .845 
Kurtosis -1.768 1.741 
SiFn- 4hrs Mean 998.1817 22.97408 
95% Confidence Interval 
for Mean 
Lower 
Bound 
939.1249  
Upper 
Bound 
1057.2384  
5% Trimmed Mean 998.1613 
 
Median 988.7300 
 
Variance 3166.850 
 
Std. Deviation 56.27477 
 
Minimum 923.42 
 
Maximum 1073.31 
 
Range 149.89 
 
Interquartile Range 106.58 
 
Skewness .209 .845 
Kurtosis -1.062 1.741 
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SiLn- 4hrs Mean 879.0783 17.08980 
95% Confidence Interval 
for Mean 
Lower 
Bound 
835.1476  
Upper 
Bound 
923.0091  
5% Trimmed Mean 877.8704 
 
Median 867.3750 
 
Variance 1752.367 
 
Std. Deviation 41.86129 
 
Minimum 839.83 
 
Maximum 940.07 
 
Range 100.24 
 
Interquartile Range 76.12 
 
Skewness .561 .845 
Kurtosis -1.667 1.741 
SiFnLn- 4hrs Mean 1193.5683 10.11880 
95% Confidence Interval 
for Mean 
Lower 
Bound 
1167.5571  
Upper 
Bound 
1219.5795  
5% Trimmed Mean 1192.9437 
 
Median 1195.2800 
 
Variance 614.341 
 
Std. Deviation 24.78590 
 
Minimum 1167.15 
 
Maximum 1231.23 
 
Range 64.08 
 
Interquartile Range 44.39 
 
Skewness .376 .845 
Kurtosis -.682 1.741 
Si+ 4hrs Mean 475.3283 14.08938 
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95% Confidence Interval 
for Mean 
Lower 
Bound 
439.1104  
Upper 
Bound 
511.5462  
5% Trimmed Mean 476.4798 
 
Median 477.6800 
 
Variance 1191.064 
 
Std. Deviation 34.51179 
 
Minimum 418.44 
 
Maximum 511.49 
 
Range 93.05 
 
Interquartile Range 57.90 
 
Skewness -.793 .845 
Kurtosis .263 1.741 
SiFn+ 4hrs Mean 609.0933 9.81691 
95% Confidence Interval 
for Mean 
Lower 
Bound 
583.8582  
Upper 
Bound 
634.3285  
5% Trimmed Mean 609.3254 
 
Median 608.8600 
 
Variance 578.231 
 
Std. Deviation 24.04643 
 
Minimum 575.05 
 
Maximum 638.96 
 
Range 63.91 
 
Interquartile Range 46.30 
 
Skewness -.153 .845 
Kurtosis -1.017 1.741 
SiLn+ 4hrs Mean 562.5917 15.32493 
95% Confidence Interval 
for Mean 
Lower 
Bound 
523.1977  
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Upper 
Bound 
601.9856  
5% Trimmed Mean 562.0896 
 
Median 560.9000 
 
Variance 1409.120 
 
Std. Deviation 37.53825 
 
Minimum 516.61 
 
Maximum 617.61 
 
Range 101.00 
 
Interquartile Range 59.37 
 
Skewness .319 .845 
Kurtosis -1.106 1.741 
SiFnLn+ 4hrs Mean 657.5183 9.95511 
95% Confidence Interval 
for Mean 
Lower 
Bound 
631.9279  
Upper 
Bound 
683.1088  
5% Trimmed Mean 657.4070 
 
Median 656.7300 
 
Variance 594.625 
 
Std. Deviation 24.38493 
 
Minimum 628.18 
 
Maximum 688.86 
 
Range 60.68 
 
Interquartile Range 42.25 
 
Skewness .083 .845 
Kurtosis -2.223 1.741 
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7.32: Keratinocyte vinculin per cell descriptives on 
different surfaces at 4 hours 
 
 
Surface at Four Hours 
Statistic Std. Error 
Vinculin/Cell Pol 4hrs Mean 1.5000 .22361 
95% Confidence Interval 
for Mean 
Lower 
Bound 
.9252  
Upper 
Bound 
2.0748  
5% Trimmed Mean 1.5000 
 
Median 1.5000 
 
Variance .300 
 
Std. Deviation .54772 
 
Minimum 1.00 
 
Maximum 2.00 
 
Range 1.00 
 
Interquartile Range 1.00 
 
Skewness .000 .845 
Kurtosis -3.333 1.741 
AdFn 4hrs Mean 17.1667 .74907 
95% Confidence Interval 
for Mean 
Lower 
Bound 
15.2411  
Upper 
Bound 
19.0922  
5% Trimmed Mean 17.1852 
 
Median 17.5000 
 
Variance 3.367 
 
Std. Deviation 1.83485 
 
Minimum 15.00 
 
Maximum 19.00 
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Range 4.00 
 
Interquartile Range 4.00 
 
Skewness -.362 .845 
Kurtosis -2.103 1.741 
AdLn 4hrs Mean 24.6667 1.14504 
95% Confidence Interval 
for Mean 
Lower 
Bound 
21.7233  
Upper 
Bound 
27.6101  
5% Trimmed Mean 24.6852 
 
Median 25.0000 
 
Variance 7.867 
 
Std. Deviation 2.80476 
 
Minimum 21.00 
 
Maximum 28.00 
 
Range 7.00 
 
Interquartile Range 5.50 
 
Skewness -.224 .845 
Kurtosis -1.864 1.741 
AdFnLn 4hrs Mean 52.6667 .80277 
95% Confidence Interval 
for Mean 
Lower 
Bound 
50.6031  
Upper 
Bound 
54.7303  
5% Trimmed Mean 52.6852 
 
Median 53.0000 
 
Variance 3.867 
 
Std. Deviation 1.96638 
 
Minimum 50.00 
 
Maximum 55.00 
 
Range 5.00 
 
Interquartile Range 3.50 
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Skewness -.254 .845 
Kurtosis -1.828 1.741 
Si- 4hrs Mean 1.3333 .21082 
95% Confidence Interval 
for Mean 
Lower 
Bound 
.7914  
Upper 
Bound 
1.8753  
5% Trimmed Mean 1.3148 
 
Median 1.0000 
 
Variance .267 
 
Std. Deviation .51640 
 
Minimum 1.00 
 
Maximum 2.00 
 
Range 1.00 
 
Interquartile Range 1.00 
 
Skewness .968 .845 
Kurtosis -1.875 1.741 
SiFn- 4hrs Mean 25.1667 1.13774 
95% Confidence Interval 
for Mean 
Lower 
Bound 
22.2420  
Upper 
Bound 
28.0913  
5% Trimmed Mean 25.1296 
 
Median 25.5000 
 
Variance 7.767 
 
Std. Deviation 2.78687 
 
Minimum 22.00 
 
Maximum 29.00 
 
Range 7.00 
 
Interquartile Range 5.50 
 
Skewness -.006 .845 
Kurtosis -1.274 1.741 
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SiLn- 4hrs Mean 30.6667 1.08525 
95% Confidence Interval 
for Mean 
Lower 
Bound 
27.8769  
Upper 
Bound 
33.4564  
5% Trimmed Mean 30.6852 
 
Median 31.5000 
 
Variance 7.067 
 
Std. Deviation 2.65832 
 
Minimum 27.00 
 
Maximum 34.00 
 
Range 7.00 
 
Interquartile Range 4.75 
 
Skewness -.422 .845 
Kurtosis -1.188 1.741 
SiFnLn- 4hrs Mean 61.5000 1.31022 
95% Confidence Interval 
for Mean 
Lower 
Bound 
58.1320  
Upper 
Bound 
64.8680  
5% Trimmed Mean 61.5000 
 
Median 62.0000 
 
Variance 10.300 
 
Std. Deviation 3.20936 
 
Minimum 57.00 
 
Maximum 66.00 
 
Range 9.00 
 
Interquartile Range 5.25 
 
Skewness -.082 .845 
Kurtosis -.514 1.741 
Si+ 4hrs Mean 1.5000 .34157 
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95% Confidence Interval 
for Mean 
Lower 
Bound 
.6220  
Upper 
Bound 
2.3780  
5% Trimmed Mean 1.4444 
 
Median 1.0000 
 
Variance .700 
 
Std. Deviation .83666 
 
Minimum 1.00 
 
Maximum 3.00 
 
Range 2.00 
 
Interquartile Range 1.25 
 
Skewness 1.537 .845 
Kurtosis 1.429 1.741 
SiFn+ 4hrs Mean 4.5000 .22361 
95% Confidence Interval 
for Mean 
Lower 
Bound 
3.9252  
Upper 
Bound 
5.0748  
5% Trimmed Mean 4.5000 
 
Median 4.5000 
 
Variance .300 
 
Std. Deviation .54772 
 
Minimum 4.00 
 
Maximum 5.00 
 
Range 1.00 
 
Interquartile Range 1.00 
 
Skewness .000 .845 
Kurtosis -3.333 1.741 
SiLn+ 4hrs Mean 1.5000 .34157 
95% Confidence Interval 
for Mean 
Lower 
Bound 
.6220  
Appendix 
 
303 
 
Upper 
Bound 
2.3780  
5% Trimmed Mean 1.5556 
 
Median 2.0000 
 
Variance .700 
 
Std. Deviation .83666 
 
Minimum .00 
 
Maximum 2.00 
 
Range 2.00 
 
Interquartile Range 1.25 
 
Skewness -1.537 .845 
Kurtosis 1.429 1.741 
SiFnLn+ 4hrs Mean 5.5000 .76376 
95% Confidence Interval 
for Mean 
Lower 
Bound 
3.5367  
Upper 
Bound 
7.4633  
5% Trimmed Mean 5.5000 
 
Median 5.5000 
 
Variance 3.500 
 
Std. Deviation 1.87083 
 
Minimum 3.00 
 
Maximum 8.00 
 
Range 5.00 
 
Interquartile Range 3.50 
 
Skewness .000 .845 
Kurtosis -1.200 1.741 
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7.33: Keratinocyte vinculin per cell area descriptives on 
different surfaces at 4 hours 
 
 
Surface at Four Hours 
Statistic 
Std. 
Error 
Vinculin/Cell 
Area 
Pol 4hrs Mean .00409 .000600 
95% Confidence 
Interval for Mean 
Lower Bound .00255 
 
Upper Bound .00563 
 
5% Trimmed Mean .00408 
 
Median .00407 
 
Variance .000 
 
Std. Deviation .001469 
 
Minimum .002 
 
Maximum .006 
 
Range .003 
 
Interquartile Range .003 
 
Skewness .102 .845 
Kurtosis -2.345 1.741 
AdFn 4hrs Mean .01999 .000972 
95% Confidence 
Interval for Mean 
Lower Bound .01749 
 
Upper Bound .02248 
 
5% Trimmed Mean .02000 
 
Median .02051 
 
Variance .000 
 
Std. Deviation .002380 
 
Minimum .017 
 
Maximum .023 
 
Range .006 
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Interquartile Range .004 
 
Skewness -.322 .845 
Kurtosis -.863 1.741 
AdLn 4hrs Mean .03096 .001683 
95% Confidence 
Interval for Mean 
Lower Bound .02664 
 
Upper Bound .03529 
 
5% Trimmed Mean .03099 
 
Median .03180 
 
Variance .000 
 
Std. Deviation .004123 
 
Minimum .026 
 
Maximum .036 
 
Range .010 
 
Interquartile Range .008 
 
Skewness -.277 .845 
Kurtosis -1.888 1.741 
AdFnLn 
4hrs 
Mean .04713 .001397 
95% Confidence 
Interval for Mean 
Lower Bound .04354 
 
Upper Bound .05072 
 
5% Trimmed Mean .04707 
 
Median .04644 
 
Variance .000 
 
Std. Deviation .003421 
 
Minimum .043 
 
Maximum .053 
 
Range .010 
 
Interquartile Range .005 
 
Skewness .652 .845 
Kurtosis .990 1.741 
Si- 4hrs Mean .00243 .000053 
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95% Confidence 
Interval for Mean 
Lower Bound .00230 
 
Upper Bound .00257 
 
5% Trimmed Mean .00243 
 
Median .00242 
 
Variance .000 
 
Std. Deviation .000129 
 
Minimum .002 
 
Maximum .003 
 
Range .000 
 
Interquartile Range .000 
 
Skewness .340 .845 
Kurtosis -1.577 1.741 
SiFn- 4hrs Mean .02531 .001362 
95% Confidence 
Interval for Mean 
Lower Bound .02180 
 
Upper Bound .02881 
 
5% Trimmed Mean .02536 
 
Median .02614 
 
Variance .000 
 
Std. Deviation .003337 
 
Minimum .020 
 
Maximum .029 
 
Range .009 
 
Interquartile Range .006 
 
Skewness -.498 .845 
Kurtosis -1.220 1.741 
SiLn- 4hrs Mean .03490 .001152 
95% Confidence 
Interval for Mean 
Lower Bound .03194 
 
Upper Bound .03786 
 
5% Trimmed Mean .03491 
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Median .03534 
 
Variance .000 
 
Std. Deviation .002821 
 
Minimum .032 
 
Maximum .038 
 
Range .007 
 
Interquartile Range .006 
 
Skewness -.217 .845 
Kurtosis -2.320 1.741 
SiFnLn- 
4hrs 
Mean .05154 .001095 
95% Confidence 
Interval for Mean 
Lower Bound .04872 
 
Upper Bound .05435 
 
5% Trimmed Mean .05160 
 
Median .05215 
 
Variance .000 
 
Std. Deviation .002682 
 
Minimum .048 
 
Maximum .054 
 
Range .006 
 
Interquartile Range .005 
 
Skewness -.370 .845 
Kurtosis -2.346 1.741 
Si+ 4hrs Mean .00381 .000913 
95% Confidence 
Interval for Mean 
Lower Bound .00146 
 
Upper Bound .00616 
 
5% Trimmed Mean .00367 
 
Median .00259 
 
Variance .000 
 
Std. Deviation .002236 
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Minimum .002 
 
Maximum .008 
 
Range .005 
 
Interquartile Range .003 
 
Skewness 1.495 .845 
Kurtosis 1.252 1.741 
SiFn+ 4hrs Mean .00741 .000441 
95% Confidence 
Interval for Mean 
Lower Bound .00628 
 
Upper Bound .00855 
 
5% Trimmed Mean .00741 
 
Median .00747 
 
Variance .000 
 
Std. Deviation .001081 
 
Minimum .006 
 
Maximum .009 
 
Range .002 
 
Interquartile Range .002 
 
Skewness .016 .845 
Kurtosis -2.744 1.741 
SiLn+ 4hrs Mean .00267 .000599 
95% Confidence 
Interval for Mean 
Lower Bound .00113 
 
Upper Bound .00421 
 
5% Trimmed Mean .00276 
 
Median .00334 
 
Variance .000 
 
Std. Deviation .001466 
 
Minimum .000 
 
Maximum .004 
 
Range .004 
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Interquartile Range .002 
 
Skewness -1.580 .845 
Kurtosis 1.939 1.741 
SiFnLn+ 
4hrs 
Mean .00841 .001221 
95% Confidence 
Interval for Mean 
Lower Bound .00527 
 
Upper Bound .01155 
 
5% Trimmed Mean .00841 
 
Median .00816 
 
Variance .000 
 
Std. Deviation .002992 
 
Minimum .004 
 
Maximum .012 
 
Range .008 
 
Interquartile Range .005 
 
Skewness .082 .845 
Kurtosis -.980 1.741 
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7.34: Keratinocyte cell area descriptives on different 
surfaces at 24 hours 
 Surface at Twenty Four Hours Statisti
c 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Pol 24hrs Mean 751.6933 17.33588 
95% Confidence 
Interval for Mean 
Lower 
Bound 
707.1300  
Upper 
Bound 
796.2566  
5% Trimmed Mean 753.4204  
Median 761.0300  
Variance 1803.197  
Std. Deviation 42.46407  
Minimum 676.83  
Maximum 795.47  
Range 118.64  
Interquartile Range 66.29  
Skewness -1.214 .845 
Kurtosis 1.525 1.741 
AdFn 24hrs Mean 1127.9967 12.24533 
95% Confidence 
Interval for Mean 
Lower 
Bound 
1096.5191  
Upper 
Bound 
1159.4743  
5% Trimmed Mean 1127.4457  
Median 1121.5300  
Variance 899.688  
Std. Deviation 29.99480  
Minimum 1097.22  
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Maximum 1168.69  
Range 71.47  
Interquartile Range 59.15  
Skewness .432 .845 
Kurtosis -1.989 1.741 
AdLn 24hrs Mean 996.2900 18.16759 
95% Confidence 
Interval for Mean 
Lower 
Bound 
949.5887  
Upper 
Bound 
1042.9913  
5% Trimmed Mean 996.3211  
Median 1001.6900  
Variance 1980.369  
Std. Deviation 44.50133  
Minimum 937.46  
Maximum 1054.56  
Range 117.10  
Interquartile Range 85.75  
Skewness -.162 .845 
Kurtosis -1.253 1.741 
AdFnLn 
24hrs 
Mean 1476.6867 16.62267 
95% Confidence 
Interval for Mean 
Lower 
Bound 
1433.9567  
Upper 
Bound 
1519.4166  
5% Trimmed Mean 1477.0513  
Median 1484.9250  
Variance 1657.878  
Std. Deviation 40.71705  
Minimum 1421.40  
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Maximum 1525.41  
Range 104.01  
Interquartile Range 80.35  
Skewness -.401 .845 
Kurtosis -1.451 1.741 
Si- 24hrs Mean 812.8950 23.10229 
95% Confidence 
Interval for Mean 
Lower 
Bound 
753.5087  
Upper 
Bound 
872.2813  
5% Trimmed Mean 812.9128  
Median 821.3450  
Variance 3202.294  
Std. Deviation 56.58882  
Minimum 744.62  
Maximum 880.85  
Range 136.23  
Interquartile Range 110.67  
Skewness -.170 .845 
Kurtosis -2.146 1.741 
SiFn- 24hrs Mean 1267.2500 16.66207 
95% Confidence 
Interval for Mean 
Lower 
Bound 
1224.4188  
Upper 
Bound 
1310.0812  
5% Trimmed Mean 1266.9122  
Median 1260.1900  
Variance 1665.747  
Std. Deviation 40.81356  
Minimum 1220.98  
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Maximum 1319.60  
Range 98.62  
Interquartile Range 80.80  
Skewness .295 .845 
Kurtosis -2.067 1.741 
SiLn- 24hrs Mean 1186.4417 11.18697 
95% Confidence 
Interval for Mean 
Lower 
Bound 
1157.6846  
Upper 
Bound 
1215.1987  
5% Trimmed Mean 1186.1841  
Median 1185.9500  
Variance 750.890  
Std. Deviation 27.40237  
Minimum 1152.69  
Maximum 1224.83  
Range 72.14  
Interquartile Range 53.26  
Skewness .175 .845 
Kurtosis -1.159 1.741 
SiFnLn- 
24hrs 
Mean 1464.9717 12.21750 
95% Confidence 
Interval for Mean 
Lower 
Bound 
1433.5656  
Upper 
Bound 
1496.3777  
5% Trimmed Mean 1464.9685  
Median 1467.7600  
Variance 895.603  
Std. Deviation 29.92664  
Minimum 1425.49  
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Maximum 1504.51  
Range 79.02  
Interquartile Range 58.24  
Skewness -.121 .845 
Kurtosis -1.185 1.741 
Si+ 24hrs Mean 494.2233 13.47255 
95% Confidence 
Interval for Mean 
Lower 
Bound 
459.5911  
Upper 
Bound 
528.8556  
5% Trimmed Mean 495.4259  
Median 502.4750  
Variance 1089.057  
Std. Deviation 33.00086  
Minimum 439.17  
Maximum 527.63  
Range 88.46  
Interquartile Range 56.86  
Skewness -.987 .845 
Kurtosis .297 1.741 
SiFn+ 
24hrs 
Mean 616.5250 14.86409 
95% Confidence 
Interval for Mean 
Lower 
Bound 
578.3156  
Upper 
Bound 
654.7344  
5% Trimmed Mean 614.8972  
Median 601.5450  
Variance 1325.646  
Std. Deviation 36.40943  
Minimum 584.92  
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Maximum 677.43  
Range 92.51  
Interquartile Range 62.45  
Skewness 1.148 .845 
Kurtosis .099 1.741 
SiLn+ 
24hrs 
Mean 693.1450 24.56269 
95% Confidence 
Interval for Mean 
Lower 
Bound 
630.0046  
Upper 
Bound 
756.2854  
5% Trimmed Mean 693.0294  
Median 705.0700  
Variance 3619.956  
Std. Deviation 60.16607  
Minimum 619.32  
Maximum 769.05  
Range 149.73  
Interquartile Range 116.92  
Skewness -.222 .845 
Kurtosis -1.699 1.741 
SiFnLn+ 
24hrs 
Mean 855.6567 19.41475 
95% Confidence 
Interval for Mean 
Lower 
Bound 
805.7495  
Upper 
Bound 
905.5639  
5% Trimmed Mean 856.2730  
Median 870.7150  
Variance 2261.594  
Std. Deviation 47.55622  
Minimum 796.64  
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Maximum 903.58  
Range 106.94  
Interquartile Range 96.04  
Skewness -.513 .845 
Kurtosis -2.144 1.741 
 
7.35: Keratinocyte vinculin per cell descriptives on 
different surfaces at 24 hours 
 
 Surface at Twenty Four Hours 
Statistic 
Std. 
Error 
Vinculin/Cell Pol 24hrs Mean 4.0000 .36515 
95% Confidence 
Interval for Mean 
Lower Bound 3.0614  
Upper Bound 4.9386  
5% Trimmed Mean 4.0000  
Median 4.0000  
Variance .800  
Std. Deviation .89443  
Minimum 3.00  
Maximum 5.00  
Range 2.00  
Interquartile Range 2.00  
Skewness .000 .845 
Kurtosis -1.875 1.741 
AdFn 24hrs Mean 38.1667 1.01379 
95% Confidence 
Interval for Mean 
Lower Bound 35.5606  
Upper Bound 40.7727  
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5% Trimmed Mean 38.1296  
Median 38.5000  
Variance 6.167  
Std. Deviation 2.48328  
Minimum 35.00  
Maximum 42.00  
Range 7.00  
Interquartile Range 4.00  
Skewness .305 .845 
Kurtosis -.001 1.741 
AdLn 24hrs Mean 44.5000 1.54380 
95% Confidence 
Interval for Mean 
Lower Bound 40.5315  
Upper Bound 48.4685  
5% Trimmed Mean 44.3333  
Median 44.0000  
Variance 14.300  
Std. Deviation 3.78153  
Minimum 41.00  
Maximum 51.00  
Range 10.00  
Interquartile Range 6.25  
Skewness 1.049 .845 
Kurtosis .923 1.741 
AdFnLn 
24hrs 
Mean 92.3333 .76012 
95% Confidence 
Interval for Mean 
Lower Bound 90.3794  
Upper Bound 94.2873  
5% Trimmed Mean 92.3148  
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Median 92.0000  
Variance 3.467  
Std. Deviation 1.86190  
Minimum 90.00  
Maximum 95.00  
Range 5.00  
Interquartile Range 3.50  
Skewness .392 .845 
Kurtosis -.943 1.741 
Si- 24hrs Mean 5.5000 .42817 
95% Confidence 
Interval for Mean 
Lower Bound 4.3993  
Upper Bound 6.6007  
5% Trimmed Mean 5.5000  
Median 5.5000  
Variance 1.100  
Std. Deviation 1.04881  
Minimum 4.00  
Maximum 7.00  
Range 3.00  
Interquartile Range 1.50  
Skewness .000 .845 
Kurtosis -.248 1.741 
SiFn- 24hrs Mean 53.6667 2.20101 
95% Confidence 
Interval for Mean 
Lower Bound 48.0088  
Upper Bound 59.3245  
5% Trimmed Mean 53.6852  
Median 54.0000  
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Variance 29.067  
Std. Deviation 5.39135  
Minimum 46.00  
Maximum 61.00  
Range 15.00  
Interquartile Range 9.00  
Skewness -.116 .845 
Kurtosis -.708 1.741 
SiLn- 24hrs Mean 60.6667 2.09231 
95% Confidence 
Interval for Mean 
Lower Bound 55.2882  
Upper Bound 66.0451  
5% Trimmed Mean 60.5741  
Median 60.5000  
Variance 26.267  
Std. Deviation 5.12510  
Minimum 55.00  
Maximum 68.00  
Range 13.00  
Interquartile Range 9.25  
Skewness .315 .845 
Kurtosis -1.582 1.741 
SiFnLn- 
24hrs 
Mean 108.8333 1.85143 
95% Confidence 
Interval for Mean 
Lower Bound 104.0741  
Upper Bound 113.5926  
5% Trimmed Mean 108.7037  
Median 108.0000  
Variance 20.567  
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Std. Deviation 4.53505  
Minimum 104.00  
Maximum 116.00  
Range 12.00  
Interquartile Range 8.25  
Skewness .722 .845 
Kurtosis -.439 1.741 
Si+ 24hrs Mean .6667 .21082 
95% Confidence 
Interval for Mean 
Lower Bound .1247  
Upper Bound 1.2086  
5% Trimmed Mean .6852  
Median 1.0000  
Variance .267  
Std. Deviation .51640  
Minimum .00  
Maximum 1.00  
Range 1.00  
Interquartile Range 1.00  
Skewness -.968 .845 
Kurtosis -1.875 1.741 
SiFn+ 24hrs Mean 8.8333 .47726 
95% Confidence 
Interval for Mean 
Lower Bound 7.6065  
Upper Bound 10.0602  
5% Trimmed Mean 8.8704  
Median 9.0000  
Variance 1.367  
Std. Deviation 1.16905  
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Minimum 7.00  
Maximum 10.00  
Range 3.00  
Interquartile Range 2.25  
Skewness -.668 .845 
Kurtosis -.446 1.741 
SiLn+ 24hrs Mean 5.5000 .56273 
95% Confidence 
Interval for Mean 
Lower Bound 4.0535  
Upper Bound 6.9465  
5% Trimmed Mean 5.5000  
Median 5.5000  
Variance 1.900  
Std. Deviation 1.37840  
Minimum 4.00  
Maximum 7.00  
Range 3.00  
Interquartile Range 3.00  
Skewness .000 .845 
Kurtosis -2.299 1.741 
SiFnLn+ 
24hrs 
Mean 9.1667 .70317 
95% Confidence 
Interval for Mean 
Lower Bound 7.3591  
Upper Bound 10.9742  
5% Trimmed Mean 9.1296  
Median 9.0000  
Variance 2.967  
Std. Deviation 1.72240  
Minimum 7.00  
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Maximum 12.00  
Range 5.00  
Interquartile Range 2.75  
Skewness .678 .845 
Kurtosis .814 1.741 
 
7.36: Keratinocyte vinculin per cell area descriptives on 
different surfaces at 24 hours 
 Surface at Twenty Four Hours 
Statistic 
Std. 
Error 
Vinculin/Cell 
Area 
Pol 24hrs Mean .00536 .000564 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00391  
Upper 
Bound 
.00681  
5% Trimmed Mean .00533  
Median .00507  
Variance .000  
Std. Deviation .001382  
Minimum .004  
Maximum .007  
Range .003  
Interquartile Range .003  
Skewness .596 .845 
Kurtosis -1.192 1.741 
AdFn 24hrs Mean .03385 .000929 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.03146  
Upper 
Bound 
.03624  
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5% Trimmed Mean .03384  
Median .03398  
Variance .000  
Std. Deviation .002275  
Minimum .031  
Maximum .037  
Range .006  
Interquartile Range .004  
Skewness .020 .845 
Kurtosis -.735 1.741 
AdLn 24hrs Mean .04464 .001117 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.04177  
Upper 
Bound 
.04751  
5% Trimmed Mean .04466  
Median .04480  
Variance .000  
Std. Deviation .002736  
Minimum .041  
Maximum .048  
Range .008  
Interquartile Range .004  
Skewness -.173 .845 
Kurtosis -.453 1.741 
AdFnLn 
24hrs 
Mean .06255 .000607 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.06099  
Upper 
Bound 
.06411  
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5% Trimmed Mean .06255  
Median .06247  
Variance .000  
Std. Deviation .001486  
Minimum .061  
Maximum .064  
Range .003  
Interquartile Range .003  
Skewness .076 .845 
Kurtosis -2.773 1.741 
Si- 24hrs Mean .00682 .000606 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00526  
Upper 
Bound 
.00838  
5% Trimmed Mean .00687  
Median .00712  
Variance .000  
Std. Deviation .001484  
Minimum .005  
Maximum .008  
Range .004  
Interquartile Range .003  
Skewness -.633 .845 
Kurtosis -1.156 1.741 
SiFn- 24hrs Mean .04240 .001897 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.03752  
Upper 
Bound 
.04728  
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5% Trimmed Mean .04238  
Median .04237  
Variance .000  
Std. Deviation .004646  
Minimum .037  
Maximum .048  
Range .011  
Interquartile Range .009  
Skewness .027 .845 
Kurtosis -2.672 1.741 
SiLn- 24hrs Mean .05116 .001821 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.04648  
Upper 
Bound 
.05584  
5% Trimmed Mean .05118  
Median .05223  
Variance .000  
Std. Deviation .004460  
Minimum .046  
Maximum .056  
Range .011  
Interquartile Range .009  
Skewness -.305 .845 
Kurtosis -2.125 1.741 
SiFnLn- 
24hrs 
Mean .07431 .001393 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.07073  
Upper 
Bound 
.07790  
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5% Trimmed Mean .07425  
Median .07288  
Variance .000  
Std. Deviation .003413  
Minimum .071  
Maximum .079  
Range .009  
Interquartile Range .006  
Skewness .727 .845 
Kurtosis -1.416 1.741 
Si+ 24hrs Mean .00133 .000422 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00025  
Upper 
Bound 
.00242  
5% Trimmed Mean .00136  
Median .00193  
Variance .000  
Std. Deviation .001034  
Minimum .000  
Maximum .002  
Range .002  
Interquartile Range .002  
Skewness -.948 .845 
Kurtosis -1.874 1.741 
SiFn+ 24hrs Mean .01443 .001018 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.01181  
Upper 
Bound 
.01705  
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5% Trimmed Mean .01449  
Median .01526  
Variance .000  
Std. Deviation .002495  
Minimum .011  
Maximum .017  
Range .006  
Interquartile Range .005  
Skewness -.728 .845 
Kurtosis -1.525 1.741 
SiLn+ 24hrs Mean .00812 .001091 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00531  
Upper 
Bound 
.01092  
5% Trimmed Mean .00810  
Median .00779  
Variance .000  
Std. Deviation .002673  
Minimum .005  
Maximum .011  
Range .006  
Interquartile Range .006  
Skewness .258 .845 
Kurtosis -1.976 1.741 
SiFnLn+ 
24hrs 
Mean .01071 .000745 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00879  
Upper 
Bound 
.01262  
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5% Trimmed Mean .01070  
Median .01123  
Variance .000  
Std. Deviation .001826  
Minimum .008  
Maximum .013  
Range .005  
Interquartile Range .003  
Skewness -.152 .845 
Kurtosis -.476 1.741 
 
7.37: Keratinocyte cell area descriptives on different 
surfaces  
 Polished Surface 
Statistic 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Pol 1hr Mean 306.6867 11.75370 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
276.4728  
Upper 
Bound 
336.9005  
5% Trimmed Mean 306.3991  
Median 303.5550  
Variance 828.897  
Std. Deviation 28.79057  
Minimum 272.02  
Maximum 346.53  
Range 74.51  
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Interquartile Range 56.23  
Skewness .287 .845 
Kurtosis -1.396 1.741 
Pol 4hrs Mean 367.9600 17.44037 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
323.1281  
Upper 
Bound 
412.7919  
5% Trimmed Mean 369.0250  
Median 376.0200  
Variance 1825.000  
Std. Deviation 42.72002  
Minimum 300.98  
Maximum 415.77  
Range 114.79  
Interquartile Range 78.59  
Skewness -.692 .845 
Kurtosis -.398 1.741 
Pol 24hrs Mean 751.6933 17.33588 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
707.1300  
Upper 
Bound 
796.2566  
5% Trimmed Mean 753.4204  
Median 761.0300  
Variance 1803.197  
Std. Deviation 42.46407  
Minimum 676.83  
Maximum 795.47  
Range 118.64  
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Interquartile Range 66.29  
Skewness -1.214 .845 
Kurtosis 1.525 1.741 
AdFn 1hr Mean 524.1333 13.26125 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
490.0442  
Upper 
Bound 
558.2225  
5% Trimmed Mean 522.5770  
Median 520.1300  
Variance 1055.165  
Std. Deviation 32.48330  
Minimum 494.27  
Maximum 582.01  
Range 87.74  
Interquartile Range 48.76  
Skewness 1.260 .845 
Kurtosis 1.706 1.741 
AdFn 4hrs Mean 860.9650 18.21252 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
814.1482  
Upper 
Bound 
907.7818  
5% Trimmed Mean 861.6528  
Median 864.4200  
Variance 1990.175  
Std. Deviation 44.61137  
Minimum 804.81  
Maximum 904.74  
Range 99.93  
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Interquartile Range 85.72  
Skewness -.169 .845 
Kurtosis -2.632 1.741 
AdFn 24hrs Mean 1127.9967 12.24533 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
1096.5191  
Upper 
Bound 
1159.4743  
5% Trimmed Mean 1127.4457  
Median 1121.5300  
Variance 899.688  
Std. Deviation 29.99480  
Minimum 1097.22  
Maximum 1168.69  
Range 71.47  
Interquartile Range 59.15  
Skewness .432 .845 
Kurtosis -1.989 1.741 
AdLn 1hr Mean 462.9733 23.73728 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
401.9547  
Upper 
Bound 
523.9920  
5% Trimmed Mean 461.9231  
Median 473.3650  
Variance 3380.751  
Std. Deviation 58.14423  
Minimum 394.29  
Maximum 550.56  
Range 156.27  
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Interquartile Range 101.78  
Skewness .194 .845 
Kurtosis -.382 1.741 
AdLn 4hrs Mean 799.4717 18.87334 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
750.9562  
Upper 
Bound 
847.9871  
5% Trimmed Mean 800.1763  
Median 801.7100  
Variance 2137.217  
Std. Deviation 46.23005  
Minimum 725.02  
Maximum 861.24  
Range 136.22  
Interquartile Range 71.95  
Skewness -.489 .845 
Kurtosis .834 1.741 
AdLn 24hrs Mean 996.2900 18.16759 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
949.5887  
Upper 
Bound 
1042.9913  
5% Trimmed Mean 996.3211  
Median 1001.6900  
Variance 1980.369  
Std. Deviation 44.50133  
Minimum 937.46  
Maximum 1054.56  
Range 117.10  
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Interquartile Range 85.75  
Skewness -.162 .845 
Kurtosis -1.253 1.741 
AdFn/Ln 1hr Mean 856.0100 16.74587 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
812.9634  
Upper 
Bound 
899.0566  
5% Trimmed Mean 855.3189  
Median 846.5050  
Variance 1682.544  
Std. Deviation 41.01883  
Minimum 813.70  
Maximum 910.76  
Range 97.06  
Interquartile Range 85.67  
Skewness .512 .845 
Kurtosis -1.779 1.741 
AdFn/Ln 
4hrs 
Mean 1120.7217 26.36353 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
1052.9520  
Upper 
Bound 
1188.4913  
5% Trimmed Mean 1121.9235  
Median 1132.1400  
Variance 4170.215  
Std. Deviation 64.57720  
Minimum 1023.77  
Maximum 1196.04  
Range 172.27  
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Interquartile Range 120.87  
Skewness -.542 .845 
Kurtosis -.809 1.741 
AdFn/Ln 
24hrs 
Mean 1476.6867 16.62267 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
1433.9567  
Upper 
Bound 
1519.4166  
5% Trimmed Mean 1477.0513  
Median 1484.9250  
Variance 1657.878  
Std. Deviation 40.71705  
Minimum 1421.40  
Maximum 1525.41  
Range 104.01  
Interquartile Range 80.35  
Skewness -.401 .845 
Kurtosis -1.451 1.741 
 
7.38: Keratinocyte vinculin per cell descriptives on 
different surfaces 
 Polished Surface 
Statistic 
Std. 
Error 
Vinculin/Cell Pol 1hr Mean 1.0000 .36515 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
.0614  
Upper 
Bound 
1.9386  
5% Trimmed Mean 1.0000  
Median 1.0000  
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Variance .800  
Std. Deviation .89443  
Minimum .00  
Maximum 2.00  
Range 2.00  
Interquartile Range 2.00  
Skewness .000 .845 
Kurtosis -1.875 1.741 
Pol 4hrs Mean 1.5000 .22361 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
.9252  
Upper 
Bound 
2.0748  
5% Trimmed Mean 1.5000  
Median 1.5000  
Variance .300  
Std. Deviation .54772  
Minimum 1.00  
Maximum 2.00  
Range 1.00  
Interquartile Range 1.00  
Skewness .000 .845 
Kurtosis -3.333 1.741 
Pol 24hrs Mean 4.0000 .36515 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
3.0614  
Upper 
Bound 
4.9386  
5% Trimmed Mean 4.0000  
Median 4.0000  
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Variance .800  
Std. Deviation .89443  
Minimum 3.00  
Maximum 5.00  
Range 2.00  
Interquartile Range 2.00  
Skewness .000 .845 
Kurtosis -1.875 1.741 
AdFn 1hr Mean 6.0000 .51640 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
4.6726  
Upper 
Bound 
7.3274  
5% Trimmed Mean 5.9444  
Median 5.5000  
Variance 1.600  
Std. Deviation 1.26491  
Minimum 5.00  
Maximum 8.00  
Range 3.00  
Interquartile Range 2.25  
Skewness .889 .845 
Kurtosis -.781 1.741 
AdFn 4hrs Mean 17.1667 .74907 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
15.2411  
Upper 
Bound 
19.0922  
5% Trimmed Mean 17.1852  
Median 17.5000  
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Variance 3.367  
Std. Deviation 1.83485  
Minimum 15.00  
Maximum 19.00  
Range 4.00  
Interquartile Range 4.00  
Skewness -.362 .845 
Kurtosis -2.103 1.741 
AdFn 24hrs Mean 38.1667 1.01379 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
35.5606  
Upper 
Bound 
40.7727  
5% Trimmed Mean 38.1296  
Median 38.5000  
Variance 6.167  
Std. Deviation 2.48328  
Minimum 35.00  
Maximum 42.00  
Range 7.00  
Interquartile Range 4.00  
Skewness .305 .845 
Kurtosis -.001 1.741 
AdLn 1hr Mean 10.5000 .42817 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
9.3993  
Upper 
Bound 
11.6007  
5% Trimmed Mean 10.5000  
Median 10.5000  
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Variance 1.100  
Std. Deviation 1.04881  
Minimum 9.00  
Maximum 12.00  
Range 3.00  
Interquartile Range 1.50  
Skewness .000 .845 
Kurtosis -.248 1.741 
AdLn 4hrs Mean 24.6667 1.14504 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
21.7233  
Upper 
Bound 
27.6101  
5% Trimmed Mean 24.6852  
Median 25.0000  
Variance 7.867  
Std. Deviation 2.80476  
Minimum 21.00  
Maximum 28.00  
Range 7.00  
Interquartile Range 5.50  
Skewness -.224 .845 
Kurtosis -1.864 1.741 
AdLn 24hrs Mean 44.5000 1.54380 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
40.5315  
Upper 
Bound 
48.4685  
5% Trimmed Mean 44.3333  
Median 44.0000  
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Variance 14.300  
Std. Deviation 3.78153  
Minimum 41.00  
Maximum 51.00  
Range 10.00  
Interquartile Range 6.25  
Skewness 1.049 .845 
Kurtosis .923 1.741 
AdFn/Ln 1hr Mean 39.0000 1.46059 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
35.2454  
Upper 
Bound 
42.7546  
5% Trimmed Mean 39.0000  
Median 39.5000  
Variance 12.800  
Std. Deviation 3.57771  
Minimum 34.00  
Maximum 44.00  
Range 10.00  
Interquartile Range 6.25  
Skewness -.118 .845 
Kurtosis -.491 1.741 
AdFn/Ln 
4hrs 
Mean 52.6667 .80277 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
50.6031  
Upper 
Bound 
54.7303  
5% Trimmed Mean 52.6852  
Median 53.0000  
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Variance 3.867  
Std. Deviation 1.96638  
Minimum 50.00  
Maximum 55.00  
Range 5.00  
Interquartile Range 3.50  
Skewness -.254 .845 
Kurtosis -1.828 1.741 
AdFn/Ln 
24hrs 
Mean 92.3333 .76012 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
90.3794  
Upper 
Bound 
94.2873  
5% Trimmed Mean 92.3148  
Median 92.0000  
Variance 3.467  
Std. Deviation 1.86190  
Minimum 90.00  
Maximum 95.00  
Range 5.00  
Interquartile Range 3.50  
Skewness .392 .845 
Kurtosis -.943 1.741 
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7.39: Keratinocyte vinculin per cell area descriptives on 
different surfaces 
  Polished Surface   Statistic Std. Error 
Vinculin/Cell Area Pol 1hr Mean .00323 .001143 
95% Confidence 
Interval for Mean 
Lower Bound .00029   
Upper Bound .00617   
5% Trimmed Mean .00323   
Median .00345   
Variance .000   
Std. Deviation .002799   
Minimum .000   
Maximum .006   
Range .006   
Interquartile Range .006   
Skewness -.166 .845 
Kurtosis -1.841 1.741 
Pol 4hrs Mean .00409 .000600 
95% Confidence 
Interval for Mean 
Lower Bound .00255   
Upper Bound .00563   
5% Trimmed Mean .00408   
Median .00407   
Variance .000   
Std. Deviation .001469   
Minimum .002   
Maximum .006   
Range .003   
Interquartile Range .003   
Skewness .102 .845 
Kurtosis -2.345 1.741 
Pol 24hrs Mean .00536 .000564 
95% Confidence Lower Bound .00391   
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Interval for Mean Upper Bound .00681   
5% Trimmed Mean .00533   
Median .00507   
Variance .000   
Std. Deviation .001382   
Minimum .004   
Maximum .007   
Range .003   
Interquartile Range .003   
Skewness .596 .845 
Kurtosis -1.192 1.741 
AdFn 1hr Mean .01143 .000864 
95% Confidence 
Interval for Mean 
Lower Bound .00920   
Upper Bound .01365   
5% Trimmed Mean .01139   
Median .01093   
Variance .000   
Std. Deviation .002116   
Minimum .009   
Maximum .014   
Range .005   
Interquartile Range .004   
Skewness .426 .845 
Kurtosis -2.214 1.741 
AdFn 4hrs Mean .03464 .000768 
95% Confidence 
Interval for Mean 
Lower Bound .03266   
Upper Bound .03661   
5% Trimmed Mean .03468   
Median .03470   
Variance .000   
Std. Deviation .001881   
Minimum .032   
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Maximum .036   
Range .004   
Interquartile Range .003   
Skewness -.317 .845 
Kurtosis -1.985 1.741 
AdFn 24hrs Mean .04035 .002041 
95% Confidence 
Interval for Mean 
Lower Bound .03510   
Upper Bound .04559   
5% Trimmed Mean .04044   
Median .04112   
Variance .000   
Std. Deviation .004998   
Minimum .033   
Maximum .046   
Range .013   
Interquartile Range .009   
Skewness -.435 .845 
Kurtosis -1.476 1.741 
AdLn 1hr Mean .02280 .000790 
95% Confidence 
Interval for Mean 
Lower Bound .02077   
Upper Bound .02483   
5% Trimmed Mean .02284   
Median .02296   
Variance .000   
Std. Deviation .001935   
Minimum .020   
Maximum .025   
Range .005   
Interquartile Range .004   
Skewness -.392 .845 
Kurtosis -1.075 1.741 
AdLn 4hrs Mean .03096 .001683 
95% Confidence Lower Bound .02664   
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Interval for Mean Upper Bound .03529   
5% Trimmed Mean .03099   
Median .03180   
Variance .000   
Std. Deviation .004123   
Minimum .026   
Maximum .036   
Range .010   
Interquartile Range .008   
Skewness -.277 .845 
Kurtosis -1.888 1.741 
AdLn 24hrs Mean .04464 .001117 
95% Confidence 
Interval for Mean 
Lower Bound .04177   
Upper Bound .04751   
5% Trimmed Mean .04466   
Median .04480   
Variance .000   
Std. Deviation .002736   
Minimum .041   
Maximum .048   
Range .008   
Interquartile Range .004   
Skewness -.173 .845 
Kurtosis -.453 1.741 
AdFn/Ln 1hr Mean .04553 .001272 
95% Confidence 
Interval for Mean 
Lower Bound .04226   
Upper Bound .04880   
5% Trimmed Mean .04557   
Median .04558   
Variance .000   
Std. Deviation .003116   
Minimum .042   
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Maximum .049   
Range .007   
Interquartile Range .006   
Skewness -.108 .845 
Kurtosis -2.175 1.741 
AdFn/Ln 4hrs Mean .04713 .001397 
95% Confidence 
Interval for Mean 
Lower Bound .04354   
Upper Bound .05072   
5% Trimmed Mean .04707   
Median .04644   
Variance .000   
Std. Deviation .003421   
Minimum .043   
Maximum .053   
Range .010   
Interquartile Range .005   
Skewness .652 .845 
Kurtosis .990 1.741 
AdFn/Ln 24hrs Mean .06255 .000607 
95% Confidence 
Interval for Mean 
Lower Bound .06099   
Upper Bound .06411   
5% Trimmed Mean .06255   
Median .06247   
Variance .000   
Std. Deviation .001486   
Minimum .061   
Maximum .064   
Range .003   
Interquartile Range .003   
Skewness .076 .845 
Kurtosis -2.773 1.741 
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7.40: Keratinocyte cell area descriptives on salinized 
non-passivated surfaces 
 
Silanized, non-Passivated 
Surface Statistic Std. Error 
Cell Area (micrometres squared) Si- 1hr Mean 289.4967 10.06019 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
263.6361  
Upper 
Bound 
315.3572  
5% Trimmed Mean 289.4446 
 
Median 287.3700 
 
Variance 607.245 
 
Std. Deviation 24.64234 
 
Minimum 255.76 
 
Maximum 324.17 
 
Range 68.41 
 
Interquartile Range 40.20 
 
Skewness .086 .845 
Kurtosis -.767 1.741 
Si-4 hrs Mean 412.2250 8.86341 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
389.4409  
Upper 
Bound 
435.0091  
5% Trimmed Mean 412.6306 
 
Median 412.9400 
 
Variance 471.360 
 
Std. Deviation 21.71084 
 
Minimum 382.27 
 
Maximum 434.88 
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Range 52.61 
 
Interquartile Range 42.72 
 
Skewness -.236 .845 
Kurtosis -1.768 1.741 
Si- 24hrs Mean 812.8950 23.10229 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
753.5087  
Upper 
Bound 
872.2813  
5% Trimmed Mean 812.9128 
 
Median 821.3450 
 
Variance 3202.294 
 
Std. Deviation 56.58882 
 
Minimum 744.62 
 
Maximum 880.85 
 
Range 136.23 
 
Interquartile Range 110.67 
 
Skewness -.170 .845 
Kurtosis -2.146 1.741 
SiFn- 1hr Mean 585.8100 13.64070 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
550.7455  
Upper 
Bound 
620.8745  
5% Trimmed Mean 585.8156 
 
Median 585.9400 
 
Variance 1116.412 
 
Std. Deviation 33.41274 
 
Minimum 541.99 
 
Maximum 629.53 
 
Range 87.54 
 
Interquartile Range 64.27 
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Skewness -.007 .845 
Kurtosis -1.404 1.741 
SiFn- 4hrs Mean 998.1817 22.97408 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
939.1249  
Upper 
Bound 
1057.2384  
5% Trimmed Mean 998.1613 
 
Median 988.7300 
 
Variance 3166.850 
 
Std. Deviation 56.27477 
 
Minimum 923.42 
 
Maximum 1073.31 
 
Range 149.89 
 
Interquartile Range 106.58 
 
Skewness .209 .845 
Kurtosis -1.062 1.741 
SiFn- 24hrs Mean 1267.2500 16.66207 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
1224.4188  
Upper 
Bound 
1310.0812  
5% Trimmed Mean 1266.9122 
 
Median 1260.1900 
 
Variance 1665.747 
 
Std. Deviation 40.81356 
 
Minimum 1220.98 
 
Maximum 1319.60 
 
Range 98.62 
 
Interquartile Range 80.80 
 
Skewness .295 .845 
Kurtosis -2.067 1.741 
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SiLn- 1hr Mean 467.8117 6.97137 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
449.8912  
Upper 
Bound 
485.7321  
5% Trimmed Mean 468.1135 
 
Median 471.2200 
 
Variance 291.600 
 
Std. Deviation 17.07629 
 
Minimum 440.48 
 
Maximum 489.71 
 
Range 49.23 
 
Interquartile Range 26.66 
 
Skewness -.601 .845 
Kurtosis .398 1.741 
SiLn- 4hrs Mean 879.0783 17.08980 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
835.1476  
Upper 
Bound 
923.0091  
5% Trimmed Mean 877.8704 
 
Median 867.3750 
 
Variance 1752.367 
 
Std. Deviation 41.86129 
 
Minimum 839.83 
 
Maximum 940.07 
 
Range 100.24 
 
Interquartile Range 76.12 
 
Skewness .561 .845 
Kurtosis -1.667 1.741 
SiLn- 24hrs Mean 1186.4417 11.18697 
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95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
1157.6846  
Upper 
Bound 
1215.1987  
5% Trimmed Mean 1186.1841 
 
Median 1185.9500 
 
Variance 750.890 
 
Std. Deviation 27.40237 
 
Minimum 1152.69 
 
Maximum 1224.83 
 
Range 72.14 
 
Interquartile Range 53.26 
 
Skewness .175 .845 
Kurtosis -1.159 1.741 
SiFnLn- 1hr Mean 810.4000 23.41552 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
750.2085  
Upper 
Bound 
870.5915  
5% Trimmed Mean 810.4061 
 
Median 821.0850 
 
Variance 3289.718 
 
Std. Deviation 57.35607 
 
Minimum 743.04 
 
Maximum 877.65 
 
Range 134.61 
 
Interquartile Range 112.54 
 
Skewness -.211 .845 
Kurtosis -2.234 1.741 
SiFnLn- 4hrs Mean 1193.5683 10.11880 
95% 
Confidence 
Lower 
Bound 
1167.5571  
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Interval for 
Mean 
Upper 
Bound 
1219.5795  
5% Trimmed Mean 1192.9437 
 
Median 1195.2800 
 
Variance 614.341 
 
Std. Deviation 24.78590 
 
Minimum 1167.15 
 
Maximum 1231.23 
 
Range 64.08 
 
Interquartile Range 44.39 
 
Skewness .376 .845 
Kurtosis -.682 1.741 
SiFnLn- 
24hrs 
Mean 1464.9717 12.21750 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
1433.5656  
Upper 
Bound 
1496.3777  
5% Trimmed Mean 1464.9685 
 
Median 1467.7600 
 
Variance 895.603 
 
Std. Deviation 29.92664 
 
Minimum 1425.49 
 
Maximum 1504.51 
 
Range 79.02 
 
Interquartile Range 58.24 
 
Skewness -.121 .845 
Kurtosis -1.185 1.741 
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7.41: Keratinocyte vinculin per cell descriptives on 
salinized non-passivated surfaces 
 Silanized, non-Passivated Surface 
Statistic 
Std. 
Error 
Vinculin/Cell Si- 1hr Mean .6667 .21082 
95% Confidence 
Interval for Mean 
Lower Bound .1247  
Upper Bound 1.2086  
5% Trimmed Mean .6852  
Median 1.0000  
Variance .267  
Std. Deviation .51640  
Minimum .00  
Maximum 1.00  
Range 1.00  
Interquartile Range 1.00  
Skewness -.968 .845 
Kurtosis -1.875 1.741 
Si-4 hrs Mean 1.3333 .21082 
95% Confidence 
Interval for Mean 
Lower Bound .7914  
Upper Bound 1.8753  
5% Trimmed Mean 1.3148  
Median 1.0000  
Variance .267  
Std. Deviation .51640  
Minimum 1.00  
Maximum 2.00  
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Range 1.00  
Interquartile Range 1.00  
Skewness .968 .845 
Kurtosis -1.875 1.741 
Si- 24hrs Mean 5.5000 .42817 
95% Confidence 
Interval for Mean 
Lower Bound 4.3993  
Upper Bound 6.6007  
5% Trimmed Mean 5.5000  
Median 5.5000  
Variance 1.100  
Std. Deviation 1.04881  
Minimum 4.00  
Maximum 7.00  
Range 3.00  
Interquartile Range 1.50  
Skewness .000 .845 
Kurtosis -.248 1.741 
SiFn- 1hr Mean 7.5000 .42817 
95% Confidence 
Interval for Mean 
Lower Bound 6.3993  
Upper Bound 8.6007  
5% Trimmed Mean 7.5000  
Median 7.5000  
Variance 1.100  
Std. Deviation 1.04881  
Minimum 6.00  
Maximum 9.00  
Range 3.00  
Appendix 
 
354 
 
Interquartile Range 1.50  
Skewness .000 .845 
Kurtosis -.248 1.741 
SiFn- 4hrs Mean 25.1667 1.13774 
95% Confidence 
Interval for Mean 
Lower Bound 22.2420  
Upper Bound 28.0913  
5% Trimmed Mean 25.1296  
Median 25.5000  
Variance 7.767  
Std. Deviation 2.78687  
Minimum 22.00  
Maximum 29.00  
Range 7.00  
Interquartile Range 5.50  
Skewness -.006 .845 
Kurtosis -1.274 1.741 
SiFn- 24hrs Mean 53.6667 2.20101 
95% Confidence 
Interval for Mean 
Lower Bound 48.0088  
Upper Bound 59.3245  
5% Trimmed Mean 53.6852  
Median 54.0000  
Variance 29.067  
Std. Deviation 5.39135  
Minimum 46.00  
Maximum 61.00  
Range 15.00  
Interquartile Range 9.00  
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Skewness -.116 .845 
Kurtosis -.708 1.741 
SiLn- 1hr Mean 11.6667 .66667 
95% Confidence 
Interval for Mean 
Lower Bound 9.9529  
Upper Bound 13.3804  
5% Trimmed Mean 11.6296  
Median 11.5000  
Variance 2.667  
Std. Deviation 1.63299  
Minimum 10.00  
Maximum 14.00  
Range 4.00  
Interquartile Range 3.25  
Skewness .383 .845 
Kurtosis -1.481 1.741 
SiLn- 4hrs Mean 30.6667 1.08525 
95% Confidence 
Interval for Mean 
Lower Bound 27.8769  
Upper Bound 33.4564  
5% Trimmed Mean 30.6852  
Median 31.5000  
Variance 7.067  
Std. Deviation 2.65832  
Minimum 27.00  
Maximum 34.00  
Range 7.00  
Interquartile Range 4.75  
Skewness -.422 .845 
Kurtosis -1.188 1.741 
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SiLn- 24hrs Mean 60.6667 2.09231 
95% Confidence 
Interval for Mean 
Lower Bound 55.2882  
Upper Bound 66.0451  
5% Trimmed Mean 60.5741  
Median 60.5000  
Variance 26.267  
Std. Deviation 5.12510  
Minimum 55.00  
Maximum 68.00  
Range 13.00  
Interquartile Range 9.25  
Skewness .315 .845 
Kurtosis -1.582 1.741 
SiFnLn- 1hr Mean 40.1667 .94575 
95% Confidence 
Interval for Mean 
Lower Bound 37.7355  
Upper Bound 42.5978  
5% Trimmed Mean 40.1296  
Median 40.0000  
Variance 5.367  
Std. Deviation 2.31661  
Minimum 37.00  
Maximum 44.00  
Range 7.00  
Interquartile Range 3.25  
Skewness .568 .845 
Kurtosis 1.499 1.741 
SiFnLn- 4hrs Mean 61.5000 1.31022 
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95% Confidence 
Interval for Mean 
Lower Bound 58.1320  
Upper Bound 64.8680  
5% Trimmed Mean 61.5000  
Median 62.0000  
Variance 10.300  
Std. Deviation 3.20936  
Minimum 57.00  
Maximum 66.00  
Range 9.00  
Interquartile Range 5.25  
Skewness -.082 .845 
Kurtosis -.514 1.741 
SiFnLn- 
24hrs 
Mean 108.8333 1.85143 
95% Confidence 
Interval for Mean 
Lower Bound 104.0741  
Upper Bound 113.5926  
5% Trimmed Mean 108.7037  
Median 108.0000  
Variance 20.567  
Std. Deviation 4.53505  
Minimum 104.00  
Maximum 116.00  
Range 12.00  
Interquartile Range 8.25  
Skewness .722 .845 
Kurtosis -.439 1.741 
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7.42: Keratinocyte vinculin per cell area descriptives on 
salinized non-passivated surfaces 
 Silanized, non-Passivated Surface 
Statistic 
Std. 
Error 
Vinculin/Cell 
Area 
Si- 1hr Mean .00240 .000764 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00044  
Upper 
Bound 
.00436  
5% Trimmed Mean .00245  
Median .00343  
Variance .000  
Std. Deviation .001871  
Minimum .000  
Maximum .004  
Range .004  
Interquartile Range .004  
Skewness -.916 .845 
Kurtosis -1.877 1.741 
Si-4 hrs Mean .00243 .000053 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00230  
Upper 
Bound 
.00257  
5% Trimmed Mean .00243  
Median .00242  
Variance .000  
Std. Deviation .000129  
Minimum .002  
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Maximum .003  
Range .000  
Interquartile Range .000  
Skewness .340 .845 
Kurtosis -1.577 1.741 
Si- 24hrs Mean .00682 .000606 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.00526  
Upper 
Bound 
.00838  
5% Trimmed Mean .00687  
Median .00712  
Variance .000  
Std. Deviation .001484  
Minimum .005  
Maximum .008  
Range .004  
Interquartile Range .003  
Skewness -.633 .845 
Kurtosis -1.156 1.741 
SiFn- 1hr Mean .01281 .000687 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.01104  
Upper 
Bound 
.01457  
5% Trimmed Mean .01277  
Median .01258  
Variance .000  
Std. Deviation .001684  
Minimum .011  
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Maximum .015  
Range .004  
Interquartile Range .003  
Skewness .378 .845 
Kurtosis -1.679 1.741 
SiFn- 4hrs Mean .02531 .001362 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.02180  
Upper 
Bound 
.02881  
5% Trimmed Mean .02536  
Median .02614  
Variance .000  
Std. Deviation .003337  
Minimum .020  
Maximum .029  
Range .009  
Interquartile Range .006  
Skewness -.498 .845 
Kurtosis -1.220 1.741 
SiFn- 24hrs Mean .04240 .001897 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.03752  
Upper 
Bound 
.04728  
5% Trimmed Mean .04238  
Median .04237  
Variance .000  
Std. Deviation .004646  
Minimum .037  
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Maximum .048  
Range .011  
Interquartile Range .009  
Skewness .027 .845 
Kurtosis -2.672 1.741 
SiLn- 1hr Mean .02500 .001612 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.02085  
Upper 
Bound 
.02914  
5% Trimmed Mean .02484  
Median .02461  
Variance .000  
Std. Deviation .003948  
Minimum .021  
Maximum .032  
Range .011  
Interquartile Range .007  
Skewness 1.009 .845 
Kurtosis 1.058 1.741 
SiLn- 4hrs Mean .03490 .001152 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.03194  
Upper 
Bound 
.03786  
5% Trimmed Mean .03491  
Median .03534  
Variance .000  
Std. Deviation .002821  
Minimum .032  
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Maximum .038  
Range .007  
Interquartile Range .006  
Skewness -.217 .845 
Kurtosis -2.320 1.741 
SiLn- 24hrs Mean .05116 .001821 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.04648  
Upper 
Bound 
.05584  
5% Trimmed Mean .05118  
Median .05223  
Variance .000  
Std. Deviation .004460  
Minimum .046  
Maximum .056  
Range .011  
Interquartile Range .009  
Skewness -.305 .845 
Kurtosis -2.125 1.741 
SiFnLn- 1hr Mean .04970 .001376 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.04616  
Upper 
Bound 
.05323  
5% Trimmed Mean .04971  
Median .05001  
Variance .000  
Std. Deviation .003369  
Minimum .046  
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Maximum .054  
Range .008  
Interquartile Range .006  
Skewness -.122 .845 
Kurtosis -2.488 1.741 
SiFnLn- 4hrs Mean .05154 .001095 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.04872  
Upper 
Bound 
.05435  
5% Trimmed Mean .05160  
Median .05215  
Variance .000  
Std. Deviation .002682  
Minimum .048  
Maximum .054  
Range .006  
Interquartile Range .005  
Skewness -.370 .845 
Kurtosis -2.346 1.741 
SiFnLn- 
24hrs 
Mean .07431 .001393 
95% Confidence 
Interval for Mean 
Lower 
Bound 
.07073  
Upper 
Bound 
.07790  
5% Trimmed Mean .07425  
Median .07288  
Variance .000  
Std. Deviation .003413  
Minimum .071  
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Maximum .079  
Range .009  
Interquartile Range .006  
Skewness .727 .845 
Kurtosis -1.416 1.741 
 
7.43: Keratinocyte cell area descriptives on salinized 
passivated surfaces 
  
Silanized, 
Passivated 
Surface   Statistic 
Std. 
Error 
Cell Area 
(micrometres 
squared) 
Si+ 1hr Mean 306.6867 11.75370 
95% Confidence 
Interval for Mean 
Lower Bound 276.4728   
Upper Bound 336.9005   
5% Trimmed Mean 306.3991   
Median 303.5550   
Variance 828.897   
Std. Deviation 28.79057   
Minimum 272.02   
Maximum 346.53   
Range 74.51   
Interquartile Range 56.23   
Skewness .287 .845 
Kurtosis -1.396 1.741 
Si+ 4hrs Mean 367.9600 17.44037 
95% Confidence 
Interval for Mean 
Lower Bound 323.1281   
Upper Bound 412.7919   
5% Trimmed Mean 369.0250   
Median 376.0200   
Variance 1825.000   
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Std. Deviation 42.72002   
Minimum 300.98   
Maximum 415.77   
Range 114.79   
Interquartile Range 78.60   
Skewness -.692 .845 
Kurtosis -.398 1.741 
Si+ 24hrs Mean 751.6933 17.33588 
95% Confidence 
Interval for Mean 
Lower Bound 707.1300   
Upper Bound 796.2566   
5% Trimmed Mean 753.4204   
Median 761.0300   
Variance 1803.197   
Std. Deviation 42.46407   
Minimum 676.83   
Maximum 795.47   
Range 118.64   
Interquartile Range 66.29   
Skewness -1.214 .845 
Kurtosis 1.525 1.741 
SiFn+ 1hr Mean 524.1333 13.26125 
95% Confidence 
Interval for Mean 
Lower Bound 490.0442   
Upper Bound 558.2225   
5% Trimmed Mean 522.5770   
Median 520.1300   
Variance 1055.165   
Std. Deviation 32.48330   
Minimum 494.27   
Maximum 582.01   
Range 87.74   
Interquartile Range 48.76   
Skewness 1.260 .845 
Kurtosis 1.706 1.741 
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SiFn+ 4hrs Mean 860.9650 18.21252 
95% Confidence 
Interval for Mean 
Lower Bound 814.1482   
Upper Bound 907.7818   
5% Trimmed Mean 861.6528   
Median 864.4200   
Variance 1990.175   
Std. Deviation 44.61137   
Minimum 804.81   
Maximum 904.74   
Range 99.93   
Interquartile Range 85.72   
Skewness -.169 .845 
Kurtosis -2.632 1.741 
SiFn+ 24hrs Mean 1161.3300 32.54592 
95% Confidence 
Interval for Mean 
Lower Bound 1077.6680   
Upper Bound 1244.9920   
5% Trimmed Mean 1158.9272   
Median 1121.5300   
Variance 6355.421   
Std. Deviation 79.72090   
Minimum 1097.22   
Maximum 1268.69   
Range 171.47   
Interquartile Range 159.16   
Skewness .877 .845 
Kurtosis -1.850 1.741 
SiLn+ 1hr Mean 462.9733 23.73728 
95% Confidence 
Interval for Mean 
Lower Bound 401.9547   
Upper Bound 523.9920   
5% Trimmed Mean 461.9231   
Median 473.3650   
Variance 3380.751   
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Std. Deviation 58.14423   
Minimum 394.29   
Maximum 550.56   
Range 156.27   
Interquartile Range 101.78   
Skewness .194 .845 
Kurtosis -.382 1.741 
SiLn+ 4hrs Mean 799.4717 18.87334 
95% Confidence 
Interval for Mean 
Lower Bound 750.9562   
Upper Bound 847.9871   
5% Trimmed Mean 800.1763   
Median 801.7100   
Variance 2137.217   
Std. Deviation 46.23005   
Minimum 725.02   
Maximum 861.24   
Range 136.22   
Interquartile Range 71.95   
Skewness -.489 .845 
Kurtosis .834 1.741 
SiLn+ 24hrs Mean 996.2900 18.16759 
95% Confidence 
Interval for Mean 
Lower Bound 949.5887   
Upper Bound 1042.9913   
5% Trimmed Mean 996.3211   
Median 1001.6900   
Variance 1980.369   
Std. Deviation 44.50133   
Minimum 937.46   
Maximum 1054.56   
Range 117.10   
Interquartile Range 85.75   
Skewness -.162 .845 
Kurtosis -1.253 1.741 
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SiFnLn+ 1hr Mean 856.0100 16.74587 
95% Confidence 
Interval for Mean 
Lower Bound 812.9634   
Upper Bound 899.0566   
5% Trimmed Mean 855.3189   
Median 846.5050   
Variance 1682.544   
Std. Deviation 41.01883   
Minimum 813.70   
Maximum 910.76   
Range 97.06   
Interquartile Range 85.67   
Skewness .512 .845 
Kurtosis -1.779 1.741 
SiFnLn+ 4hrs Mean 1120.7217 26.36353 
95% Confidence 
Interval for Mean 
Lower Bound 1052.9520   
Upper Bound 1188.4913   
5% Trimmed Mean 1121.9235   
Median 1132.1400   
Variance 4170.215   
Std. Deviation 64.57720   
Minimum 1023.77   
Maximum 1196.04   
Range 172.27   
Interquartile Range 120.87   
Skewness -.542 .845 
Kurtosis -.809 1.741 
SiFnLn+ 24hrs Mean 1476.6867 16.62267 
95% Confidence 
Interval for Mean 
Lower Bound 1433.9567   
Upper Bound 1519.4166   
5% Trimmed Mean 1477.0513   
Median 1484.9250   
Variance 1657.878   
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Std. Deviation 40.71705   
Minimum 1421.40   
Maximum 1525.41   
Range 104.01   
Interquartile Range 80.35   
Skewness -.401 .845 
Kurtosis -1.451 1.741 
 
7.44: Keratinocyte vinculin per cell descriptives on 
salinized passivated surfaces 
  
Silanized, 
Passivated Surface   Statistic Std. Error 
Vinculin/Cell Si+ 1hr Mean 1.0000 .36515 
95% Confidence 
Interval for Mean 
Lower Bound .0614   
Upper Bound 1.9386   
5% Trimmed Mean 1.0000   
Median 1.0000   
Variance .800   
Std. Deviation .89443   
Minimum .00   
Maximum 2.00   
Range 2.00   
Interquartile Range 2.00   
Skewness .000 .845 
Kurtosis -1.875 1.741 
Si+ 4hrs Mean 1.5000 .22361 
95% Confidence 
Interval for Mean 
Lower Bound .9252   
Upper Bound 2.0748   
5% Trimmed Mean 1.5000   
Median 1.5000   
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Variance .300   
Std. Deviation .54772   
Minimum 1.00   
Maximum 2.00   
Range 1.00   
Interquartile Range 1.00   
Skewness .000 .845 
Kurtosis -3.333 1.741 
Si+ 24hrs Mean 4.0000 .36515 
95% Confidence 
Interval for Mean 
Lower Bound 3.0614   
Upper Bound 4.9386   
5% Trimmed Mean 4.0000   
Median 4.0000   
Variance .800   
Std. Deviation .89443   
Minimum 3.00   
Maximum 5.00   
Range 2.00   
Interquartile Range 2.00   
Skewness .000 .845 
Kurtosis -1.875 1.741 
SiFn+ 1hr Mean 6.0000 .51640 
95% Confidence 
Interval for Mean 
Lower Bound 4.6726   
Upper Bound 7.3274   
5% Trimmed Mean 5.9444   
Median 5.5000   
Variance 1.600   
Std. Deviation 1.26491   
Minimum 5.00   
Maximum 8.00   
Range 3.00   
Interquartile Range 2.25   
Skewness .889 .845 
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Kurtosis -.781 1.741 
SiFn+ 4hrs Mean 31.3333 1.62617 
95% Confidence 
Interval for Mean 
Lower Bound 27.1531   
Upper Bound 35.5135   
5% Trimmed Mean 31.2037   
Median 31.0000   
Variance 15.867   
Std. Deviation 3.98330   
Minimum 27.00   
Maximum 38.00   
Range 11.00   
Interquartile Range 6.50   
Skewness .857 .845 
Kurtosis .597 1.741 
SiFn+ 24hrs Mean 46.6667 1.89150 
95% Confidence 
Interval for Mean 
Lower Bound 41.8044   
Upper Bound 51.5289   
5% Trimmed Mean 46.7407   
Median 48.5000   
Variance 21.467   
Std. Deviation 4.63321   
Minimum 40.00   
Maximum 52.00   
Range 12.00   
Interquartile Range 8.25   
Skewness -.659 .845 
Kurtosis -1.205 1.741 
SiLn+ 1hr Mean 10.5000 .42817 
95% Confidence 
Interval for Mean 
Lower Bound 9.3993   
Upper Bound 11.6007   
5% Trimmed Mean 10.5000   
Median 10.5000   
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Variance 1.100   
Std. Deviation 1.04881   
Minimum 9.00   
Maximum 12.00   
Range 3.00   
Interquartile Range 1.50   
Skewness .000 .845 
Kurtosis -.248 1.741 
SiLn+ 4hrs Mean 24.6667 1.14504 
95% Confidence 
Interval for Mean 
Lower Bound 21.7233   
Upper Bound 27.6101   
5% Trimmed Mean 24.6852   
Median 25.0000   
Variance 7.867   
Std. Deviation 2.80476   
Minimum 21.00   
Maximum 28.00   
Range 7.00   
Interquartile Range 5.50   
Skewness -.224 .845 
Kurtosis -1.864 1.741 
SiLn+ 24hrs Mean 44.5000 1.54380 
95% Confidence 
Interval for Mean 
Lower Bound 40.5315   
Upper Bound 48.4685   
5% Trimmed Mean 44.3333   
Median 44.0000   
Variance 14.300   
Std. Deviation 3.78153   
Minimum 41.00   
Maximum 51.00   
Range 10.00   
Interquartile Range 6.25   
Skewness 1.049 .845 
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Kurtosis .923 1.741 
SiFnLn+ 1hr Mean 39.0000 1.46059 
95% Confidence 
Interval for Mean 
Lower Bound 35.2454   
Upper Bound 42.7546   
5% Trimmed Mean 39.0000   
Median 39.5000   
Variance 12.800   
Std. Deviation 3.57771   
Minimum 34.00   
Maximum 44.00   
Range 10.00   
Interquartile Range 6.25   
Skewness -.118 .845 
Kurtosis -.491 1.741 
SiFnLn+ 4hrs Mean 52.6667 .80277 
95% Confidence 
Interval for Mean 
Lower Bound 50.6031   
Upper Bound 54.7303   
5% Trimmed Mean 52.6852   
Median 53.0000   
Variance 3.867   
Std. Deviation 1.96638   
Minimum 50.00   
Maximum 55.00   
Range 5.00   
Interquartile Range 3.50   
Skewness -.254 .845 
Kurtosis -1.828 1.741 
SiFnLn+ 24hrs Mean 92.3333 .76012 
95% Confidence 
Interval for Mean 
Lower Bound 90.3794   
Upper Bound 94.2873   
5% Trimmed Mean 92.3148   
Median 92.0000   
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Variance 3.467   
Std. Deviation 1.86190   
Minimum 90.00   
Maximum 95.00   
Range 5.00   
Interquartile Range 3.50   
Skewness .392 .845 
Kurtosis -.943 1.741 
 
7.45: Keratinocyte vinculin per cell area descriptives on 
salinized passivated surfaces 
  
Silanized, 
Passivated 
Surface   Statistic Std. Error 
Vinculin/Cell 
Area 
Si+ 1hr Mean .00174 .000622 
95% Confidence 
Interval for Mean 
Lower Bound .00015   
Upper Bound .00334   
5% Trimmed Mean .00172   
Median .00206   
Variance .000   
Std. Deviation .001523   
Minimum .000   
Maximum .004   
Range .004   
Interquartile Range .003   
Skewness .039 .845 
Kurtosis -.733 1.741 
Si+ 4hrs Mean .00381 .000913 
95% Confidence 
Interval for Mean 
Lower Bound .00146   
Upper Bound .00616   
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5% Trimmed Mean .00367   
Median .00259   
Variance .000   
Std. Deviation .002236   
Minimum .002   
Maximum .008   
Range .005   
Interquartile Range .003   
Skewness 1.495 .845 
Kurtosis 1.252 1.741 
Si+ 24hrs Mean .00133 .000422 
95% Confidence 
Interval for Mean 
Lower Bound .00025   
Upper Bound .00242   
5% Trimmed Mean .00136   
Median .00193   
Variance .000   
Std. Deviation .001034   
Minimum .000   
Maximum .002   
Range .002   
Interquartile Range .002   
Skewness -.948 .845 
Kurtosis -1.874 1.741 
SiFn+ 1hr Mean .00276 .000342 
95% Confidence 
Interval for Mean 
Lower Bound .00189   
Upper Bound .00364   
5% Trimmed Mean .00276   
Median .00274   
Variance .000   
Std. Deviation .000837   
Minimum .002   
Maximum .004   
Range .002   
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Interquartile Range .002   
Skewness .019 .845 
Kurtosis -3.243 1.741 
SiFn+ 4hrs Mean .00741 .000441 
95% Confidence 
Interval for Mean 
Lower Bound .00628   
Upper Bound .00855   
5% Trimmed Mean .00741   
Median .00747   
Variance .000   
Std. Deviation .001081   
Minimum .006   
Maximum .009   
Range .002   
Interquartile Range .002   
Skewness .016 .845 
Kurtosis -2.744 1.741 
SiFn+ 24hrs Mean .01443 .001018 
95% Confidence 
Interval for Mean 
Lower Bound .01181   
Upper Bound .01705   
5% Trimmed Mean .01449   
Median .01526   
Variance .000   
Std. Deviation .002495   
Minimum .011   
Maximum .017   
Range .006   
Interquartile Range .005   
Skewness -.728 .845 
Kurtosis -1.525 1.741 
SiLn+ 1hr Mean .00185 .000684 
95% Confidence 
Interval for Mean 
Lower Bound .00009   
Upper Bound .00361   
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5% Trimmed Mean .00181   
Median .00210   
Variance .000   
Std. Deviation .001675   
Minimum .000   
Maximum .004   
Range .004   
Interquartile Range .003   
Skewness .310 .845 
Kurtosis -.220 1.741 
SiLn+ 4hrs Mean .00267 .000599 
95% Confidence 
Interval for Mean 
Lower Bound .00113   
Upper Bound .00421   
5% Trimmed Mean .00276   
Median .00334   
Variance .000   
Std. Deviation .001466   
Minimum .000   
Maximum .004   
Range .004   
Interquartile Range .002   
Skewness -1.580 .845 
Kurtosis 1.939 1.741 
SiLn+ 24hrs Mean .00812 .001091 
95% Confidence 
Interval for Mean 
Lower Bound .00531   
Upper Bound .01092   
5% Trimmed Mean .00810   
Median .00779   
Variance .000   
Std. Deviation .002673   
Minimum .005   
Maximum .011   
Range .006   
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Interquartile Range .006   
Skewness .258 .845 
Kurtosis -1.976 1.741 
SiFnLn+ 1hr Mean .00628 .000517 
95% Confidence 
Interval for Mean 
Lower Bound .00495   
Upper Bound .00761   
5% Trimmed Mean .00622   
Median .00605   
Variance .000   
Std. Deviation .001266   
Minimum .005   
Maximum .008   
Range .003   
Interquartile Range .002   
Skewness 1.162 .845 
Kurtosis 1.234 1.741 
SiFnLn+ 4hrs Mean .00841 .001221 
95% Confidence 
Interval for Mean 
Lower Bound .00527   
Upper Bound .01155   
5% Trimmed Mean .00841   
Median .00816   
Variance .000   
Std. Deviation .002992   
Minimum .004   
Maximum .012   
Range .008   
Interquartile Range .005   
Skewness .082 .845 
Kurtosis -.980 1.741 
SiFnLn+ 24hrs Mean .01071 .000745 
95% Confidence 
Interval for Mean 
Lower Bound .00879   
Upper Bound .01262   
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5% Trimmed Mean .01070   
Median .01123   
Variance .000   
Std. Deviation .001826   
Minimum .008   
Maximum .013   
Range .005   
Interquartile Range .003   
Skewness -.152 .845 
Kurtosis -.476 1.741 
 
 
7.46: p values for keratinocyte bioassay-cell area  
1 hour 
 
Pol 
1hr 
AdFn 
1hr 
AdLn 
1hr 
AdFnL
n 1hr 
Si- 
1hr 
SiFn- 
1hr 
SiLn- 
1hr 
SiFnLn
- 1hr 
Si+ 
1hr 
SiFn+ 
1hr 
SiLn+ 
1hr 
SiFnLn
+ 1hr 
Pol 1hr - 0.004 0.004 0.004 
0.3
37 
0.004 0.004 0.004 
0.00
4 
0.004 0.004 0.004 
AdFn 
1hr 
- - 0.037 0.004 
0.0
04 
0.016 0.423 0.004 
0.00
4 
0.001 0.004 0.01 
AdLn 
1hr 
- - - 0.004 
.00
4 
0.004 0.001 0.004 
0.00
4 
0.109 0.873 0.055 
AdFnL
n 1hr 
- - - - 
0.0
04 
0.004 0.004 0.2 
0.00
4 
0.004 0.004 0.004 
Si- 1hr - - - - - 0.004 0.004 0.004 
0.00
4 
0.004 0.004 0.0 
SiFn- 
1hr 
- - - - - - 0.004 0.004 4 0.055 0.004 0.004 
SiLn- 
1hr 
- - - - - - - 0.004 
0.00
4 
0.004 0.522 0.423 
SiFnLn
- 1hr 
- - - - - - - - 
0.00
4 
0.004 0.004 0.004 
Si+ 1hr - - - - - - - - - 0.004 0.025 0.004 
SiFn+ 
1hr 
- - - - - - - - - - 0.055 0.037 
SiLn+ 
1hr 
- - - - - - - - - - - 0.006 
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7.47: p values for keratinocyte bioassay-vinculin per 
cell 1 hour 
  
Pol 
1hr 
AdFn 
1hr 
AdLn 
1hr 
AdFnL
n 1hr 
Si- 
1hr 
SiFn- 
1hr 
SiLn- 
1hr 
SiFnLn
- 1hr 
Si+ 
1hr 
SiFn+ 
1hr 
SiLn+ 
1hr 
SiFnLn
+ 1hr 
Pol 1hr  - 0.004 0.004 0.004 
0.4
84 0.004 0.004 0.004 
0.73
3 0.299 0.733 0.003 
AdFn 
1hr  -  - 0.004 0.004 
0.0
04 0.059 0.936 0.004 
0.00
3 0.003 0.004 0.004 
AdLn 
1hr  -  -  - 0.004 
0.0
04 0.004 0.217 0.004 
0.00
3 0.004 0.004 0.004 
AdFnL
n 1hr  -  -  - -  
0.0
04 0.006 0.004 0.57 
0.00
3 0.004 0.004 0.004 
Si- 1hr  -  -  -  -  - 0.003 0.003 0.003 
0.71
5 0.004 0.014 0.004 
SiFn- 
1hr  -  -  -  -  -  - 0.004 0.004 
0.00
3 0.003 0.004 0.004 
SiLn- 
1hr  -  -  -  -  -  -  - 0.004 
0.00
3 0.004 0.004 0.004 
SiFnLn
- 1hr  -  -  -  -  -  -  -  - 
0.00
3 0.004 0.004 0.004 
Si+ 1hr  -  -  -  -  -  -  -  -  - 0.116 0.001 0.003 
SiFn+ 
1hr  -  -  -  -  -  -  -  -  -  - 0.116 0.003 
SiLn+ 
1hr  -  - -   - -   - -   - -   - -  0.003 
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7.48: p values for keratinocyte bioassay-vinculin per 
cell area 1 hour 
  
Pol 
1hr 
AdFn 
1hr 
AdLn 
1hr 
AdFnL
n 1hr 
Si- 
1hr 
SiFn- 
1hr 
SiLn- 
1hr 
SiFnLn
- 1hr 
Si+ 
1hr 
SiFn+ 
1hr 
SiLn+ 
1hr 
SiFnLn
+ 1hr 
Pol 1hr  - 0.004 0.004 0.004 
0.7
44 0.004 0.004 0.004 
0.32
8 0.748 0.328 0.054 
AdFn 
1hr  -  - 0.004 0.004 
0.0
04 0.2 0.337 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
1hr  -  -  - 0.004 
0.0
04 0.004 0.262 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 1hr  -  -  -  - 
0.0
04 0.2 0.0 0.109 
0.00
4 0.004 0.004 0.004 
Si- 1hr  -  -  -  -  - 0.004 0.004 0.004 
0.51
4 0.2 0.522 0.004 
SiFn- 
1hr  -  -  -  -  -  - 0.004 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
1hr  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnLn
- 1hr  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 1hr  -  -  -  -  -  -  -  - -  0.423 0.744 0.004 
SiFn+ 
1hr  -  -  -  -  -  -  -  -  -  - 0.423 0.004 
SiLn+ 
1hr  - -   - -   - -   - -   - -   - 0.004 
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7.49: p values for keratinocyte bioassay-vinculin per 
cell area 4 hours 
  
Pol 
4hrs 
AdFn 
4hrs 
AdLn 
4hrs 
AdFnL
n 4hrs 
Si- 
4hr
s 
SiFn- 
4hrs 
SiLn- 
4hrs 
SiFnLn
- 4hrs 
Si+ 
4hrs 
SiFn+ 
4hrs 
SiLn+ 
4hrs 
SiFnLn
+ 4hrs 
Pol 
4hrs  - 0.004 0.004 0.004 
0.03
7 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
AdFn 
4hrs  -  - 0.037 0.004 
0.00
4 0.004 0.078 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
4hrs  -  -  - 0.004 
0.00
4 0.004 0.016 0.004 
0.00
4 0.109 0.004 0.337 
AdFnL
n 4hrs  -  -  -  - 
0.00
4 0.004 0.004 0.037 
0.00
4 0.004 0.004 0.004 
Si- 
4hrs  -  -  -  -  - 0.004 0.004 0.004 
0.01
6 0.004 0.004 0.004 
SiFn- 
4hrs  -  -  -  -  -  - 0.006 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
4hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnLn
- 4hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
4hrs  -  -  -  -  -  -  -  -  - 0.004 0.004 0.004 
SiFn+ 
4hrs  -  -  -  -  -  -  -  -  -  - 0.055   0.01 
SiLn+ 
4hrs  - -   - -   - -   - -   - -   - 0.004 
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7.50: p values for keratinocyte bioassay-vinculin  
4 hours 
  
Pol 
4hrs 
AdFn 
4hrs 
AdLn 
4hrs 
AdFnL
n 4hrs 
Si- 
4hr
s 
SiFn- 
4hrs 
SiLn- 
4hrs 
SiFnLn
- 4hrs 
Si+ 
4hrs 
SiFn+ 
4hrs 
SiLn+ 
4hrs 
SiFnLn
+ 4hrs 
Pol 
4hrs  - 
 
0.003 0.003 0.003 
0.57
5 0.003 0.003 0.003 
0.78
4 0.003 0.784 0.003 
AdFn 
4hrs  -  - 0.004 0.004 
0.00
4 0.004 0.004 0.004 
0.00
4 0.003 0.004 0.004 
AdLn 
4hrs  -  -  - 0.004 
0.00
4 0.004 0.01 0.004 
0.00
4 0.004 0.003 0.004 
AdFnL
n 4hrs  -  -  -  - 
0.00
4 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
Si- 
4hrs  -  -  -  -  - 0.003 0.003 0.003 
0.84
7 0.004 0.004 0.004 
SiFn- 
4hrs  -  -  -  -  -  - 0.013 0.004 
0.00
4 0.003 0.004 0.004 
SiLn- 
4hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.003 0.004 
SiFnLn
- 4hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
4hrs  -  -  -  -  -  -  -  -  - 0.003 0.73 0.004 
SiFn+ 
4hrs  -  -  -  -  -  -  -  -  -  - 0.003 0.319 
SiLn+ 
4hrs  - -   - -   - -   - -   - -   - 0.003 
7.51: p values for keratinocyte bioassayvinculin per cell 
area 4 hours 
  
Pol 
4hrs 
AdFn 
4hrs 
AdLn 
4hrs 
AdFnL
n 4hrs 
Si- 
4hr
s 
SiFn- 
4hrs 
SiLn- 
4hrs 
SiFnLn
- 4hrs 
Si+ 
4hrs 
SiFn+ 
4hrs 
SiLn+ 
4hrs 
SiFnLn
+ 4hrs 
Pol 
4hrs  - 0.004 0.004 0.004 0.01 0.004 0.004 0.004 
0.33
7 0.004 0.262 0.016 
AdFn 
4hrs  -  - 0.004 0.004 
0.00
4 0.025 0.078 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
4hrs  -  -  - 0.004 
0.00
4 0.004 0.078 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 4hrs  -  -  -  - 
0.00
4 0.004 0.004 0.025 
0.00
4 0.004 0.004 0.004 
Si- 
4hrs  -  -  -  -  - 0.004 0.004 0.004 0.2 0.749 0.337 0.004 
SiFn- 
4hrs  -  -  -  -  -  - 0.004 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
4hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnLn
- 4hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
4hrs  -  -  -  -  -  -  -  -  - 0.016 0.749 0.025 
SiFn+ 
4hrs  -  -  -  -  -  -  - -   -  - 0.004 0.423 
SiLn+ 
4hrs  - -   - -   - -   -  -  -  - -  0.004 
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7.52: p values for keratinocyte bioassay-cell area  
24 hours 
  
Pol 
24hr
s 
AdFn 
24hrs 
AdLn 
24hrs 
AdFnL
n 
24hrs 
Si- 
24hr
s 
SiFn- 
24hrs 
SiLn- 
24hrs 
SiFnL
n- 
24hrs 
Si+ 
24hr
s 
SiFn+ 
24hrs 
SiLn+ 
24hrs 
SiFnLn
+ 
24hrs 
Pol 
24hrs  - 0.004 0.004 0.004 
0.10
9 0.004 0.004 0.004 
0.00
4 0.006 0.078 0.004 
AdFn 
24hrs  -  - 0.004 0.004 
0.00
4 0.004 0.15 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
24hrs  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 
24hrs  -  -  -  - 
0.00
4 0.004 0.004 0.522 
0.00
4 0.004 0.004 0.004 
Si- 
24hrs  -  -  -  -  - 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
SiFn- 
24hrs  -  -  -  -  -  - 0.006 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
24hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnL
n- 
24hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
24hrs  -  -  -  -  -  -  -  -  - 0.004 0.004 0.004 
SiFn+ 
24hrs  -  -  -  -  -  -  - -   -  - 0.025 0.004 
SiLn+ 
24hrs  - -   - -   - -   -  -  - -   - 0.004 
 
7.53: p values for keratinocyte bioassay-vinculin  
24 hours 
  
Pol 
24hr
s 
AdFn 
24hrs 
AdLn 
24hrs 
AdFnL
n 
24hrs 
Si- 
24hr
s 
SiFn- 
24hrs 
SiLn- 
24hrs 
SiFnL
n- 
24hrs 
Si+ 
24hr
s 
SiFn+ 
24hrs 
SiLn+ 
24hrs 
SiFnLn
+ 
24hrs 
Pol 
24hrs  - 0.004 0.004 0.004 
0.03
2 0.004 0.004 0.004 
0.00
3 0.004 0.07 0.004 
AdFn 
24hrs  -  - 0.01 0.004 
0.00
4 0.004 0.055 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
24hrs  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 
24hrs  -  -  -  - 
0.00
4 0.006 0.004 0.004 
0.00
4 0.004 0.004 0.004 
Si- 
24hrs  -  -  -  -  - 0.004 0.004 0.004 
0.00
3 0.871 0.053 0.009 
SiFn- 
24hrs  -  -  -  -  -  - 0.065 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
24hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnL
n- 
24hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
24hrs  -  -  -  -  -  -  -  -  - 0.003 0.003 0.003 
SiFn+ 
24hrs  -  -  -  -  -  -  -  -  -  - 0.006 0.869 
SiLn+ 
24hrs  - -   - -   - -   - -   - -   - 0.006 
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7.54: p values for keratinocyte bioassay-vinculin per 
cell area 24 hours 
  
Pol 
24hr
s 
AdFn 
24hrs 
AdLn 
24hrs 
AdFnL
n 
24hrs 
Si- 
24hr
s 
SiFn- 
24hrs 
SiLn- 
24hrs 
SiFnL
n- 
24hrs 
Si+ 
24hr
s 
SiFn+ 
24hrs 
SiLn+ 
24hrs 
SiFnLn
+ 
24hrs 
Pol 
24hrs  - 0.004 0.004 0.004 
0.10
9 0.004 0.004 0.004 
0.00
4 0.004 0.037 0.004 
AdFn 
24hrs  -  - 0.004 0.004 
0.00
4 0.004 0.15 0.004 
0.00
4 0.004 0.004 0.004 
AdLn 
24hrs  -  -  - 0.004 
0.00
4 0.004 0.037 0.004 
0.00
4 0.004 0.004 0.004 
AdFnL
n 
24hrs  -  -  -  - 
0.00
4 0.423 0.004 0.004 
0.00
4 0.004 0.004 0.004 
Si- 
24hrs  -  -  -  -  - 0.004 0.004 0.004 
0.00
4 0.337 0.004 0.109 
SiFn- 
24hrs  -  -  -  -  -  - 0.025 0.004 
0.00
4 0.004 0.004 0.004 
SiLn- 
24hrs  -  -  -  -  -  -  - 0.004 
0.00
4 0.004 0.004 0.004 
SiFnL
n- 
24hrs  -  -  -  -  -  -  -  - 
0.00
4 0.004 0.004 0.004 
Si+ 
24hrs  -  -  -  -  -  -  -  -  - 0.004 0.004 0.004 
SiFn+ 
24hrs  -  -  - -   -  -  -  -  -  - 0.01 0.037 
SiLn+ 
24hrs  - -   -  -  - -   - -   - -   - 0.109 
 
 
 
 
 
 
 
 
 
 
